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ABSTRACT
Prenatal cadmium exposure dysregulates sonic hedgehog and Wnt/β-catenin
signaling in the thymus resulting in immunomodulatory effects
Miranda Leah Hanson

Cadmium (Cd) is both an environmental pollutant as well as a component of
cigarette smoke. Recent data suggests increased cancer risks and increased mortality
in environmentally exposed populations. Although evidence demonstrates that adult
exposure to Cd causes changes in the immune system, there are limited reports in the
literature of immunomodulatory effects of prenatal exposure to Cd.
The sonic
hedgehog (Shh) and Wnt/β−catenin pathways are required for thymocyte maturation.
Several studies have demonstrated that Cd exposure affects these pathways in different
organ systems. Our experiments were designed to investigate the effect of prenatal Cd
exposure on thymocyte development, and to determine if these effects were linked to
dysregulation of Shh and Wnt/β-catenin pathways. In addition, longer term effects of
prenatal Cd on the immune system were investigated. Pregnant C57Bl/6 mice were
exposed to an environmentally relevant dose (10 ppm) of Cd during pregnancy and
effects on the thymus of the offspring were assessed on post-natal day 0 (PND0), while
effects on the thymus and spleen were assessed on PND14 and 49. On PND0,
thymocyte phenotype was determined by flow cytometry. A Gli:luciferase reporter cell
line was used to measure Shh signaling. Transcription of target genes and translation
of key components of both signaling pathways was assessed using real-time RT-PCR
and western blot, respectively. On PND14 and 49, thymocyte and splenocyte
phenotypes were analyzed, and cytokine production of splenic T cells was determined
by ELISA. On PND0, prenatal Cd exposure increased the number of CD4+ cells and a
subpopulation of double-negative cells (DN; CD4-CD8-). Shh and Wnt/β-catenin
signaling were both decreased in the thymus; however, this was not due to altered Shh
and Wnt protein levels. Target genes of Shh and Wnt/β-catenin were affected
differentially among thymocyte subpopulations. On PND14 and 49, prenatal Cd
exposure increased the number of DN thymocytes. In the spleen, prenatal Cd exposure
had a cell type-, sex-specific effect on splenocyte phenotype and cytokine production.
Collectively, these findings suggest that even very low exposure to Cd during gestation
dysregulates two signaling pathways in the thymus resulting in altered thymocyte
development, and this dysregulation can result in long term detrimental effects on the
immune system of the offspring.
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CHAPTER 1: Literature Review I

1

Development of the Immune System

Thymus
The immune system originates from bone-marrow-resident hematopoietic stem
cells (HSCs) that give rise to progenitor populations with increasingly restricted lineage
potential, ultimately leading to production of all lineages of mature blood cells. The
majority of hematopoietic lineages mature in the marrow, while the thymus is the
primary lymphoid organ for T cell generation (Miller and Osoba, 1967). The thymus is
the site of marrow-derived progenitors and is responsible for maintaining multistage
lineage commitment and differentiation steps to produce mature, self-tolerant, functional
T cells. Even though the thymus is a vital part of the hematopoietic system, the thymus
does not contain self-renewing stem cells. In adults, the thymus is constantly being
seeded from the bone marrow by small numbers of progenitor cells, which reach the
thymus via the blood stream (Wallis et al., 1975) and enter the cortex-medulla boundary
(Ceredig and Schreyer, 1984; Lind et al., 2001). The thymus is divided into an outer
cortex, where most differentiation takes place, and an inner medulla, where newly
formed cells undergo final maturation before exiting and seeding peripheral lymphoid
organs (Scollay and Godfrey, 1995).

The pattern of movement of developing

thymocytes differs between the adult and fetal thymus, with progenitor cells entering the
fetal thymus through the outside of the thymus rudiment (Suniara et al., 1999; Manley,
2000), and in the adult thymus through blood vessels in the medulla or perimedullary
cortex (Lind et al., 2001; Petrie, 2003; Benz et al., 2004).
During murine embryogenesis, the thymus primordium is formed between
embryonic day (E) 10.5 and E11.5 from the third pharyngeal pouch endoderm, which is
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a process that depends on interactions with the surrounding neural crest (NC)-derived
mesenchyme.

NC cells migrate from the dorsal portion of the neural tube during

embryogenesis and contribute to a variety of neuronal and non-neuronal cell types.
NC-derived mesenchyme is necessary for thymus organogenesis and thymus function
(Manley, 2000; Owen et al., 2000; Anderson and Jenkinson, 2001; Petrie, 2002). The
thymic epithelium is derived from the embryonic endodermal layer (Blackburn and
Manley, 2004). Differentiation is dependent on and controlled by cellular interactions
(Bockman, 1997). The roof of the endodermal yolk sac is folded into the expanding
embryo as the foregut. The thymus rudiment begins to express Foxn1 at about E11.5.
Foxn1 encodes a transcription factor whose function is essential for subsequent
epithelial differentiation; without it, colonization of the rudiment by thymocyte progenitors
fails (Bleul and Boehm, 2000), and thymopoiesis is aborted, resulting in severe
immunodeficiency (Nehls et al., 1996). It is still unknown which signal(s) determine(s)
the site and size of the thymic rudiment and whether these or other signals stimulate
Foxn1 expression.

Genetic abnormalities involving the formation of pharyngeal

pouches, such as deficiencies in the transcriptional regulators, Tbx1, Pbx1, Eya1, and
Six1, also have an impact on thymus formation (Manley et al., 2004; Arnold et al., 2006;
Zou et al., 2006). Wnt and bone morphogenic protein (BMP) signals have also been
implicated in initiating (Balciunaite et al., 2002) and/or maintaining (Bleul and Boehm,
2005; Patel et al., 2006) Foxn1 expression in the thymic epithelium.. During embryonic
development, Sonic hedgehog (Shh) signaling is involved in restricting the size of the
thymic field as measured by Foxn1 expression (Moore-Scott and Manley, 2005).
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At E12, the thymic rudiment is first colonized by lymphocyte progenitors
(Jotereau et al., 1987), which enter through the capsule via a chemoattractive
mechanism (Liu et al., 2006). At this point, the rudiment does not have histologically
defined cortex and medulla regions that are present in the adult thymus. Rather, it
contains mostly thymic epithelial cell (TEC) progenitors that subsequently undergo an
ill-defined lineage commitment and differentiation program, resulting in distinct cortical
and medullary TEC subsets, which are the major cells of the stroma (Rossi et al., 2006).
The epithelial cells attract lymphoid precursor cells that are transported to this region
through the bloodstream. By E13.5 in mice, the parathyroid and thymus are separated
into physically distinct organs.

Shortly following this, the thymus reaches its

approximate adult position within the embryo.

Other nonhematopoietic stromal

elements, such as fibroblast and endothelial cells, and distinct hematopoietic-derived
myeloid dendritic cells (DCs) and macrophages also contribute to the final thymic
structure. Macrophages are distributed throughout the cortex and medulla where they
are involved in phagocytosis of apoptotic cells (Surh and Sprent, 1994).

DCs are

predominately located in medullary regions, but they reach into cortico-medullary areas
and have access to immature thymocytes (Kyewski et al., 1987; Shortman and Vremec,
1991; Surh and Sprent, 1994).
Thymus growth in the mouse takes place in two well defined periods: from E14 to
E17-18, and from day 3 to day 6 after birth, as well as another less characteristic period
from day 8 to day 14, when the thymus reaches its maximum, steady state size (Penit
and Vasseur, 1989). The overall size of the thymus is probably determined by the
action of p63 and fibroblast growth factor (Fgf) signaling through the Fgfr2IIIb receptor,
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with p63 acting upstream of Fgfr2 (Candi et al., 2007; Senoo et al., 2007). The thymic
epithelium is necessary for T cell development which is demonstrated by the phenotype
of nude mice, in which disruption of the transcription factor FoxN1 arrests TEC
development at an immature progenitor stage and leads to loss of intrathymic T cell
development and severe immunodeficiency (Nehls et al., 1996; Su et al., 2003; Bleul et
al., 2006). The specialized TEC subsets of the cortex and medulla facilitate distinct
phases of T cell development.

Thymocytes at different maturation stages occupy

distinct regions in the adult thymus, implying that differentiation is coupled with the
coordinated migration between microenvironments. Progenitors enter at the corticomedullary junction (CMJ), migrate through the cortex to the outer subcapsular zone
(SCZ) during the early progenitor stages, and then move back toward the CMJ and into
the medulla (Lind et al., 2001; Petrie and Zuniga-Pflucker, 2007).

Cortical TECs

(cTECs) support early T cell progenitor commitment and differentiation and play a
primary role in β-selection and positive selection processes (Anderson et al., 1993;
Anderson et al., 1994). Medullary TECs (mTECs), along with DCs, are needed for
effective negative selection during the late stages of development (Derbinski et al.,
2001; Gallegos and Bevan, 2004). There are multiple checkpoints during thymocyte
maturation to limit the generation of cells having nonfunctional or autoreactive T cell
receptor (TCR) complexes. αβ T cell differentiation is characterized by CD4 and CD8
coreceptor expression (Figure 1). Lymphoid progenitor cells that seed the thymus are
the immature CD4-CD8- double-negative (DN) precursor subset (Schmitt and ZunigaPflucker, 2005). The first checkpoint during thymocyte development is TCR β-selection
which makes sure that only DN thymocytes that have generated a productively
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rearranged TCRβ chain are selected for further differentiation to the CD4+CD8+ doublepositive (DP) stage (Dudley et al., 1994; von Boehmer et al., 1999).
The
Figure 1. Thymocyte maturation in the mouse

second
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takes place when DP cells
go through positive and
negative

selection,

allowing differentiation of
MHC-restricted

self-

tolerant mature CD4 and CD8 single positive (SP) T cells (Starr et al., 2003). In a
mature thymus, ~5% are DN cells, ~80% are DP cells, ~10% are CD4+ cells, and ~5%
are CD8+ cells (Ceredig et al., 1983). In the mouse, the DN population can be further
subdivided

into

four

sequential

developmental

subsets

as

follows:

DN1

(CD117+CD44+CD25-), DN2 (CD117+CD44+CD25+), DN3 (CD117lo/-CD44-CD25+), and
DN4 (CD117-CD44-CD25-) (Godfrey et al., 1993). In the human thymus, CD34+CD1acells correspond to murine DN1 and DN2 thymocytes and CD34+CD1a+ cells are
homologous to DN3 thymocytes (Dik et al., 2005). The DN1 cell population has multilineage potential, including B-cell, T-cell, myeloid cell, natural killer (NK)-cell and DC
potential (Ardavin et al., 1993; Matsuzaki et al., 1993; Moore and Zlotnik, 1995;
Shortman and Wu, 1996). The DN2 population lacks B-cell potential but still has NKcell and DC potential in addition to T cell potential (Wu et al., 1996; Schmitt et al., 2004).
Final T-cell lineage commitment occurs at the DN3 stage when extensive
rearrangement of TCRβ, TCRγ, and TCRδ loci occurs (Ismaili et al., 1996; Capone et
al., 1998). DN3 cells with productive TCRβ rearrangements give rise to αβ-lineage DP
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cells that are short lived and the dominant T-lineage cell type in the adult mouse thymus
(Huesmann et al., 1991). DN precursors give rise to two distinct T cell lineages, αβ and
γδ, however, the exact timing of when this occurs has not been determined. The TCR
signal strength determines αβ or γδ lineage outcome (Haks et al., 2005; Hayes et al.,
2005). Relatively weaker signals are associated with the pre-TCR, which is thought to
signal autonomously, while stronger signals are associated with the γδ-TCR, possibly
via ligand engagement (Irving et al., 1998; Yamasaki et al., 2006).
Recombination-activating gene (RAG) 1- and RAG2-mediated rearrangements of
the TCRβ, TCRγ, and TCRδ loci, which are needed for TCR assembly, are first detected
in DN2 cells and continue predominantly during the mostly noncycling DN3 stage
(Godfrey et al., 1994; Capone et al., 1998; Livak et al., 1999). Immature thymocytes
expressing a functional TCRβ chain, which associates with the invariant pre-TCRα
chain and CD3 signaling molecules to form the pre-TCR complex, are selected for αβ
lineage differentiation (Wu et al., 1996). The pre-TCR mediates the TCR β-selection
event by signaling rescue from apoptosis, intensive cellular expansion, termination of
TCRβ locus recombination, and differentiation to the DP stage (Dudley et al., 1994). In
addition to the pre-TCR, signals from chemokines, interleukins, adhesion molecules,
and Notch-receptor-ligand-interactions are necessary for differentiation from the DN3
stage to the DP stage (Misslitz et al., 2004; Radtke et al., 2004; Misslitz et al., 2006). In
mice with gene deficiencies in Rag1, Rag2, or any component of the pre-TCR complex,
severe arrest in αβ T cell development at the DN3 stage occurs, thus demonstrating the
critical role of pre-TCR formation (von Boehmer et al., 1999; Michie and ZunigaPflucker, 2002). During the pre-TCR-induced transition to the DP stage, selected cells
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downregulate CD25 and progress through a brief, intermediate immature CD8 single
positive (ISP) stage.
Previous studies have established that proliferation is mostly associated with the
DN and early DP populations (Scollay and Godfrey, 1995), therefore most cortical DP
thymocytes are small nondividing cells. These cells have a finite lifespan of 3-4 days,
but are able to undergo positive selection and differentiation into CD4+ or CD8+ cells
(Lundberg and Shortman, 1994; Swat et al., 1994). Continued TCRα chain gene
rearrangement has been demonstrated in the DP population, increasing chances of
positive selection (Petrie et al., 1993). In regards to proliferation of the DN population,
studies have shown that cells that are mostly nondividing following entry into the thymus
undergo two phases of proliferation separated by a stable period at the DN3 stage
(Penit et al., 1995).
Interactions between thymocytes and stromal cells are essential for the
development of both T cell precursors and the thymic stroma. A study in which severe
combined immunodeficient (SCID) mice displayed an absence of mTECs until the
introduction of normal bone marrow, at which point regeneration of mTECs occurred,
demonstrated that development of the thymic medulla is dependent upon the presence
of thymocytes (Shores et al., 1991). In addition, absence of medullary areas has been
noted in TCRα-deficient mice (Palmer et al., 1993). The importance of the thymocytestromal interaction is also evident in positive and negative selection. Two-photon
imaging studies of thymocyte behavior showed longer dwell times of thymocytes in a
positively selecting environment, indicating that, similar to mature T cells, thymocytes
require sustained interactions with their environment for the delivery of selection signals
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(Bousso and Robey, 2004). In general, most negative selection occurs in the medulla
once the thymocyte has been positively selected and chosen to commit to the CD4 or
CD8 lineage. Negative selection depends on tissue-specific antigen expression by the
transcription factor Aire as well as mTEC integrity (Anderson et al., 2002; Kajiura et al.,
2004; Akiyama et al., 2005; Kinoshita et al., 2006). The chemokine CCR7 has been
shown to be necessary for the migration of the developing thymocyte from the cortex to
the medulla (Ueno et al., 2004), and this migration is needed for the establishment of
self-tolerance (Kurobe et al., 2006).
Many studies have implicated transcription factors, cytokines, growth factor
receptors, signaling molecules, and extracellular matrix molecules as playing important
roles in thymocyte maturation, including Wnt molecules, Hh molecules, and FGFs
(Staal and Clevers, 2003; Rowbotham et al., 2007b). Also, roles for BMPs and the
TGF-β superfamily have been implicated in thymocyte development, mostly for their
ability to influence FGF and Wnt-stimulated signals (Tsai et al., 2003; Licona-Limon and
Soldevila, 2007).
During the neonatal and early postnatal stages of development, the immune
response varies greatly from that of a fully developed adult.

One of the major

differences is that neonatal T cells have poor cytokine production in comparison to the
adult (Bryson et al., 1981) particularly in relation to Th1 cytokines. The underlying
mechanisms that account for this deficiency are not fully understood, but appear to
derive partly from the secretory functions of the placenta (Wegmann et al., 1993). The
relatively poor capacity of neonatal T cells to produce cytokines is considered to
contribute to the impaired responses of other neonatal cell populations that depend on
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these factors for their functions, e.g. poor IFN-γ production could help to reduce cellular
cytotoxicity by NK cells (Yabuhara et al., 1990),and reduced IL-4 has a role in reduced
IgE production by neonatal B cells (Pastorelli et al., 1990).

Spleen
Splenic development in the mouse begins at E11.5, and at E12.5, it is detectable
by the condensation and proliferation of Hox11+ mesenchymal cells as a ridge attached
to the dorsal area of the stomach (Roberts et al., 1994). The first hematopoietic cells to
populate the mouse spleen appear at around E15.5. Spleen development depends on
Hox11+ and in mice lacking this homeobox gene, development of the splenic rudiment
begins normally but development arrests between E12.5-13.5, prior to colonization by
hematopoietic cells (Roberts et al., 1994). Critical roles in spleen development have
also been identified for the transcription factors Wilms tumor suppressor (wt1), Bapx1,
and capsulin. Mice lacking the wt1 gene die during late gestation (Herzer et al., 1999).
Analysis of wt1-deficient embryos demonstrated that the spleen rudiment formed at
E11-12 but involuted by E15 (Herzer et al., 1999). Bapx1 deficiency also results in a
variety of developmental defects and is associated with perinatal lethality. Analysis at
E11.5 showed that the spleen rudiment failed to form and Hox11 expression could not
be detected, suggesting a very early role for Bapx1 (Tribioli and Lufkin, 1999; Lettice et
al., 2001).

Capsulin-deficient mice also die perinatally (Lu et al., 2000).

Capsulin

expression was detected within the undifferentiated mesoderm corresponding to the
embryonic origin of the spleen in the dorso-lateral wall of the stomach (Lu et al., 2000).

10

Morphogen Signaling

Thymocyte development and T-cell lineage commitment are influenced by the
mammalian homologues of many protein families that were first identified as
developmental regulators of Drosophila, including Notch (Radtke et al., 1999; Radtke et
al., 2004; Guidos, 2006), Wnt (Verbeek et al., 1995; Schilham et al., 1998; Mulroy et al.,
2002), BMP (Graf et al., 2002; Hager-Theodorides et al., 2002; Tsai et al., 2003;
Cejalvo et al., 2007), and Hh family of proteins (Outram et al., 2000; Sacedon et al.,
2003; Shah et al., 2004). The Hh and Wnt family proteins, and the BMPs, act as
morphogens during vertebrate embryogenesis and organogenesis by regulating
patterning and cell fate. Morphogens are secreted signaling molecules produced at a
localized source that specify cell fate in a concentration-dependent manner.

Hh signaling
The Hh family of secreted proteins is comprised of intercellular signaling
molecules that specify cell fate and patterning during the development of many tissues.
In mammals, there are three Hh family members, Sonic hedgehog (Shh), Indian
hedgehog (Ihh), and Desert hedgehog (Dhh) (Ingham and McMahon, 2001), of which
Shh is the best studied. Shh-/- animals have a multitude of defects including cyclopia,
poor neural patterning, lack of limb growth, and abnormal organ and foregut
development (Ingham and McMahon, 2001). In addition, a variety of diseases and
malformations can occur when other genes of the Shh signaling pathway are mutated
(Wynshaw-Boris, 2006) (Table 1). In general, the processing and signaling of Hh family

11

members is similar across the various mammalian paralogs
Table 1. Human genetic diseases caused by mutations in the Shh pathway
Gene mutated
SHH

Disease
Holoprosencephaly

PTCH-1

Gorlin syndrome

PTCH-1 or -2

Cancer

SMO

Cancer

GLI1

Cancer

GLI3

Greig syndrome
Pallister-Hall syndrome

Manifestations
Variable midline defects
(single maxillary incisor,
hypotelorism,
holoprosencephaly, cyclopia)
Dysmorphic syndrome (short
metacarpals, rib defects,
broad face, dental
abnormalities), cancer
predisposition
(rhabdomyosarcoma,
medulloblastoma)
Basal cell carcinomas,
medulloblastomas
Basal cell carcinomas,
medulloblastomas
Glioblastoma, osteosarcoma,
rhabdomyosarcoma, B cell
lymphomas
Hypertelorism, syndactyly,
preaxial polydactyly
Postaxial polydactyly,
syndactyly, hypothalamic
hamartomas
Adapted from Wynshaw-Boris (2006)

members is similar across the various mammalian paralogs and is also evolutionary
conserved. Hh is initially synthesized as a preprotein, which subsequently enters the
secretory pathway where the signal sequence is removed to yield an approximately 45
kDa precursor protein (Ingham and McMahon, 2001; Torroja et al., 2005) (Figure 2).
The precursor protein undergoes an intramolecular cleavage reaction to generate a 19
kDa amino-terminal polypeptide (Hh-N) and a carboxyl-terminal polypeptide (Hh-C) (Lee
et al., 1994; Bumcrot et al., 1995).

During this cleavage, cholesterol is covalently

attached to the C-terminus of the Hh-Np (p for processed) (Porter et al., 1995). This
cleavage takes place in an undefined intracellular compartment. Hh is the only known
secreted ligand that is covalently modified by cholesterol. It is likely that this unique
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modification results in many of the unusual biological mechanisms that have been
described in the Hh pathway. A palmitoyl acid is also added to the N-terminus of Shh-N
(Pepinsky et al., 1998). This palmitoylation is catalyzed by the membrane bound Oacyltransferase commonly known as Skinny Hh (Ski) (Mann and Beachy, 2004; Torroja
et al., 2005). Animals lacking Ski function exhibit phenotypes resembling Hh-/- animals,
demonstrating the importance of palmitoylation for transduction of the Hh signal
(Pepinsky et al., 1998; Chamoun et al., 2001; Chen et al., 2004). The majority of Hh
found in vivo appears to be modified by both cholesterol and palmitate (Pepinsky et al.,
1998; Chamoun et al., 2001). The lipid modifications serve an important role in
regulating Hh localization

Figure 2. Shh processing and secretion
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it is unable to efficiently leave the cell (Ingham and McMahon, 2001; Torroja et al.,
2005). Complete loss of Disp function leads to strong Hh loss of function phenotypes,
indicating a positive role for Disp in Hh signaling (Torroja et al., 2005; Guerrero and
Chiang, 2007). The dually modified Hh is secreted as a multimeric form (Zeng et al.,
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2001; Chen et al., 2004; Gallet et al., 2006). Formation of multimeric Hh allows the
normally hydrophobic Hh-Np to transmit a signal far from its site of synthesis, as
disruption of these multimeric Hh structures results in loss of long-range Hh signaling
(Chen et al., 2004; Gallet et al., 2006).
Shh and Ihh are both expressed in the thymus. Shh is produced by the thymic
epithelium, and Ihh expression is mainly associated with blood vessels in the medulla
(Outram et al., 2000), and more recently has been shown to be produced by DP cells
(Outram et al., 2008). Each of the Hh proteins has different expression patterns and
essential nonredundant roles during embryogenesis, but do share a common signaling
pathway (Figure 3). They bind to their surface receptor Patched (Ptc), in order to signal
to neighboring cells (Marigo et al., 1996; Stone, 1996).

There are two Patched

isoforms, Ptc1 and Ptc2. The mouse and zebrafish homologues of Ptc2 have been
reported to be expressed in a partly overlapping pattern with Ptc1 during embryonic
development and to be induced by Shh (Concordet et al., 1996; Motoyama et al., 1998).
Tissue distribution analysis indicates that Ptc2 is preferentially expressed in the skin
and in the testis, where it is likely to mediate the action of Dhh, which is required for
germ cell development (Carpenter, 1998). Ptc2 is expressed in the thymus, but its
expression is restricted to CD34+ thymic progenitor cells and cortical and medullary
cytokeratin-positive epithelial cells (Sacedon et al., 2003). Ptc2 is generally weaker
than Ptc1 in its tumor-suppressor ability (Carpenter, 1998). When Hh is present, Ptc
(both isoforms) releases its suppression of the cell surface molecule Smoothened
(Smo), enabling the Hh signal to be transmitted into the target cell (van den Heuvel and
Ingham, 1996) (Figure 3). This transduction is regulated by complex interactions and
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modifications of many cytoplasmic proteins ultimately resulting in the activation of
members of the Gli family of zinc finger transcription factors (Gli 1-3) (Ingham and
McMahon, 2001). When Hh protein is absent, Ptc inhibits the ability of Smo to signal
(Chen and Struhl, 1998; Taipale et al., 2002).

Gli1 is an activator of transcription

whereas Gli2 and Gli3 probably function both as positive and negative regulators of
transcription (Koebernick and Pieler, 2002). Gli1 and Gli2 transcription is positively
regulated by Hh signaling, while Gli3 transcription is downregulated by Hh (Ruiz i
Altaba, 1999). Gli1 is not required to initiate the Hh signal and is itself a target gene of
the Hh pathway, so measurement of its transcription can be used as a read-out of Hh
signaling in a population of cells. When Hh signaling is absent, Gli2 and Gli3 undergo
modification by phosphorylation and cleavage of their
Figure 3. Hh signaling pathway
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preventing nuclear accumulation of Gli1 and Gli2 (Barnfield et al., 2005). Gli2 and Gli3
are each essential for mouse development and have unique, as well as partially
overlapping functions (Mo et al., 1997). Although Gli2 and Gli3 are bifunctional, Gli2
has been reported to act in vivo as a transcriptional activator, while Gli3 mainly
functions as a transcriptional repressor (Wang et al., 2000; Bai et al., 2002).
Several factors that influence the response of a cell to the signal received include
Hh concentration and length of exposure to the signal (Stamataki et al., 2005). The
presence

of

cell-surface

molecules

such

as

CDO

(cell-adhesion-molecule-

related/downregulated by oncogenes; also called CDON), BOC (bioregional CDON
binding protein) and GAS1 (growth-arrest-specific 1) enhances Shh signaling (Tenzen
et al., 2006; Allen et al., 2007). In addition, cells can migrate in and out of range of the
Hh signal. Cells near the source of Hh secretion can modulate the range of the signal
by upregulating their expression of Ptc1, which can sequester Hh and thereby prevent it
from spreading further (Chen and Struhl, 1996).
Components of the Hh signaling pathway, including Shh, Ihh, Ptc, Smo, Gli1,
Gli2, and Gli3 are expressed in the murine thymus in both the adult and the fetus
(Outram et al., 2000; Li et al., 2002a; Li et al., 2002b). Immunohistochemical studies
have located Shh production to epithelial cells scattered in the subcapsular region and
in the medulla and cortico-medullary junction of both mice and human thymi (Outram et
al., 2000; Sacedon et al., 2003; Shah et al., 2004; Andaloussi et al., 2006; Virts et al.,
2006).

Cell-surface expression of the signal transduction molecule Smo is mostly

restricted to DN thymocytes and is downregulated on the subsequent DP and CD4+ and
CD8+ populations. Analysis of DN populations showed that the DN1 cells that are not
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committed to the T-cell lineage (Haks et al., 1999) do not express significant levels of
Smo (Outram et al., 2000). In DN2 cells, Smo expression is upregulated, but then
decreases in the DN3 and DN4 populations, and is then almost undetectable in DP
populations (Outram et al., 2000; Andaloussi et al., 2006). Smo expression is then
upregulated on SP, with expression on 9% of CD4+ cells and 20% of CD8+ cells
(Outram et al., 2000). This expression pattern suggests that the thymocytes that are
responding to the Hh signal are the DN cells and a proportion of SP cells.
Analysis of fetal thymocyte development in Shh-and Gli3-deficient embryos has
demonstrated that Shh provides a positive signal for thymocyte differentiation and
proliferation at the DN1 to DN2 transition (Shah et al., 2004; Hager-Theodorides et al.,
2005) (Figure 4).

Thymi from Shh-/- mice contained approximately 10 times fewer

thymocytes than thymi from control littermates, and had reduced thymocyte proliferation
and a partial arrest in development at the DN1 stage (Shah et al., 2004). There was a
partial thymocyte block at the DN1 stage in Gli3-/- thymi, but thymocyte number and
proliferation was unaffected, suggesting that Gli3 is downstream of Shh in signaling for
Figure 4. Role of morphogens in thymocyte development
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CD8

differentiation only (Hager-Theodorides et al., 2005). Using Smo knockouts, a role of
Shh signaling in differentiation of early DN cells in adult thymi has been established
(Andaloussi et al., 2006). Specifically, Shh signaling is critical for DN1 to differentiate to
the DN2 stage. Analysis of Shh-/- mouse embryos has suggested that Shh influences
very early thymocyte development prior to the DN1 to DN2 transition (Shah et al.,
2004). The Shh-/- thymi of mice on embryonic day 13.5 were smaller and contained a
reduced proportion of cells of hematopoietic origin, suggesting that Shh is necessary for
their development either before or during entry of thymocyte progenitors to the thymus
(Shah et al., 2004). The function of Hh signaling at the transition from DN to DP cells is
controversial due to conflicting data which suggests that Hh can have a positive role
(Shah et al., 2004), a negative role (Outram et al., 2000), or no role at all during this
transition (Andaloussi et al., 2006). The most likely model is one that takes all data into
account, in which Shh signals positively for thymocyte development prior to pre-TCR
transduction, but acts as an inhibitor from the DN3 to DP transition after the pre-TCR
signal (Crompton et al., 2007).

Since Shh is a morphogen, it produces certain

outcomes depending on the concentration and duration of the signal received, as well
as the competence of the signal-receiving cell, so it is possible that Shh can act as
either a positive or negative regulator based upon its concentration. For example, in
Shh-/- fetal thymic organ cultures (FTOC), treatment with low-dose recombinant Shh
increased DP cell production, while treatment with higher concentrations of recombinant
Shh arrested differentiation (Shah et al., 2004).
Activation of the Shh signaling pathway in developing thymocytes influences
TCR repertoire selection and the differentiation from DP to SP cells by influencing the
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strength of the TCR signal through a mechanism upstream of extracellular-signalregulated kinase (ERK) activation (Rowbotham et al., 2007a). In Shh-/- FTOCs, the
ratio of mature CD4+ to CD8+ cells was increased, which is consistent with an increase
in TCR-signal strength during positive selection (Rowbotham et al., 2007a). When wildtype E17.5 FTOCs were treated with recombinant Shh, the ratio of mature CD4+ to
CD8+ cells was decreased (Rowbotham et al., 2007a). In summation, studies on Shh’s
role in the thymus demonstrate the necessity of Shh in thymocyte development and T
cell activation.

Wnt signaling
The Wnt pathway derives its name from the Drosophila Wingless gene
and the mouse INT-1 gene. Wnt genes encode a large family of secreted glycoproteins
Figure 5. Wnt processing and secretion
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immature protein to the endoplasmic reticulum (ER) (Figure 5). In the ER, the signal
peptide is cleaved by a protease and the Wnt protein is modified by addition of sugars
and lipids by the acyl-transferase porcupine in order for proper secretion to occur. The
attachment of a palmitate moiety to a conserved cysteine residue on the Wnts, which
convert them into hydrophobic proteins, is essential for their biological activity (Willert et
al., 2003; Zhai et al., 2004). Transport and secretion of the Wnt protein in secretory
vesicles is controlled by the multi-pass transmembrane protein Wntless (Wls)/Evenness
interrupted (Evi) (Ching and Nusse, 2006).
Table 2. Human genetic diseases caused by mutations in the Wnt pathway
Gene mutated
Wnt3
LRP5
FZD4
Axin2
APC

Disease
Tetra-amelia
Osteoporosis-pseudoglioma
syndrome, familial exudative
vitroretinopathy
Familial exudative
vitroretinopathy
Tooth agenesis,
predisposition to colorectal
cancer
Polyposis coli, colon cancer

Manifestations
Absence of limbs
Bone density defects, Retinal
angiogenesis defects
Retinal angiogenesis defects
Absence of multiple
permanent teeth
Polyps in colon and rectum
Adapted from Logan and Nusse (2004)

Wnt signals are transduced through at least three different signaling pathways;
however, the canonical β-catenin/T-cell factor-lymphoid enhancer factor (TCF-LEF)
primarily functions during thymocyte development (Figure 6). The canonical pathway is
stimulated by Wnt proteins that bind to cell surface Frizzled (Fz) receptors and the coreceptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6 (Bhanot et
al., 1996).

Signaling through Fz receptors following Wnt binding results in the

stabilization of β-catenin (Behrens et al., 1996). β-catenin is a multifunctional protein
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that enters the nucleus, engages with LEF-1 and the TCFs, TCF1, TCF3, TCF4, and
functions as a transcription factor (Novak and Dedhar, 1999).

TCF and LEF are

transcription factors that are bound to DNA and, in the absence of β-catenin, interact
with transcriptional corepressors, such as Groucho, which inhibits transcription (Roose
et al., 1998). Other proteins in the nucleus that control Wnt signaling events include
Chibby, which is a nuclear antagonist that binds to the C-terminus of β-catenin
(Takemaru et al., 2003), and Inhibitor of β-catenin and TCF (ICAT) (Tago et al., 2000),
which blocks the binding of β-catenin to TCF (Tago et al., 2000), but also leads to
dissociation of β-catenin and LEF complexes (Daniels and Weis, 2005). Activation of
the

Wnt

target

gene

program

is

achieved

when

β-catenin

displaces

the

Groucho/Transducin-like Enhancer of Split (TLE) corepressor proteins from Tcf (Daniels
and Weis, 2005) and efficiently recruits a variety of proteins capable of effecting
changes in local chromatin structure to the Wnt target genes (Stadeli et al., 2006). Many
of these co-activator proteins, such as the histone acetylase cyclic-AMP-responsiveelement binding protein (CREB)-binding protein (CBP), Brahma-related gene (BRG)-1,
and Hyrax interact directly with the C-terminus of β-catenin. Another protein, Pygopus,
indirectly binds the N-terminus of β-catenin via a common binding partner, Bcl9 (legless
in Drosophila). The exact role of the β-catenin/Bcl9/Pygopus complex is controversial,
in that one line of evidence suggests that it facilitates the nuclear import/retention of βcatenin (Townsley et al., 2004), while another study supports a direct role for the
complex in enhancing the ability of β-catenin to activate Wnt target genes (Hoffmans et
al., 2005). When Wnt signaling is absent, free β-catenin is bound by a destruction
complex consisting of the tumor-suppressor gene products axis inhibitor (AXIN) and
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adenomatous polyposis coli (APC), and the serine/threonine kinases casein kinase 1
(CK1) and glycogen synthase kinase 3β (GSK3β) (Behrens et al., 1996). After binding
AXIN and APC, β-catenin is phosphorylated by CK1 and GSK3β in a sequential manner
on at least four conserved N-terminal serine and threonine residues.

CK1

phosphorylates β-catenin at Ser45, creating a priming site for GSK3β to subsequently
phosphorylate the remaining residues, Thr41, Ser37, and Ser33.

This creates a

recognition motif for an E3-ubiqutin-ligase complex that contains β-transducin repeat
containing protein (β-TRCP), which tags β-catenin with ubiquitin molecules, targeting it
for proteosomal degradation (Ikeda et al., 1998; Amit et al., 2002; Gao et al., 2002). In
contrast, when Wnt proteins bind to their receptors, formation of the FrizzledLRP5/LRP6 complex through DVL (mammalian homologue of Drosphila Dishevelled)
promotes the phosphorylation of LRP5 or LRP6 by CK1 and GSK3β (Zeng et al., 2008).
Phosphorylation of LRP5 or LRP6 allows docking of AXIN1 thru the phosphorylated
LRP residues, which removes AXIN1 from the destruction complex in the cytoplasm
(Zeng et al., 2005).

The recruitment of AXIN1 to the plasma membrane leads to

inihibition of the phosphorylating ability of GSK3β and the destruction complex. This
results in the escape of β-catenin and its movement to the nucleus. Relocation of βcatenin from the cytoplasm to the nucleus following its Wnt-induced stabilization is
necessary for achieving efficient activation of Wnt target genes and ensuring
appropriate physiological response. The way in which this is achieved has not been
determined. These genes have not been well-defined in the hematopoietic system, with
the exception of immature thymocytes, in which proliferation, cell adhesion, and antiapoptotic genes have been identified as Wnt targets (Staal et al., 2004).
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TECs are the main source of Wnt proteins in the thymus, while the Wnt receptor
Fz is mostly found on thymocytes, which indicates a crosstalk between TECs
Figure 6. Wnt/β-catenin signaling pathway
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and thymocytes (Pongracz et al., 2003). Wnt signaling occurs in the thymus and is
most active in the immature DN stages (Weerkamp et al., 2006) (Figure 4). The first
report to identify a functional role for Wnt signaling in thymocyte differentiation used
retroviruses encoding the extracellular Wnt-binding domains of Fz receptors as
extracellular inhibitors of Wnt signaling. Fetal liver stem cells were transduced with
these soluble Fz receptors and subsequently assessed for their ability to develop into T
cells using FTOC (Staal et al., 2001). These experiments showed a complete block of
early thymocyte development, similar to that seen in Tcf1Δ5/Δ5Lef1-/- double-knockout
mice. This finding indicated that secreted Wnt factors are essential for intrathymic T
lineage development. In addition, the direct effects of Wnt factors on fetal thymocytes
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were observed in an in vitro culture system (Staal et al., 2001). Specifically, expression
of Wnt1 and Wnt4 through retroviral transduction resulted in increased numbers of
cultured thymocytes in the absence of thymic stroma, likely attributed to a combined
effect on survival and proliferation (Staal et al., 2001). Therefore, Wnt proteins act as
growth factors for early thymocytes. The aforementioned findings were supported by in
vivo studies that demonstrated reduced cellularity in the thymus due to reduced
proliferation of cells mainly at the DN and ISP stages of development in Wnt1-/-Wnt4-/mice (Mulroy et al., 2002). Studies have also shown that defects in T cell development
occur in mice deficient for TCF1. Young TCF1-deficient mice have an incomplete block
at the DN1, DN2, and ISP stages of thymocyte development, whereas older mice have
a complete block most likely at the DN1 stage (Verbeek et al., 1995).
Several studies have shown that Wnt signaling is important at the DN to DP
transition of thymocyte development. Expression of ICAT (Pongracz et al., 2006), which
inhibits Wnt signaling by preventing binding of β-catenin to TCF and LEF factors, blocks
this transition, but does not affect later stages of development.

The secreted Wnt

inhibitor Dikkopf-1 (DKK1), which blocks binding of Wnt to the required LRP coreceptor, inhibits thymocyte differentiation at the DN stage in a dose-dependent
manner, such that high levels of DKK1 lead to complete inhibition of T-cell development
at the DN1 stage (Weerkamp et al., 2006). Activation of the Wnt pathway by
overexpressing activated forms of β-catenin resulted in the generation of more
thymocytes (Mulroy et al., 2003), lack of requirement for pre-TCR signals in mice
lacking pre-TCR (Gounari et al., 2001; Goux et al., 2005), and activated proliferationassociated genes in immature thymocytes (Staal et al., 2004).
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Conditional T-cell-

specific deletion of β-catenin, using the proximal lymphocyte protein tyrosine kinase
(LCK) promoter to control Cre expression, impaired T-cell development at the TCR βselection checkpoint, contributing to a marked decrease in the number of peripheral T
cells (Xu et al., 2003). In addition, conditional deletion of the APC tumor-suppressor
gene, which is part of the β-catenin destruction complex, also disrupts T cell
development in the thymus, partly due to its effect on β-catenin signaling (Gounari et al.,
2001).
Some studies have demonstrated a role for Wnt signaling in DP to SP thymocyte
transition, although Wnt/β-catenin signaling is less active in signaling at this stage.
Expression of CD4 by DP thymocytes is regulated partially by β-catenin-TCF signaling
(Huang et al., 2006), and TCF1-deficient mice express lower levels of CD4 on DP and
CD4+ SP cells. A series of studies showed that overexpressing stabilized β-catenin
regulates the positive selection of thymocytes (Yu and Sen, 2007; Yu et al., 2007); the
generation of fully selected CD4+ and CD8+ SP thymocytes occurred simultaneously
when stabilized β-catenin was overexpressed, in contrast to the normal situation when
generation of CD8+ cells occurs less frequently than generation of CD4+ cells.
Collectively, previous studies have demonstrated a role for Wnt/β-catenin signaling in
DN proliferation and differentiation, DP survival, and CD8+ generation.
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Cadmium

Human exposure
Cadmium (Cd), a heavy metal, is an environmental pollutant due to its
widespread and continual use. It currently ranks seventh on the Agency for Toxic
Substances and Disease Registry/Environmental Protection Agency (ATSDR/EPA) list
of Hazardous Substances (ATSDR, 2007). Cd levels in the environment vary widely due
to its ability to be transported through air, water, and soil. Humans normally absorb Cd
into the body either by ingestion or inhalation (Lauwerys et al., 1986). The daily intake
of Cd is estimated to be approximately 10–50 µg, but can reach levels of 200–1000 µg
in highly contaminated areas (Nordberg, 2006). Cd concentrations in food normally
range from 10-20 µg, while a cigarette contains 1-2 µg. Cd has a half-life of 15-20 years
in humans, which contributes to its toxicity (Jin et al., 1998). The heavy metal’s toxicity
is contributed mostly to its interaction with essential nutrients, such as zinc (Zn), iron
(Fe), calcium (Ca), and copper (Cu) (Flora et al., 2008) (Figure 7).

Cd has no

physiological function in humans, thus, excessive accumulation in the body often results
in diseases and occasionally death (Othumpangat et al., 2005).
Exposure to the heavy metal and its compounds primarily occurs in workplaces
such as mining, smelting, processing, and battery manufacturing, whereas nonoccupational exposures come from various foods, contaminated water, and tobacco
smoke. Natural sources of Cd that put Cd into the air include volcanic activity, forest
fires, and windblown transport of soil particles. Food is usually the largest source of
non-occupational exposure for non-smokers. Contamination of soil caused by mining,
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application of phosphate fertilizers, and atmospheric deposition of airborne Cd leads to
increased uptake by crops and vegetables grown for human consumption. Foods that
have high concentrations of Cd include mollusks and crustaceans, offal products such
as kidney and liver, oil seeds, cocoa beans, and certain wild mushrooms. In addition,
cereals such as rice and wheat, green leafy vegetables, potatoes, and root vegetables
contain a higher concentration of Cd than other plant foods. Based on estimation of Cd
intake, more than 80% of Cd from food comes from cereals, vegetables, and potatoes
(Olsson et al., 2002). Cd in drinking water contributes only to less than a few percent of
the total Cd intake (Olsson et al., 2002). In heavily contaminated areas, however, such
as those in the vicinity of Cd emitting plants or in mining districts, both well water and
rivers may be substantially contaminated by Cd.
Figure 7. Cadmium interacts with essential nutrients
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Absorption and excretion
Cd absorption from the gastrointestinal tract is the main route of Cd exposure in
non-smoking humans.

Approximately 3-10% of ingested Cd is absorbed from the

gastrointestinal system, while 50% of Cd in inhaled smoke is absorbed through the
bloodstream (Sahmoun et al., 2005).

Smokers generally have Cd blood levels 4-5

times those of non-smokers (Elinder et al., 1976).
In animal studies, the fraction of Cd that is absorbed from the gastrointestinal
tract is low, but increases with dose (Lehman and Klaassen, 1986). Once Cd is
absorbed, it is transported into the liver, bound to albumin (Nordberg et al., 1992),
where it induces the synthesis of metallothionein (MT). MT is a small molecular weight,
cysteine-rich stress response protein that binds heavy metals with high affinity (Hamer,
1986). MT’s high affinity for metals allows for protection against Cd toxicity as well as
maintaining the homeostasis of certain essential metals in mammals (Klaassen et al.,
1999b). The primary site for MT synthesis is the liver (Coyle et al., 1995; Quaife et al.,
1999);however, other cells such as lymphocytes and monocytes as well as lymphoid
tissues such as the thymus can produce MT in response to particular stimuli (Olafson,
1985; Coto et al., 1992; Leibbrandt and Koropatnick, 1994; Yurkow and Makhijani,
1998). Following release from the liver, MT-bound Cd enters the plasma. MT-bound
Cd emerges in the glomerular filtrate, from where it is reabsorbed intracellularly by renal
tubule cells. While in the renal tubule cells, Cd is cleaved from MT by lysosomal action,
and Cd2+ ions are re-excreted into the tubular fluid.

Cd is eliminated in the urine,

however, the amount excreted only represents 0.005-0.01% of the total body burden
(Friberg, 1986).
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Numerous studies have been conducted to determine the function of MT in Cd
toxicology (Klaassen et al., 1999a). MT is easily induced by Cd and various metal ions,
as well as by other stimuli (Kagi and Schaffer, 1988). Cd toxicity can be ameliorated by
various MT inducers, particularly Zn (Klaassen et al., 1999a; Waalkes, 2003). Although
MT plays a limited role in the initial distribution of Cd to various tissues (Liu et al., 1996),
the retention of Cd in various tissues is MT-dependent. Cd mainly accumulates in
kidney and liver, where high MT levels are found. Induction of hepatic MT abolishes
biliary excretion of Cd (Klaassen, 1978), and renal Cd concentration is proportional to
renal MT levels (Liu et al., 1996; Jarup et al., 1998). Molecules other than MT, such as
albumin, cysteine, glutathione (GSH), and sulfydryl-rich proteins, can also form
associations with Cd.
Cd uptake is mediated by transport proteins such as divalent metal transport 1
(DMT1), metal transport protein1, calcium channel proteins, and the 8-transmembrane
zinc-related iron-related protein (ZIP8) to reach the target tissues.

Alteration of

transport protein expression can affect cellular Cd uptake and accumulation, and as a
result, impact Cd toxicity (Zalups and Ahmad, 2003; Dalton et al., 2005; Leslie et al.,
2006).

For example, a diet low in iron increases the expression of the DMT1, which

transports iron.

DMT1 also transports Cd, thus low iron stores can increase Cd

absorption, possibly contributing to toxicity.
The finding that pretreatment of animals with a low dose of Cd makes animals
highly tolerant to Cd-induced lethality first demonstrated the role of MT in Cd toxicity
(Goering and Klaassen, 1983). In wild-type and MT-null mice administered increasing
doses of Cd, wild-type mice acquired tolerance to Cd lethality, with a 7-fold difference in
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LD50 values, while MT-null mice did not display such tolerance (Park et al., 2001),
indicating a critical role for MT as a major protein in protecting acute Cd poisoning. The
liver is the major target organ of toxicity following acute Cd poisoning, and Cd
hepatotoxicity is the major cause of acute Cd lethality (Goering and Klaassen, 1983).
Acquired tolerance to acute Cd hepatotoxicity depends on the presynthesized MT in
the liver, which functions to sequester Cd in the cytosol, which in turn, reduces the
amount of Cd available for other critical organelles (Goering and Klaassen, 1983). The
liver, spleen, and bone are important hematopoietic organs, that are all targets of Cd
exposure (Klaassen et al., 1999a). Therefore, mice deficient in MT are likely more
sensitive than wild-type mice to Cd-induced anemia and immunotoxicity (Liu et al.,
1999). Blood MT is non-protective, however, low to moderate levels of blood MT has
effects on the severity of autoimmune disease and on the development of adaptive
immune functions (Lynes and Yin, 2006). Mice deficient in MT exhibited a significantly
higher humoral response to challenge with ovalbumin compared to wild-type controls.
Overall circulatory immunoglobulin levels are also significantly higher in MT-null mice
than in wild-type mice (Crowthers et al., 2000).

Toxicology and Carcinogenicity
Itai-Itai disease
Public awareness of the toxic effects of Cd began with the post World-War-II
(1950) outbreak in Toyama Prefecture, Japan, of “itai-itai” disease, which was the first
Cd poisoning in the world. Itai-itai, or “ouch ouch” disease, so named due to the severe
pain in the joints and spine, was caused by ingestion of runoff water containing Cd
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released from mining companies in surrounding mountains (Kagawa, 1994). Farmers
used the contaminated water to irrigate crops, such as rice paddies. Cd concentrated in
those crops, and when people ingested them, particularly women, they experienced
excruciating pain. Cd interfered with calcium (Ca) metabolism leading to reduction in
Ca levels, which reduced density and strength of bones, often leading to bone
breakage.

Reproductive effects
Oocyte development and associated events have been disrupted by Cd
administration in numerous different species, including Xenopus laevis (Lienesch et al.,
2000; Fort et al., 2001; Fort et al., 2002), rats (Paksy et al., 1989; Paksy et al., 1992;
Piasek and Laskey, 1994; Paksy et al., 1997b), mice (Rehm and Waalkes, 1988),
hamsters (Saksena and Salmonsen, 1983; Rehm and Waalkes, 1988), pigs (Vrsanska
et al., 2003; Mlynarcikova et al., 2005), and sheep (Leoni et al., 2002). Exposure to Cd
of cultured human ovarian granulosa cells was found to cause reduction in
progesterone production when compared with controls, and also caused morphological
alterations in a time-and dose-dependent manner, with rounding up of cells after 4-8 h,
retraction of cellular extensions, and detachment from neighboring cells (Paksy et al.,
1997a). Testicular changes due to Cd toxicity have been seen in a variety of animal
models at different stages of growth and maturity. Gonadal development in mouse
embryos exposed to Cd in early organogenesis was studied by Tam and Liu (1985).
Genital ridge size was reduced in exposed animals, with retarded germ cell migration
into the ridges, resulting in depleted populations of germ cells, defective maturation of

31

gametes and subfertility in male offspring (Tam and Liu, 1985). Also, adult male rats
have been shown to develop gonadal damage following administration of Cd, either
orally or subcutaneously (SC). Focal testicular necrosis and reduced spermatogenesis
were seen in rats that received a single dose of 100-150 mg Cd/kg orally within 2 weeks
of administration (Kotsonis and Klaassen, 1977). Rats injected with a large dose of
CdCl2 (7 mg/kg SC) showed pronounced testicular hemorrhage and edema 24 h after
treatment (El-Ashmawy and Youssef, 1999).

In addition, heavy smoking has been

associated with low sperm count and motility. A strong positive relationship has been
identified between smoking, serum and seminal fluid Cd levels in infertile Nigerian
males (Akinloye et al., 2006). Other studies, however, have shown no differences in
semen quality or fertility between smokers and non-smokers, even though significantly
increased amounts of Cd were found in seminal fluid in those smoking 20 or more
cigarettes a day (Saaranen et al., 1989). In the rat model, increased rates of abnormal
sperm morphology have been noted with increased seminal Cd levels, with positive
correlation with TNF-α and IFN-γ, and a negative relationship with IL-4 (Al-Bader et al.,
1999). All seminal parameters and cytokine differences in this model were reversible by
administration of Zn with Cd.

It has been suggested that absence of certain

micronutrients in the diet contribute to male infertility associated with increased Cd
levels (Akinloye et al., 2006).
Cd may also reduce the possibility of a successful pregnancy by interfering with
the development of the pre-implantation embryo. Gamete fusion in the ovine model
was found to be significantly reduced following exposure to 2-20 µM Cd (Leoni et al.,
2002). Fertilization of mouse oocytes was unaffected when cultured at 1.6 µM Cd, and
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treated ova cleaved into two-cell stage embryos at a comparable rate to controls,
although a reduced number of these embryos reached blastocyst stage (Schmid et al.,
1983).

In vitro studies in which murine embryos were cultured at higher Cd

concentrations (10-50 µM) at the two-cell stage, demonstrated a dose-dependent
inhibition of developmental progression (Storeng and Jonsen, 1980). In vivo exposure
of the murine embryo to Cd at the two-cell stage by SC injection of the dam with 25-38
µM Cd/kg body weight on the morning of day 2 (D2) failed to prevent initiation and
maintenance of pregnancy when examined on D8, but did delay implantation (De et al.,
1993). Embryos that implanted went on to become normal fetuses, with resorption
rates and body weights comparable to controls (De et al., 1993). Studies have shown
that Cd inhibits gap junction, intercellular communication, and connexin phosphorylation
(Jeong et al., 2000; Fang et al., 2001), all of which are necessary for progression from
the eight-cell stage through to compaction (Hardy et al., 1996; Kidder and Winterhager,
2001). Protection of the early embryo from Cd toxicity has been achieved by preventing
Cd uptake by cells by pre- or co-incubation with Zn at 100x molar dose of Cd (Yu and
Chan, 1988; De et al., 1993) and by co-culture with nifedipine (Ca2+ channel blocker) at
0.01x molar dose of Cd (De et al., 1993). Antioxidants are also known to be protective
against Cd toxicity (Peters et al., 1995).
The presence of MT in the placenta is generally accepted to be a protective
mechanism against Cd toxicity within the cells in which it is produced, and is also
thought to restrict Cd movement across the placenta, as the level of Cd is lower in fetal
than in maternal blood (Goyer and Cherian, 1992).

In contrast, some (Goyer and

Cherian, 1992; Torreblanca et al., 1992) think MT has detrimental effects, by binding Zn
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or by interfering with the ability of trophoblast cells to handle Ca and Zn at the cytosolic
level. Using the perfused human placenta, Wier et al. (1990) demonstrated a reduction
in transplacental Zn transfer to the fetus, and also a drop in human chorionic
gonadotrophin (hCG) production by the placenta, beginning 4 h after exposure.
Placentas of smoking mothers contained twice the Cd and approximately half the
progesterone of those of non-smokers. Piasek et al found a reduction in placental iron
in smokers with elevated levels of placenta Cd (Piasek et al., 2001). Cd interference
with progesterone biosynthesis in cultured human trophoblast cells has been linked with
reduced activity of P450 cholesterol side-chain cleavage enzyme and decreased 3βhydroxysteroid dehydrogenase enzyme mRNA (Kawai et al., 2002).

Teratogenicity
Cd is known to exert teratogenic and embryotoxic effects in many species
as confirmed by animal studies (Webster and Messerle, 1980; Messerle and Webster,
1982; Menoud and Schowing, 1987; De et al., 1990; Sunderman et al., 1992). The
changes induced are dependent on the strain and species studied, the dose of Cd
administered, the route of administration, and the stage of embryogenesis (Layton and
Layton, 1979; Feuston and Scott, 1985; Holt and Webb, 1987; De et al., 1990). Toxic
renal effects in 2- to 60-day-old postnatal offspring were observed when pregnant rats
were administered CdCl2 (0.5 mg/kg-1/day) orally throughout gestation (Jacquillet et al.,
2007). When pregnant rats were treated with 0.3 or 0.6 mg/kg-1 Cd subcutaneously
from E7 to E15, sensorimotor development delays were observed in the offspring
(Minetti and Reale, 2006). In the hamster, Gale and Layton (1980) injected a single
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dose of 2 mg/kg CdSO4 intravenously on E8, and found numerous craniofacial, skeletal,
and soft tissue abnormalities upon examination of fetuses on E15. When a wholeembryo culture assay was used for hamster embryos, a 70% abnormality rate in
embryos cultured at 0.25 mM Cd on E8 was observed, with animals exhibiting growth
retardation, reduction in somite gain, axial anomaly and neural tube defect (Wlodarczyk
et al., 2001). Cd has also been shown to have teratogenic effects on limb development.
Following administration of CdSO4 to C57Bl/6 mice at day 9.5 of gestation, a high
incidence of postaxial forelimb ectrodactyly in offspring resulted due to inhibition of the
anterior/posterior formation process (Scott et al., 2005). This process is controlled by
Shh signaling.
Cd has not been shown to be teratogenic in humans; however, an inverse
relationship has been found between birth weight and cord blood Cd levels (GaliciaGarcia et al., 1997), birth weight and placental Cd concentration (Ronco et al., 2005),
and between birth length and maternal blood Cd (Nishijo et al., 2004). There is an
association between maternal Cd exposure and early delivery, which may serve as an
explanation for smaller babies born to women who smoke during pregnancy (Nishijo et
al., 2002). An inverse relationship has also been demonstrated between birth weight
and Cd content in hair of newborns (Huel et al., 1981; Frery et al., 1993). Cd blood
levels in newborn infants have been found to be 70% of maternal levels (Lagerkvist et
al., 1992). The difference in Cd level can most likely be attributed to placental function,
as perfusion of human placentas with Cd showed that transfer rate from maternal to
fetus was very slow (Boadi et al., 1991). Cd did not appear on the fetal side of the
placenta until 40 minutes (min) after perfusion started, and reached a steady state
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approximately 1 hour (h) later, at which time the concentration in the fetal perfusate was
1/20 that of the maternal.
Postnatal effects due to abnormally high levels of Cd during gestation include
significantly increased DNA synthesis in the bowel and bone marrow in 6-week old rats
following administration of Cd orally to pregnant dams at a dose of 50 parts per million
(ppm) in drinking water (Konecki et al., 2000), and depressed immune function and
sensorimotor abilities in children (Schoeters et al., 2006).

Human studies are not

conclusive, so additional work must be done to determine the extent and type of
damage to children following prenatal exposure.

Immunotoxicity
There have been numerous studies on the immunomodulatory effect of Cd in
humans and experimental animals; however, the findings remain controversial
(Descotes, 1992). Dan et al. (2000) showed that Cd causes significant suppression of
humoral and cell-mediated immune response in mice, and suggested that this effect
may be due to its cytotoxic action on liver, kidney, and immune cells. There have also
been reports that Cd induces immunostimulation in experimental animals (Koller and
Roan, 1977). This conflict amongst findings may be attributed to varying doses, route of
administration, length of Cd treatment, and sensitivity of immune systems between
different animal species.

Strain specific immune responses to Cd may be due to

variation of Cd binding to MT and tissue storage or possibly because strains differ in
their proliferative response level to polyclonal T cell mitogens (Dan et al., 2000).

The

thymus is a target organ of Cd-induced toxicity. Following Cd-treatment, damage to the
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thymus as well as changes in the proliferation rate of thymocytes in rats results (Morselt
et al., 1988).

In addition, several in vivo experiments have demonstrated that Cd

causes decreased thymus weight as well as thymic atrophy (Borgman et al., 1986;
Mackova et al., 1996; Liu et al., 1999). In adult mice, Dong et al. (2001) observed a
decrease in DP cells.

Pathak and Khandelwal supported these findings and

demonstrated that Cd exposure increased the number of DN cells (2007).
Cd exposure results in modulation of antibody production, inhibition of B-cell
activation, enhancement of mortality in mice challenged with streptococci, and
decreased mortality of influenza-infected mice (Koller et al., 1976; Gardner et al., 1977;
Fujimaki et al., 1982; Chaumard et al., 1983; Ohsawa et al., 1986; Daum et al., 1993).
In vitro exposure to 10 µM Cd induced apoptotic features in mouse thymocytes
(Fujimaki et al., 2000). A study demonstrated that Cd (0-100 ppm), when given to rats
in drinking water, showed a differential effect on the blood lymphocyte phenotyping
(Lafuente et al., 2004). Evidence suggests the mechanism of Cd toxicity is attributed to
oxidative stress, i.e. increased lipid peroxidation, reactive oxygen species (ROS)
generation, and alterations in GSH and related enzymes, under both in vitro and in vivo
conditions (Stohs and Bagchi, 1995; Hart et al., 1999; Thevenod et al., 2000; de la
Fuente et al., 2002). The role of ROS in Cd induced apoptosis (Pulido and Parrish,
2003; Lemarie et al., 2004) is further supported by activation of redox sensitive AP-1
transcription factor and alteration in GSH metabolism prior to apoptosis (Hart et al.,
1999). Immune cells are highly sensitive to oxidative stress due to major production of
ROS (Meydani et al., 1995). ROS plays a major role in immune function by acting as
intracellular signals. Also, oxidant-antioxidant balance is important for maintenance of
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the immune response (Kim et al., 2001).

The apoptogenic potential of Cd was

demonstrated in murine thymocytes involving mitochondrial membrane depolarization,
and caspase activation, and ROS and GSH acting as critical mediators (Pathak and
Khandelwal, 2006). Differential effects of Cd on the spleen and thymus have been
demonstrated (Pathak and Khandelwal, 2007b). Suppression of cell proliferative
response, thymic atrophy, and splenomegaly following Cd exposure may be due to
oxidative stress followed by activation of the mitochondrial-caspase dependent
apoptotic pathway (Pathak and Khandelwal, 2007b).

Differential susceptibility of

various T subsets to the apoptogenic effects of Cd in the order of CD8+>DN>CD4+>DP
was reported (Dong et al., 2001). In addition, Cd treatment affected cell surface marker
expression and led to phenotypic changes, characterized by a decline in DP cells and a
marked lowering in CD4+/CD8+ ratio mainly due to a significant increase in CD8+
subsets (Dong et al., 2001). The authors concluded that Cd was capable of inducing
apoptosis in cultured mouse thymocytes in a dose and time-dependent manner (Dong
et al., 2001).

Another study examining the effect of in vitro exposure to Cd on

thymocyte development showed that Cd significantly suppressed the proportion of CD4+
cells followed by DP (Pathak and Khandelwal, 2007a). The DN and CD8+ cells, on the
other hand, were markedly enhanced (Pathak and Khandelwal, 2007a). In addition,
cytokine analysis demonstrated an inhibition of IL-2 and IFN-γ release by Th1 cells, and
IL-4 release by Th2 cells (Pathak and Khandelwal, 2007a). The authors attributed this
to a lowered CD4+ population resulting in a decreased proportion of Th1 and Th2 cells,
or to an indirect influence of the metal mediated by the endocrine system (Lafuente et
al., 2004). Th1 and Th2 cells mediate cytotoxic and local inflammatory reactions, and
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therefore play important roles in combating intracellular pathogens including viruses,
bacteria, and parasites.
When adult male rats were exposed for one month to CdCl2, Cd accumulated in
the spleen (at ≥50 ppm ), and in the thymus (at ≥ 10 ppm on (Lafuente et al., 2003). In
both spleen and thymus, the B lymphocytes increased with doses of 5 and 10 ppm, and
decreased with the doses of 25-100 ppm (Lafuente et al., 2003). In the spleen, doses
of 25 and 50 ppm decreased CD4+ cells and the doses of 5 and 10 ppm increased
CD8+ cells (Lafuente et al., 2003). In addition, results suggest that the spleen is more
sensitive to Cd exposure than the thymus, although the accumulation of the metal was
higher in the thymus than the spleen (Lafuente et al., 2003). Another study by Lafuente
et al. (2004) demonstrated that Cd effects on the distribution of blood lymphocyte
subsets suggest that Cd inhibits the humoral and cellular immune responses with lower
doses (5-10 ppm), but opposite effects are demonstrated with higher doses (25-100
ppm). In a study that investigated the role of estradiol (E2) on the immunotoxic effects
of Cd in the rat, results indicated that Cd and E2 not only share certain similar cellular
pathways but also can interact to alter immune functions (Pillet et al., 2006). In addition,
Cd can also modulate the hormonal balance and may exert estrogenic effects via
interaction with estrogen receptors (ERs). This suggests that females may be at a
greater risk than males for Cd-induced immunomodulation.
In immune and inflammatory responses, macrophages are activated (Auger,
1992) and secrete cytokines, ROS, reactive nitrogen species such as nitric oxide (NO)
(Ding et al., 1988) and eicosanoids such as prostaglandin E2 (PGE2).

These

substances all contribute to tissue damage mediated by activated macrophages (Laskin
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and Pendino, 1995). Both NO and PGE2 are inflammatory and immunomodulatory
mediators in mammalian physiology (Moncada et al., 1991; Reilly et al., 1998). Several
oxidative stressors can induce the co-expression of inducible nitric oxide synthase
(iNOS) and cyclooxygenase type-2 (COX-2), which synthesizes NO and PGE2,
respectively (Feng et al., 1995; Swierkosz et al., 1995; O'Banion, 1999).

A study

reported that in vitro Cd exposure in non-cytotoxic conditions induces iNOS expression
(Ramirez et al., 1999) and enhances lipid peroxidation, arachidonic release, and GSH
release from mouse peritoneal macrophages (Ramirez et al., 2001).

Ramirez and

Gimenez (2003) demonstrated that chronic exposure through drinking water (15 ppm for
2 months) induces redox changes in favor of pro-oxidant conditions, and increases
synthesis of NO and PGE2 in mouse peritoneal macrophages (Ramirez and Gimenez,
2003).
Neonatal exposure to environmentally relevant levels of Cd (10 ppb or 5 ppm) via
maternal milk resulted in gender-specific delays in the development of females (Pillet et
al., 2005). Also, exposure to Cd through maternal milk also produced transitory and
persistent alterations of immune functions (Pillet et al., 2005). The immunotoxic effects
were dependent on the type of immune cell, the developmental stage, and the level of
exposure. Transitory and persistent alterations of the cytotoxic activity of NK-cells were
only observed in males (Pillet et al., 2005). This was the first report of a gender-specific
difference in the immunotoxic effects of Cd.
Exposure to Cd at sub-toxic levels has been documented to cause impairment of
immunosurveillance, which controls expression and inactivation of viruses and bacteria.
Significant depression in the phagocytic activity (Loose et al., 1978) as well as
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suppression of humoral and cell-mediated immune responses (Dan et al., 2000) were
also reported. It was found that susceptibility to bacteria in Cd-exposed mice was due
to a defect of macrophage recruitment to sites of infection (Simonet et al., 1984). Two
studies demonstrated that Cd increases susceptibility of affected individuals to bacterial
and viral infections (Shen et al., 2001; Simonyte et al., 2003).
The effects of Cd on human cytokine responses, in particular T cell-derived
cytokines, are fragmentary and contradictory.

One study reported a significant

depression of NK cell activity, but no changes in IFN-γ production by Cd treatment
(Daniels et al., 1987).

In contrast, another study demonstrated a significant

enhancement in the IFN-γ production following occupational Cd exposure in men
(Yucesoy et al., 1997). Hemdan et al. (2006) showed that human peripheral blood
mononuclear cells exposure to low and moderate Cd doses (0.013-13.3 µM) resulted in
a clear bias of the immune response toward Th1 or Th2 depending on the activation
method applied (Hemdan et al., 2006).

When the cells were activated with

mononuclear antibodies (anti-CD3/anti-CD28/anti-CD40) and exposed to Cd acetate for
24 h, secretion of IL-1β, TNF-α, and IFN-γ was greatly inhibited compared to the
production of IL-4 and IL-10, which indicates a Th2 biased immune response. When
the cells were stimulated with bacterial antigen (heat-killed Salmonella Enteritidis) and
exposed to Cd acetate for 24 h, secretion of IL-10 was highly suppressed compared to
that of IFN-γ and TNF-α, while IL-4 was undetectable. These results imply that low Cd
polarizes the immune response toward Th2 in cells stimulated via T cell receptor, while
a polarized Th1 response is induced by bacterial antigens (Hemdan et al., 2006). In a
study by Krocova et al. (2000), in vitro treatment of splenocytes from Balb/c mice with
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Cd (20 µg/ml) demonstrated that Cd seemed to trigger the Th2 cytokine pathway (IL-4,
IL-10). This effect of Cd may imply the possible autoimmune or allergic complications in
individuals exposed to this heavy metal (Krocova et al., 2000).

Carcinogenic effects
The toxicology and carcinogenicity of Cd, and its environmental impacts have
been well studied (Waalkes, 2000; Waalkes, 2003). There is sufficient evidence in
humans to classify Cd and Cd compounds as carcinogens based on epidemiological
studies demonstrating a link between Cd and lung, and possibly prostate, cancer (IARC,
2004).

In addition, experimental animal studies demonstrate that Cd and Cd

compounds by multiple routes of exposure induce benign and malignant tumor
formation at various sites in many species of experimental animals (Waalkes et al.,
1992a; Waalkes et al., 1992b; Waalkes and Rehm, 1994; Waalkes et al., 1999a;
Waalkes et al., 1999b; Waalkes, 2000; Achanzar et al., 2001; Waalkes, 2003; Goyer et
al., 2004).

In rodents, Cd has induced tumors in several organs.

Various Cd

compounds produced adenocarcinomas of the lung in rats after inhalation (Takenaka et
al., 1983). Tumors of the prostate and the pancreas were induced by subcutaneous
injection of CdCl2 in rats, tumors of the testis were observed following oral exposure of
rats, and Cd produced local tumors at various sites of injection, typically sarcomas, in
rats and mice (Waalkes, 2000). Cd administration that was linked with tumors of the
prostate and testis in experimental animals was prevented by Zn administration
(Nordberg et al., 1992).

Although a positive relationship has been demonstrated
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between proliferative testicular lesions and Cd in rats (Waalkes et al., 1999a; Waalkes
et al., 1999b), no definitive link exists in humans.
The first studies to suggest a link between Cd and prostate cancer showed an
increased risk of disease in occupationally exposed workers in a nickel-Cd battery
factory (Potts, 1965; Kipling, 1967). Additional occupational studies demonstrated an
association between Cd exposure and an increase in prostate cancer risk and mortality
(Blair and Fraumeni, 1978; Dubrow and Wegman, 1984). More recent studies failed to
show a link between occupational exposure to Cd and prostate cancer; however,
studies have found that prostate cancer was associated with dietary exposure to Cd
through drinking water and food (Bako et al., 1982; Elghany et al., 1990; West et al.,
1991).

Mechanisms of toxicity
Oxidative stress
Cd, unlike other heavy metals, is unable to generate free radicals by itself;
however, reports have indicated that superoxide radical, hydroxyl radical, and NO
radicals could be generated indirectly (Galan et al., 2001). Cd can generate non-radical
hydrogen peroxide, which by itself becomes a significant source of free radicals via
Fenton chemistry (Watanabe et al., 2003). Cd could replace Fe and Cu from many
cytoplasmic and membrane proteins like ferritin, which would then release and increase
the concentration of unbound Fe2+ or Cu2+ ions. These free ions participate in causing
oxidative stress via Fenton reactions (Casalino et al., 1997; Waisberg et al., 2003).
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Numerous studies in animal models have shown that Cd intoxication significantly
increased malondialdehyde and GSH peroxidase (Yang et al., 2003). Acute intoxication
of animals with Cd has shown increased activity of antioxidant defense enzymes like
Cu-Zn containing superoxide dismutase, catalase, GSH peroxidase, GSH reductase,
and glutathione-S-transferase (Ognjanovic et al., 2003). Studies have shown that the
number of cells with DNA single strand breaks and the levels of cellular DNA damage
were significantly higher in Cd exposed animals. Reports have shown that antioxidants
like vitamin C and vitamin E have demonstrated protection against Cd induced toxicity
in different animal models (Ognjanovic et al., 2003). Supplementation of these natural
antioxidants reduced ROS levels, lipid peroxidation, hematological values, and
enzymatic and non-enzymatic components of antioxidant defense system.

Genotoxicity
The Cd2+ ion easily substitutes for the Ca2+ ion in biological systems, because it
carries the same charge and has a similar radius. Compared to the Zn2+ ion, the radius
of the Cd2+ ion is larger, but Cd2+ ions can substitute for Zn2+ ions in many enzymes and
transcription factors. The genotoxicity of Cd is attributed to indirect mechanisms such
as the generation of ROS, inhibition of DNA repair enzymes, and deregulation of cell
proliferation. Cd has been shown to induce the formation of ROS, both in vitro and in
vivo. CdS induced H2O2 formation in human polymononuclear leukocytes, and CdCl2
increased production of superoxide in rat and human phagocytes (Sugiyama, 1994). In
support of this, induction of DNA strand breaks and chromosomal aberrations by Cd in
mammalian cells was suppressed by antioxidants and antioxidative enzymes (Ochi et
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al., 1987; Stohs et al., 2001; Valko et al., 2006). The induction of oxidative stress by Cd
is interpreted by its inhibitory effects on antioxidant enzymes such as catalase,
superoxide dismutase, GSH reductase, and GSH peroxidase (Valko et al., 2006). Cd is
considered co-mutagenic and exacerbates the mutagenicity of UV raditation, alkylation,
and oxidation in mammalian cells (Hartwig and Schwerdtle, 2002). Cd inhibits several
types of DNA repair such as base excision, nucleotide excision, mismatch repair, and
the elimination of the premutagenic DNA precursor 8-oxo-dGTP (Hartwig and
Schwerdtle, 2002). Low concentrations of Cd inhibited the repair of oxidative DNA
damage in mammalian cells (Dally and Hartwig, 1997; Fatur et al., 2003). In regards to
nucleotide excision repair, Cd interfered with the removal of thymine dimers after UV
irradiation by inhibiting the first step of this repair pathway, which is the incision at the
DNA lesion (Hartwig and Schwerdtle, 2002; Fatur et al., 2003).

Cd disrupted the

removal of 8-oxo-dGTP from the nucleotide pool by inhibiting the 8-oxo-dGTPases of
bacterial and human origin (Bialkowski and Kasprzak, 1998). A molecular mechanism
related to the inactivation of DNA repair proteins involves the displacement of Zn from
Zn-finger proteins structures in the DNA repair proteins such as from the xeroderma
pigmentosum group A (XPA) protein, which is required for nucleotide excision repair,
and from the formamidopyrimidine [fapy]-DNA glycosylase (Fpg) protein, which is
involved in base excision repair in E.coli

(Asmuss et al., 2000).

Cd induces a

conformation shift in the Zn binding domain of the tumor suppressor protein p53
(Meplan et al., 1999). In addition to inhibiting repair proteins directly, Cd downregulates
genes involved in DNA repair in vivo (Zhou et al., 2004). In Cd-adapted cells, the
impairment of DNA repair by Cd may be especially harmful. Cd induces several genes
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for Cd and ROS tolerance such as those coding for MT, GSH synthesis and function,
catalase and superoxide dismutase (Stohs et al., 2001), which establishes an
environment where prolonged cell survival in the presence of Cd occurs (Chubatsu et
al., 1992).
Tolerance to Cd toxicity may constitute an extended opportunity for induction of
further critical mutations (Achanzar et al., 2002). Cd interacts with a number of cellular
signaling pathways, many of which are associated with mitogenic signaling.

DNA

synthesis and proliferation of rat myoblast cells (von Zglinicki et al., 1992) and rat
macrophages (Misra et al., 2002) were stimulated by submicromolar concentrations of
Cd. In various cell types in vitro, Cd induces receptor-mediated release of second
messengers inositol-1,4,5-trisphosphate and Ca, it activates various mitogenic protein
kinases, transcription, and translation factors, and it induces the expression of cellular
proto-oncogenes c-fos, c-myc, and c-jun (Waisberg et al., 2003).
In addition to directly stimulating mitogenic signals, Cd also inhibits negative
controls of cell proliferation, such as inactivating the tumor suppressor protein p53 and
inhibiting the p53 response to damaged DNA (Meplan et al., 1999).

Another

mechanism by which Cd affects cell proliferation is through disruption of the WNT/βcatenin pathway resulting in dysregulation of cadherin-mediated cell-cell adhesion
system and of cell-cell communication. Studies have shown that Cd perturbs the Wnt
pathway in chick embryonic periderm (Thompson et al., 2008) and proximal tubule cells
(Prozialeck et al., 2003; Thevenod et al., 2007).
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Estrogenic effects
At a dose similar to the World Health Provisional Tolerable Weekly Intake,
Cd mimics the in vivo effects of estrogen in target organs in animal studies (Johnson et
al., 2003). Johnson et al. (2003) determined that, similar to estrogens, exposure of
ovariectomized animals to a low dose of Cd (5 µg/kg body weight) results in the
induction of estrogen target genes and an increase in uterine wet weight that are
blocked by an antiestrogen. In the mammary gland, Cd also induces estrogen target
genes and promotes the growth and differentiation that are blocked by an antiestrogen.
In utero exposure to Cd mimics in utero exposure to estradiol (Johnson et al., 2003).
When female offspring are exposed to Cd in utero, there is an accelerated onset of
puberty and altered mammary gland development (Johnson et al., 2003). In support of
a role for Cd in breast cancer, exposure to the metal has been linked to an increased
risk of the disease in a hypothesis-generating case-control study that examined over
33,000 death certificates attributed to breast cancer and over 117,000 non-cancer
deaths between 1984-1989 that were coded for occupation and industry (Cantor et al.,
1995). The study found that Cd was associated with an approximate 8 to 20% increase
in breast cancer risk among white women and 50-130% increase in risk among AfricanAmerican women. Similar to estradiol, Cd activates ERα through the ligand binding
domain.

When COS-1 cells are transiently cotransfected with GAL-ER, a chimeric

receptor containing the DNA binding domain of the transcription domain of ERα, a
GAL4-responsive reporter gene, and treated with Cd, there is an increase in reporter
gene activity that is blocked by an antiestrogen suggesting that Cd activates ERα
through the ligand binding domain of the receptor (Stoica et al., 2000). It has been
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reported that Cd modulates steroid hormone-dependent signaling in ovaries in rats, in a
breast cancer cell line, and in Cd-transformed prostate epithelial cells (BenbrahimTallaa et al., 2007; Brama et al., 2007). However, in in vitro estrogenicity assays based
on ER activity, no effect of Cd was detected (Silva et al., 2006).

Androgenic effects
The exact mechanism by which androgens affect prostate carcinogenesis
remains to be elucidated; however, the hormones are strong promoters of the disease.
The growth and development of the prostate gland is controlled by androgenic sex
steroids. Androgens also play a central role in the development of prostate cancer. A
causal relationship between androgens and prostate cancer is supported by the
sensitivity and response of many prostate cancers to hormonal therapy (Waalkes and
Rehm, 1994; Bosland, 2000). The LNCaP cells are an androgen dependent human
prostate cancer cell line (Horoszewicz et al., 1980). In LNCaP cells, Cd mimics the
effects of androgens on cell growth (Webber et al., 1985; Martin et al., 2002) and gene
expression (Martin et al., 2002). Environmentally relevant doses of Cd mimic androgen
effects in castrated rats and mice (Martin et al., 2002). Cd produces a dose-dependent
increase in the wet weight of the prostate gland and the seminal vesicle complex that is
blocked by an antiandrogen, which suggests that the metal activates the androgen
receptor in target tissue (Martin et al., 2002). In intact animals, Cd addition to the
drinking water significantly increases the weight of the prostate and seminal vesicles
and the increase in weight was not reversed upon castration (Visser and Deklerk,
1978). The aforementioned data suggest that Cd is also a metalloandrogen and may
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explain to some degree the heightened risk of prostate cancer associated with Cd
exposure.
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Summary
Industrial and environmental pollutants exert adverse effects on a number of
organ systems in humans and animals. Cd, a heavy metal, is one such pollutant.
Although there is evidence demonstrating that adult exposure to Cd causes changes in
the immune system, there are limited reports of immunomodulatory effects of prenatal
exposure to Cd.

After combining studies that show prenatal Cd exposure causes

perturbations in Shh and Wnt/β-catenin signaling, and these pathways play a role in
thymocyte development, it is not difficult to postulate that prenatal exposure to Cd may
affect thymocyte development via the Shh and Wnt/β-catenin pathways. Due to Cd’s
long half-life, determining whether the effects of prenatal exposure to Cd at birth
continue to adulthood is also vital to understanding Cd’s toxic mechanism. Since
humans are exposed to Cd on a daily basis via the environment, and that pregnant
women are more susceptible to Cd absorption than the rest of the population (Akesson
et al., 2002), determining the effects that prenatal Cd exposure has on offspring will
allow a better understanding of Cd’s toxic effect on the immune response. In addition,
the findings may also elucidate the teratogenic mechanism of Cd in other organ
systems that rely on Shh and Wnt/β-catenin signaling for proper development.
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ABSTRACT
Cadmium (Cd) is both an environmental pollutant as well as a component of cigarette
smoke. Although evidence demonstrates that adult exposure to Cd causes changes in
the immune system, there are limited reports in the literature of immunomodulatory
effects of prenatal exposure to Cd.

The sonic hedgehog (Shh) and Wnt/β-catenin

pathways are required for thymocyte maturation. Several studies have demonstrated
that Cd exposure affects these pathways in different organ systems. This study was
designed to investigate the effect of prenatal Cd exposure on thymocyte development,
and to determine if these effects were linked to dysregulation of Shh and Wnt/β-catenin
pathways. Pregnant C57Bl/6 mice were exposed to an environmentally relevant dose
(10 ppm) of Cd throughout pregnancy and effects on the thymus were assessed on the
day of birth. Thymocyte phenotype was determined by flow cytometry. A Gli:luciferase
reporter cell line was used to measure Shh signaling. Transcription of target genes and
translation of key components of both signaling pathways was assessed using real-time
RT-PCR and western blot, respectively. Prenatal Cd exposure increased the number of
CD4+ cells and a subpopulation of double-negative cells (DN; CD4-CD8-), DN4 (CD44CD25-). Shh and Wnt/β-catenin signaling were both decreased in the thymus; however,
this was not due to altered Shh and Wnt protein levels. Target genes of Shh (Patched1
and Gli1) and Wnt/β-catenin (c-fos, c-jun, and c-myc) were affected differentially among
thymocyte subpopulations.

These findings suggest that prenatal exposure to Cd

dysregulates two signaling pathways in the thymus, resulting in altered thymocyte
development.
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INTRODUCTION

Cadmium (Cd), a heavy metal, is an environmental pollutant due to its widespread
and continual use. It currently ranks seventh on the Agency of Toxic Substances and
Disease Registry/Environmental Protection Agency (ATSDR/EPA) list of Hazardous
Substances (ATSDR, 2007).

Humans normally absorb Cd into the body either by

ingestion or inhalation (Lauwerys et al., 1986). The daily intake is estimated to be
approximately 10–50 µg, but can reach levels of 200–1000 µg in highly contaminated
areas (Nordberg, 2006). Cd concentrations in food normally range from 10-20 µg, while
a cigarette contains 1-2 µg. Cd levels in soils, particularly areas in which phosphate
fertilizers have been applied, can range from 10 to 200 µg/g (Cook, 1995). Cd has a
half-life of 15-20 years in humans, which contributes to its toxicity (Jin et al., 1998). Cd
exposure during gestation leads to a variety of fetal malformations in rodents, such as
postaxial forelimb ectrodactyly (Scott et al., 2005), delayed effects on renal function
(Jacquillet et al., 2007), and sensorimotor development (Minetti and Reale, 2006).
Despite the known teratogenic effects of Cd, only one report concerning the effect of Cd
exposure during gestation on the immune system was found (Soukupova et al., 1991).
In that study, pregnant ICR mice were administered Cd on day 16 of gestation, and the
immune responses of their offspring were tested at 4 and 8 weeks of age. Proliferative
responses of spleen cells to mitogens and activity of peritoneal macrophages were
increased, while delayed type hypersensitivity to sheep red blood cells after
immunization was decreased, in Cd-exposed offspring.
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The thymus is a target organ of Cd-induced toxicity. Cd-treatment of adult rats
results in damage to the thymus as well as changes in the proliferation rate of
thymocytes (Morselt et al., 1988). T-cell development in the thymus is essential for the
establishment and maintenance of the adaptive immune system. Thymocytes mature
through a series of stages defined by expression of cell surface markers CD4 and CD8.
The most immature thymocytes are CD4-CD8- double-negative (DN). This population
gives rise to CD4+CD8+ double-positive (DP) cells, which then give rise to mature
CD4+CD8- single-positive (SP) and CD4-CD8+ SP cells. The DN population is then
further subdivided in mice based on the expression of surface markers CD25 and
CD44: CD44+CD25- (DN1) cells differentiate into CD44+CD25+ (DN2) cells, which then
develop into CD44-CD25+ (DN3) cells, which differentiate into CD44-CD25- (DN4) cells.
Several in vivo experiments in adult rodents have demonstrated that Cd causes
decreased thymus weight as well as thymic atrophy (Borgman et al., 1986; Mackova et
al., 1996; Liu et al., 1999). In adult mice, Dong et al. observed a decrease in DP cells
(2001). Pathak and Khandelwal supported these findings and demonstrated that Cd
exposure increased the number of DN cells (Pathak and Khandelwal, 2007).
The Hedgehog (Hh) and Wnt family proteins act as morphogens during thymocyte
development.

The Hh family of secreted intercellular signaling molecules is an

important regulator in patterning and organogenesis during animal development. There
are three mammalian Hh proteins: sonic hedgehog (Shh), Indian hedgehog (Ihh), and
desert hedgehog (Dhh). Hh proteins share a common signaling pathway. They bind to
their surface receptor Patched (Ptc), in order to signal to neighboring cells (Marigo et
al., 1996; Stone, 1996).

Ptc releases its suppression of the cell surface molecule

105

Smoothened (Smo), enabling the Hh signal to be transmitted into the target cell (van
den Heuvel and Ingham, 1996). This transduction is regulated by complex interactions
and modifications of many cytoplasmic proteins ultimately resulting in the activation of
members of the Gli family of zinc finger transcription factors (Gli 1-3) (Ingham and
McMahon, 2001). When Hh protein is absent, Ptc inhibits the ability of Smo to signal
(Chen and Struhl, 1998; Taipale et al., 2002). Shh signaling, in particular, is critical in
the development of thymocytes and T-cell activation (Shah et al., 2004). Shh proteins
act as regulators at several stages of T-cell development in the thymus.
In addition to Hh proteins, the Wnt family of glycoproteins is involved in regulating
thymocyte maturation (Staal et al., 2001). Wnt proteins are secreted morphogens that
are involved in a variety of cell activities in development. Wnt signals are transduced
through at least three different signaling pathways; however, the canonical β-catenin/Tcell factor-lymphoid enhancer factor (TCF-LEF) primarily functions during thymocyte
development. The canonical pathway is stimulated by Wnt proteins that bind to cell
surface Frizzled (Fz) receptors (Bhanot et al., 1996). Signaling through Fz receptors
following Wnt binding results in the stabilization of β-catenin (Behrens et al., 1996). βcatenin is a multifunctional protein that can enter the nucleus and function as a
transcription factor (Novak and Dedhar, 1999). When Wnt signaling is absent, free βcatenin is phosphorylated by glycogen synthase kinase-3β (GSK-3β) and quickly
targeted for proteosomal degradation (Ikeda et al., 1998; Amit et al., 2002; Gao et al.,
2002).

Inhibition of the Wnt pathway results in reduced DN proliferation and

differentiation, and decreased DP survival (Verbeek et al., 1995; Okamura et al., 1998;
Schilham et al., 1998).
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Cd has been found to downregulate Shh signaling in mouse embryonic limb buds
(Scott et al., 2005) and zebrafish embryos (Yu et al., 2006), as well as to dysregulate
the Wnt pathway in chick embryonic periderm (Thompson et al., 2008) and proximal
tubule cells (Prozialeck et al., 2003; Thevenod et al., 2007). The purpose of this study
was to investigate the effect of prenatal Cd exposure on thymocyte development, and to
determine if these effects were linked to dysregulation of the Shh and Wnt/β-catenin
pathways.
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MATERIALS AND METHODS
Breeding and Dosing Methodology
C57Bl/6 mice at 8-10 weeks of age were obtained from Hilltop Lab Animals, Inc.
(Scottsdale, PA). The C57Bl/6 strain of mouse was used for these experiments due to
its reported teratogenic susceptibility to Cd treatment (Hovland et al., 1999). Mice were
allowed to acclimate on site for at least one week. Two females were placed in a cage
with one male for 72 hours to maximize pregnancy rate. Females were inspected for a
vaginal plug and if present, this day was declared as gestational day 0. For each
experiment, ten dams were used as controls, having free access to deionized distilled
water (ddH2O), while ten additional dams had free access to 10 ppm of Cd as CdCl2
(Sigma-Aldrich; St. Louis, MO) dissolved in ddH2O. The dose of 10 ppm was chosen
because it is the greatest concentration that will elicit immunomodulatory effects in adult
rodents without causing systemic effects (Lafuente et al., 2003). Cd administration was
stopped at birth.

At post-natal day 0 (PND0), which was <12 h following birth, 3

offspring from each litter were euthanized and thymi were removed.

Cd concentration in kidneys
Cd levels in the kidneys of dams, and the kidneys and livers of offspring were
measured following parturition, due to Cd’s known accumulation and retention in these
organs (Webb, 1972). The purpose of determining how much Cd was retained in the
kidneys of the dams was to verify that the dams were consuming approximately equal
amounts of water, and thus, Cd dosing was consistent between dams. To measure Cd
content, kidney and liver samples were dissolved in 2 ml of 70% nitric acid.
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The

acidified samples were neutralized in 5 ml of ddH2O and filtered through Whatman no.1
paper. Samples were then diluted to volume in 10 ml ddH2O. Cd concentrations were
measured using an inductively coupled plasma optical emission spectrometry (ICPOES) (model P400 Perkin Elmer, Shelton, CT). The minimum level of detection of the
ICP-OES for Cd is 2.5 ppb.

Sex determination
The sex of newborn mice was determined by amplifying the Y-chromosomespecific SRY gene by PCR. The end piece of each tail (≈5 mm) was tr immed and lysed
in DirectPCR Lysis Reagent (Viagen Biotech, Inc., Los Angeles, CA) containing freshly
prepared 0.2-0.4 mg/ml Proteinase K (Sigma-Aldrich, St. Louis, MO). After incubation
at 55°C for 5-6 h with vigorous shaking, crude lysates were incubated at 85°C for 45
min by floating the tubes on a water bath. One µl of DNA was used in a 25 µl PCR
reaction also containing 0.5 µM SRY primers (F: 5’- GAGAGCATGGAGGGCCAT-3’; R:
5’-CCACTCCTCTGTGACACT-3’),

0.5

µM

β-actin

primers

(F:

5’-

TGTGATGGTGGGAATGGGTCAG-3’; R: 5’-TTTGATGTCACGATTTCC-3’), 15 µl of 5
PRIME HotMasterMix (Gaithersburg, MD) and molecular biology grade water. β-actin, a
housekeeping gene, was used as a positive control for the PCR reaction. The PCR
reaction was performed with a GenAmp PCR System 9700 thermal cycler (Perkin-Elmer
Applied Biosystems, Foster City, CA). PCR program was 1.5 min at 94°C, then 30
cycles of 30 s at 94°C, 30 s at 60°C, and 1 min at 72°C, then 5 min at 72°C. Ten µl of
the PCR product underwent electrophoresis on a 1% agarose gel and was visualized
under UV illumination using ethidium bromide staining (5µg/ml).
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Tissue Isolation and Cell Preparation
Thymi were harvested from euthanized mice and single cell suspensions
prepared. The organs from each mouse were kept separate. Red blood cells were
lysed using an ammonium chloride lysis buffer. Viable cells were enumerated using
trypan blue and a hemacytometer.

Whole thymic lysates and cytoplasmic/nuclear extraction
Thymic lysates used in the Shh-Light 2 cell assay and western blots were
prepared by homogenization and sonication of whole thymi in 200 µl serum-free
Dulbecco’s Modified Eagle’s Medium (DMEM) (ATCC, Manassas, VA) supplemented
with 2 µl Protease Inhibitor Cocktail (Sigma-Aldrich). Protein levels were quantitated
using the BCA Protein Assay Kit (Pierce, Rockford, IL). Cytoplasmic/nuclear extracts of
thymocytes were prepared from single-cell suspensions. Cells were harvested and
washed in 1x PBS. The pellet was resuspended in 500 µl of cytoplasm extraction buffer
(10mM HEPES, 40 mM KCl, 2 mM MgCl2, 10% glycerol, 1 mM NaPPi, 1 µg/ml
pepstatin, 1 µg/ml aprotinin, 1 µg/ml leupeptin, 1 mM NaVO4, 1 mM NaF, 1 mM PMSF,
ddH20 to 50 ml), then vortexed vigorously. Samples were centrifuged at 14,000 rpm for
15 min at 4°C. The supernatant (cytoplasmic fraction) was removed. The remaining
pellet was washed several times in 1x PBS. The pellet was resuspended in 500 µl of
nuclear extraction buffer (10 mM HEPES, 500 mM NaCl, 1% Triton-X 100, 10%
glycerol, 1 mM NaPPi, 1 µg/ml, pepstatin, 1 µg/ml, aprotinin, 1 µg/ml leupeptin, 1 mM
NaVO4, 1 mM NaF, 1 mM PMSF, ddH20 to 50 ml), then sonicated for 30 s with a 1 min
rest 8 times.

The pellet was centrifuged at 14,000 rpm for 15 min at 4°C.
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The

supernatant (nuclear fraction) was removed. Protein levels of extracts were quantified
using the 2-D Quant Kit (GE Healthcare, Piscataway, NJ).

Cell staining, flow cytometry, and cell sorting
Single cell suspensions of thymocytes were prepared as described above.
Thymocytes were stained using combinations of the following fluorochrome directly
conjugated antibodies: anti-CD45-biotin (eBioscience; San Diego, CA), anti-streptavidinPacific Blue (Invitrogen; Carlsbad, CA), anti-CD44-PE-Cy5 (eBioscience), anti-CD25PE-Cy7 (eBioscience), anti-CD4-FITC (BD Biosciences Pharmingen; San Jose, CA),
and anti-CD8-PE (BD Biosciences Pharmingen). SP and DP cell subpopulations were
identified using anti-CD4 and anti-CD8. To identify the different DN subpopulations,
anti-CD44 and anti-CD25 were determined on the CD4-CD8- population. Cells (1 x 106)
were stained using the following procedure: cells were washed with PBSAz (phosphate
buffered saline containing 2% FBS and 0.2% sodium azide) and then incubated with
whole rat and mouse IgG (Jackson ImmunoResearch, West Grove, PA) for 30 minutes
on ice to block Fc receptors, followed by a PBSAz wash. The cells were incubated for
30 mins on ice with fluorochrome labeled antibodies. The cells were washed several
times with PBSAz and fixed overnight at 4°C with 0.4% paraformaldehyde.

The

paraformaldehyde was removed and cells resuspended in PBSAz. Stained cells were
analyzed using a FACSAria and FACSDiva software (BD Biosciences Pharmingen). A
total of 10,000 events were collected for each sample.
For experiments represented in Figures 4 and 7, purified populations of
thymocytes (DN, DP, CD4+, CD8+) were sorted by flow cytometry using the antibodies
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listed above. Cells were stained, washed, and resuspended in FACS buffer (PBS, 1%
FBS, 25 mM HEPES, 2.5 mM EDTA). Final purity of all cell populations was in excess
of 93%.

Shh signaling
Shh signaling was assessed using Shh-Light 2 cells (ATCC), an NIH-3T3-derived
stable cell line containing integrated Gli-luciferase and constitutive Renilla luciferase
reporters. Shh-Light 2 cells (1 x 104 cells/well) were cultured in DMEM containing 10%
FBS to maximal density (full contact inhibition of growth) in a 96-well plate. The media
was then removed and replaced by thymic cell lysate containing 10 µg of protein in 100
µl of DMEM containing 0.5% FBS and 5 mM HEPES buffer (pH 7.4) added to the wells
in duplicate. A duplicate set of wells contained only 100 µl DMEM containing 0.5% FBS
and 5 mM HEPES served as background. Another set of duplicate wells contained 10
µg protein from a control offspring to which was added 5µM cyclopamine-KAAD
(Calbiochem, San Diego, CA), an inhibitor of Shh signaling, to verify that luciferase was
based on Shh signaling.

Cells were incubated for 36 h.

Luciferase activity was

measured and normalized to a Renilla control using the Dual-Luciferase Reporter Assay
System (Promega, Madison, WI) and Synergy HT Multi-Detection Microplate Reader
(Biotek, Winooski, VT)

Western blots
A 20-30 µg aliquot of each whole thymic lysate or cytoplasmic/nuclear extract
was boiled for 5 min to denature the proteins and electrophoresed through a 12% Tris
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polyacrylamide gel with a 5% stacking gel at 25 mAmps for 18 h. Proteins were
transferred onto Hybond-P membranes (Amersham Pharmacia, Piscataway, NJ) at 0.5
amps for 3 h. Blots were washed in TBS for 5 min at room temperature, blocked for 1 h
in TBS + 0.1% Tween 20 (TBS/T) plus 5% dry milk at room temperature and then
washed three times in TBS/T.

Blots were incubated overnight at 4°C with primary

antibodies specific for anti-Shh-N-terminal (R & D Systems, Minneapolis, MN), anti-Gli1
(Novus Biologicals, Littleton, CO), anti-Wnt10b (Abcam, Cambridge, MA), anti-active-βcatenin, clone 8E7 (Millipore, Temecula, CA), anti-phospho-β-catenin (Sigma), antiGAPDH (Santa Cruz, Santa Cruz, CA) or anti-Oct-1 (Santa Cruz) in TBS/T plus 5%
BSA or milk. The next day, blots were washed three times in TBS/T, incubated for 1 h
at room temperature with anti-Biotin (Cell Signaling Technology, Inc., Danvers, MA) and
either a goat anti-mouse IgG-horseradish peroxidase (HRP) (Millipore) or an anti-rabbit
IgG-HRP antibody (Sigma). Finally, the blots were washed three times in TBS/T and
developed using Phototope-HRP detection kit for western blots (Cell Signaling
Technology, Inc) and bands were visualized on X-Ray film (BioMax MR, Eastman
Kodak Company). Densitometric analysis was performed using ImageJ software (NIH,
Bethesda, MD).

Whole thymic and cytoplasmic protein levels were normalized to

GAPDH protein levels, while nuclear extracts were normalized to Oct-1 protein levels for
each sample.

Real-time RT-PCR
RNA isolation from whole thymi and thymocytes was performed using an RNeasy
Mini Kit (Qiagen, Valencia, CA). Total cDNA was synthesized from 40 ng RNA/sample
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with Sensiscript Reverse Transcriptase (Qiagen) according to the instructions of the
commercial supplier, and used as a target in PCR amplifications. QuantiTect Primer
Assays for Ptc1, Gli1, Wnt10b, c-jun, c-fos, c-myc, and β-actin were purchased from
Qiagen. All PCR reactions were performed on a Lightcycler 2.0 Real-time PCR System
(Roche, Indianapolis, IN) using QuantiTect SYBR Green Master Mix (Qiagen) under the
following conditions: 15 min at 95°C to activate HotStarTaq DNA polymerase then 45
cycles of 15 s at 94°C, 20 s at 55°C, and 20 s at 72°C. Melting curve analysis of PCR
products was performed to verify their specificity and identity. β-actin was used as the
reference gene.

Statistics
Results are expressed as mean ± S.E.M. For Figures 1-3, 5, and 6A, a mean of
the data from 3 mice/litter was taken and used as the N=1 data for the corresponding
dam. For Figures 4, 6B, and 7, a mean of the data from 2 mice/litter was taken and
used as the N=1 data for the corresponding dam. Statistical analyses comparing the
values for a particular cell population, protein expression, or luciferase activity between
Cd-exposed (single dose) and control offspring were performed using the t-test. An
alpha value of p≤0.05 was considered significant. Relative gene expression data was
analyzed using the 2-ΔΔCT method described in Livak and Schmittgen (2001). The foldchange reported includes the standard error. The luciferase assay and real-time RTPCR was repeated 2 times, while all other experiments were repeated at last three
times.
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RESULTS
Tissue Cd levels
The average Cd concentration for the dams was 4.37±0.76 (SEM) µg/g kidney
tissues, which demonstrates a low environmentally relevant exposure level that is
consistent between dams.

Analysis of Cd levels in the offspring was attempted;

however no Cd was detected in the kidneys and liver Cd levels were slightly above the
minimum level of detection for the ICP-OES (2.5 ppb) when livers from 3 offspring from
Cd-treated dams were pooled. Cd was not detected in the offspring from control dams.
This finding demonstrates that the offspring were exposed to Cd; however,
transplacental transfer was very low.

Effect of prenatal Cd exposure on thymocyte phenotype in post-natal day 0 offspring
Thymocyte phenotype of representative offspring from each litter was measured
by cell surface marker expression using flow cytometry. Total thymocyte number was
not significantly different between Cd-treated and control offspring (7.74±0.53 x 106 vs.
8.75±0.63 x 106, respectively). The number of CD4+ cells was significantly increased in
Cd-treated offspring compared to control offspring [3.09±0.44 x 106 vs 1.48±0.21 x 106
(p<0.05), respectively] (Figure 1A). The number of CD8+ cells showed a decreasing
trend in Cd-treated offspring, though the difference was not significant (p<0.06). The
significantly increased number of CD4+ cells and the decreased number of CD8+ cells
resulted in a nearly 10-fold increase in the CD4+/CD8+ ratio [Cd-treated, 93.14±22.94
vs. control, 9.53±3.63 (p<0.001)] (Figure 1B).

Analysis of the DN subpopulations

showed that Cd-treated offspring had significantly more DN4 cells (3.64±0.12 x 105)
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compared to control offspring (1.93±0.08 x 105) (p<0.01) (Figure 1C).

The DN3

population also showed an increasing trend in Cd-treated offspring, though the
difference was not significant (p<0.06). It should be noted that none of these effects
were sex specific.

Effect of prenatal Cd exposure on Shh signaling in the thymus
Shh signaling activity was measured in whole thymic lysates using Shh-Light 2
cells, which produce luciferase in response to active Shh proteins. In the thymus, Shh
production is restricted to thymic epithelial cells (TECs), thus this assay quantified Shh
signaling level in TECs. Thymic lysates from Cd-treated offspring had an approximate
24% decrease in Shh signaling ability compared to control offspring (Figure 2).
Cyclopamine (5µM), an inhibitor of Shh signaling, eliminated total luciferase activity in
control thymic lysates (not shown), indicating that the observed luciferase activity was
based on Shh signaling.

Effect of prenatal Cd exposure on Shh and Gli1 protein expression in the thymus
To determine if the decrease in Shh signaling activity was due to a decrease in
Shh protein levels, thymic lysates were analyzed by western blot. In Shh producing
cells, full length Shh is autocatalytically cleaved to generate an active N-terminal
fragment (Shh-N) modified by cholesterol.

Using an antibody specific for Shh-N,

western blot analysis demonstrated comparable levels of Shh protein in Cd-treated
offspring compared to controls (Figure 3A).
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It should be noted that the variability

observed in Cd-treated offspring was not correlated to sex, litter, or Cd concentration in
the dam.
When Shh is present, Gli1 proteins are translocated to the nucleus where they
activate target gene transcription. When Shh is absent, Gli1 proteins are sequestered
in the cytoplasm by a multiprotein complex that contains suppressor of fused (SUFU).
To determine if decreased Shh signaling from TECs affected Gli1 expression, protein
level analysis in whole thymic lysates was performed by western blot. Gli1 protein
levels were not significantly different between Cd-treated and control offspring (Figure
3B). To determine whether nuclear translocation of Gli1 was affected, total thymocytes
were fractionated and Gli1 protein levels were determined in cytoplasm and nuclear
fractions. The protein levels in each fraction were comparable between Cd-treated and
control offspring (data not shown).

Effect of prenatal Cd exposure on Shh target genes
mRNA levels of the Shh target genes Gli1 and Ptc1 were measured in sorted
thymocyte subpopulations using real-time RT-PCR.

Analysis of Gli1 mRNA levels

showed nearly a 5-fold increase in relative expression in DN thymocytes of Cd-treated
offspring (9.37±0.91) compared to control offspring (1.0±0.75), and a greater than 3-fold
increase in relative expression in CD8+ thymocytes of Cd-treated offspring (7.67±0.89)
compared to control offspring (1.0±0.97) (Figure 4A). Similarly, analysis of Ptc1 mRNA
showed nearly a 5-fold increase in DN thymocytes of Cd-treated offspring (6.5±1.01)
compared to control offspring (1.0±0.16), and a more than 6-fold increase in CD8+
thymocytes of Cd-treated offspring (15.24±1.44) compared to control offspring
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(1.0±1.23) (Figure 4B). In summary, prenatal Cd exposure increased expression of Shh
target genes, Gli1 and Ptc1, in DN and CD8+ thymocytes, despite decreased Shh
signaling in TECs.

Effect of prenatal Cd exposure on β-catenin protein expression in thymocytes
In order to determine the effect of prenatal Cd exposure on the Wnt/β-catenin
pathway, active β-catenin (ABC) and phosphorylated β-catenin (phospho-β-catenin)
protein levels were determined in the nucleus and cytoplasm, respectively. Western
blot analysis showed a significant decrease in ABC levels in thymocyte nuclei of Cdtreated offspring compared to control offspring [2.04±0.25 vs. 3.71±0.21 (p<0.05),
respectively] (Figure 5A).

In addition, western blot analysis of phospho-β-catenin

showed a significant increase in protein levels in thymocyte cytoplasm of Cd-treated
offspring compared to control offspring [0.48±0.07 vs. 0.19±0.07 (p<0.05), respectively]
(Figure 5B). In summary, prenatal Cd exposure increased phosphorylation of β-catenin
in the cytoplasm, resulting in decreased ABC levels in the nucleus.

Effect of prenatal Cd exposure on Wnt10b expression in the thymus
To determine whether the alteration in β-catenin levels in Cd-treated offspring
was due to a decrease in Wnt protein levels, translational and transcriptional levels of
Wnt10b were determined by western blot and real-time RT-PCR, respectively. Wnt10b
was chosen for analysis due to its expression by mouse TECs at embryonic day 15
(Pongracz et al., 2003) and its involvement in the Wnt/β-catenin pathway (Austin et al.,
1997; Van Den Berg et al., 1998). Analysis of Wnt10b protein in thymic lysates showed
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comparable levels between Cd-treated and control offspring (Figure 6A). Analysis of
Wnt10b mRNA expression showed a greater than 4-fold decrease in thymi of Cdtreated offspring compared to thymi of control offspring (0.02±0.08 vs. 1.0±0.57,
respectively) (Figure 6B). Protein levels of Wnt10b protein in thymocytes could not be
detected by western blot, thus the Wnt10b that was detected in whole thymic lysates
was from TECs.

Effect of prenatal Cd exposure on Wnt/β-catenin target genes
Wnt/β-catenin target genes c-fos, c-jun, and c-myc were measured in sorted
thymocyte subpopulations using real-time RT-PCR. Analysis of c-fos showed a 3-fold
increase in relative expression in DN and DP thymocytes of Cd-treated offspring (DN,
4.0±0.58; DP, 4.9±0.68) compared to control offspring (DN, 1.0±0.12; DP, 1.0±0.35), as
well as a greater than 5-fold increase in CD4+ thymocytes of Cd-treated offspring
(12.1±1.18) compared to control offspring (1.0±0.97) (Figure 7A). Analysis of c-jun
showed no significant difference between Cd-treated and control offspring (Figure 7B).
Analysis of c-myc showed a 3-fold increase in relative expression in DN and DP
thymocytes of Cd-treated offspring (DN, 4.4±0.41; DP, 4.4±0.44) compared to control
offspring (DN, 1±0.34; DP, 1±0.3) (Figure 7C).

In summary, prenatal Cd exposure

increased at least one Wnt/β-catenin target gene in all thymocyte subpopulations
analyzed except CD8+ thymocytes.
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Figure 1. Thymocyte phenotype of PND0 offspring. Thymocytes were isolated from
newborn mice (< 12 h old) whose mothers were exposed to 10 ppm Cd throughout
pregnancy. Single cell suspensions were prepared for flow cytometry analysis. Each
bar represents the mean ± SEM. Data is representative of 3 independent experiments
where N=6 in each group. (A) Thymocyte phenotype was determined based on CD4
and CD8 cell surface expression. *, p < 0.05 (B) CD4+/CD8+ ratio was based on
thymocyte number. *, p < 0.001 (C) DN subpopulation phenotype was determined
based on CD44 and CD25 cell surface expression. *, p < 0.01
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Figure 2
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Figure 2. Shh signaling activity in thymic lysates of PND0 offspring. Thymic
lysates were prepared from newborn mice (< 12 h old) whose mothers were exposed to
10 ppm Cd throughout pregnancy. Shh signaling was measured by luciferase activity in
Shh-Light 2 cells. Each bar represents the mean ± SEM. The mean value of control
samples was given a value of 100. Data is representative of 2 independent
experiments where N=7 in each group. *, p < 0.05
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Figure 3. Shh and Gli1 expression in thymic lysates of PND0 offspring. Thymic
lysates were prepared from newborn mice (< 12 h old) whose mothers were exposed to
10 ppm Cd throughout pregnancy. Protein levels were determined by western blot.
GAPDH was used as loading control. Each bar represents the mean ± SEM. Data is
representative of 3 independent experiments where N=3 in each group. The ratio of NShh protein to GAPDH protein (A) and the ratio of Gli1 protein to GAPDH protein (B)
was determined using densitometry of the detected bands.
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Figure 4.

Hh target gene expression in thymocyte subpopulations of PND0

offspring. Primers specific for (A) Gli1 and (B) Ptc1 were used to determine their
expression in DN, DP, CD4+, and CD8+ thymocyte populations.

β-actin was used as

the reference gene. Relative quantification of target genes was calculated using 2-ΔΔCT.
Data is representative of 2 independent experiments where N=2 in each group. *, ≥ 3fold difference between control and Cd-treated groups.
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Figure 5. Active β-catenin and phospho-β-catenin expression in thymocytes of
PND0 offspring. Thymocytes were isolated from newborn mice (< 12 h old) whose
mothers were exposed to 10 ppm Cd throughout pregnancy. Cytoplasmic and nuclear
fractions were extracted and analyzed by western blot. GAPDH (cytoplasmic) and Oct1 (nuclear) were used as loading controls. Each bar represents the mean ± SEM. Data
is representative of 3 independent experiments where N=3 in each group. The ratio of
active β-catenin protein to Oct-1 protein in nuclear fractions (A) and the ratio of
phospho-β-catenin protein to GAPDH protein in cytoplasmic fractions (B) was
determined using densitometry of the detected bands. *, p < 0.05

129

Figure 6
A

Wnt10b/GAPDH

0.4

0.3

0.2

0.1

0.0

B

Relative expression of Wnt10b mRNA

Control

Cd-treated

1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4

*

0.2
0.0
Control

130

Cd-treated

Figure 6. Wnt10b expression in thymus of PND0 offspring. (A) Thymic lysates
were prepared from newborn mice (< 12 h old). Protein levels were determined by
western blot. GAPDH was used as loading control. Each bar represents the mean ±
SEM. Data is representative of 3 independent experiments where N=3 in each group.
(B) Primers specific for Wnt10b were used to determine mRNA expression in whole
thymus. β-actin was used as the reference gene. Relative quantification of target genes
was calculated using 2-ΔΔCT.

Data is representative of 2 independent experiments

where N=2 in each group. *, ≥ 3-fold difference between control and Cd-treated groups.
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Figure 7. Wnt/β-catenin target gene expression in thymocyte subpopulations of
PND0 offspring.

Primers specific for (A) c-fos, (B) c-jun, and (C) c-myc were used to

determine their expression in DN, DP, CD4+, and CD8+ thymocyte populations. β-actin
was used as the reference gene. Relative quantification of target genes was calculated
using 2-ΔΔCT.

Data is representative of 2 independent experiments where N=2 in each

group. *, ≥ 3-fold difference between control and Cd-treated groups.
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DISCUSSION
Immunotoxic effects following Cd exposure in adult animals are well
documented;

however,

there

have

been

no

studies

that

investigate

the

immunomodulatory effects of gestational Cd exposure to the offspring on thymocyte
development. Studies demonstrating a dysregulation of Shh (Scott et al., 2005) and
Wnt/β-catenin (Thompson et al., 2008) signaling by prenatal Cd exposure, coupled with
the requirement for Shh (Outram et al., 2000) and Wnt/β-catenin (Oosterwegel et al.,
1991; Verbeek et al., 1995; Hattori et al., 1996; Ioannidis et al., 2001) in thymocyte
development, led to the hypothesis that prenatal Cd exposure dysregulates these
signaling pathways in the offspring, leading to changes in thymocyte phenotype. To our
knowledge, this is the first study to link prenatal Cd exposure to changes in thymocyte
development and to dysregulation of the Wnt/β-catenin pathway in a mouse model.
Our ex vivo analysis of thymocyte phenotype showed that prenatal Cd exposure
increased the number of CD4+ and DN4+ cells, as well as the CD4+/CD8+ ratio. Other
studies that have examined the effect of direct in vitro Cd exposure on thymocyte
phenotype, however, report a decrease in DP cells (Dong et al., 2001; Pathak and
Khandelwal, 2007), an increase in DN cells (Pathak and Khandelwal, 2007), and a
decrease in the CD4+/CD8+ ratio (Dong et al., 2001; Pathak and Khandelwal, 2007). In
those studies, primary thymocytes from 3-6 week old male Balb/c mice were exposed in
vitro to various Cd concentrations (5-50 μM) for several time intervals (3-24 h).
However, the relevance of these studies to the interpretation of those reported herein is
questionable because of the differences in experimental design such as in vitro vs. in
vivo exposure, Cd dose, length of exposure, mouse strain, and developmental stage of
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the exposed cells. In addition, in vitro exposure would not account for possible effects
on the thymic epithelium in addition to the thymocytes that as described below, could
have a significant impact on the phenotype.

In our study, thymocytes are being

exposed to an indirect, environmentally relevant concentration of Cd. Although Cd was
detected in pooled livers of the offspring, the level was close to the minimum level of
detection, thus we believe that any possible direct Cd effect is minimal to nil. The
increased CD4+/CD8+ ratio observed in our study could have several consequences in
cell-mediated immunity and T-cell host response to infection including an increased
chance of developing autoimmune disease and allergies, as well as an increased
susceptibility to viruses and tumor cells.
Analysis of Shh signaling showed that prenatal Cd exposure dysregulates
several components of this pathway (Figure 8A). Shh is produced by thymic epithelial
cells (TECs), while its receptor molecules Ptc and Smo are expressed by thymocytes
(Outram et al., 2000), thus the decreased Shh signaling activity observed in the ShhLight 2 cell assay can be attributed to a down- regulation in signal transduction from the
Shh-producing cells to the Shh-receiving cells (Figure 8A, top). The downregulation of
Shh target gene Wnt10b in the whole thymus further supports an inhibitory role of
prenatal Cd exposure on Shh signaling from the epithelium. Analysis of Shh protein in
thymic lysates via western blot indicates that active Shh protein levels are unchanged.
Several processing events must occur for proper secretion of the processed Shh (ShhNp). Such events include: post-translation cleavage of the original 45 kDa protein along
with cholesterol modification of the active 19 kDa fragment (Porter et al., 1995),
palmitoylation of the N-terminal cysteine (Pepinsky et al., 1998), requirement of the
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protein Dispatched for secretion (Burke et al., 1999), and multimerization of the Shh
protein (Zeng et al., 2001). Since the antibody used in this study recognizes the
cholesterol-modified form of Shh, it is unlikely that Cd affects this step of modification;
however, any of the other steps may be altered following prenatal Cd exposure.
Cells near the source of Shh secretion can modulate the range of the signal by
upregulating their expression of Ptc, which can sequester Shh and thereby prevent it
from spreading further (Chen and Struhl, 1996). Studies determining the expression
pattern of Smo and the Gli genes suggest that the thymocytes responding to the Shh
signal are DN cells and CD8+ cells (Outram et al., 2000). In addition, analysis of Shh-/thymi showed that Shh is necessary for efficient proliferation of DN thymocytes (Shah et
al., 2004). In our study, analysis of Shh target genes Ptc1 and Gli1 in Cd-treated
offspring showed a significant upregulation of both genes in the DN and CD8+ cell
population, while there was no difference in either gene in the DP and CD4+ cell
populations (Figure 8A, bottom).

Based on our data, we hypothesized that in an

environment where Shh signaling is decreased, DN and CD8+ cells may upregulate
Ptc1 in order to sequester the limited signal. Upregulation of Gli1 transcription indicates
that Shh signaling is increased in the DN and CD8+ cell populations, despite the
decreased Shh signal from the TECs and the unchanged protein level of Gli1 in the total
thymocyte population. Analysis of thymocyte phenotype showed a significant increase
in the DN4 cell population as well as a trended increase in the DN3 cell population,
thus, increased Shh signaling may contribute to increased proliferation of these cell
populations. The role that Shh signaling plays in single positive cells has not been well
defined, however, one study showed that Shh signaling in developing thymocytes
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influences TCR repertoire selection and differentiation from DP to SP cells (Rowbotham
et al., 2007). Specifically, in Shh-/- fetal thymic organ cultures, the CD4+/CD8+ ratio was
increased, therefore, the decreased Shh signal from TECs in the present study is likely
contributing to the increased CD4+/CD8+ ratio observed in prenatal Cd-treated offspring.
In addition, the increased transcription of Ptc1 and Gli1 in CD8+ and no change in these
genes in CD4+ cells may also contribute to the significantly increased CD4+/CD8+ ratio
observed in thymocyte phenotype analysis.
Analysis of Wnt/β-catenin signaling showed that prenatal Cd exposure
dysregulates several components of this pathway (Figure 8B). Wnt proteins begin as
precursors containing an N-terminal hydrophobic signal peptide that directs the
immature protein to the endoplasmic reticulum (ER). In the ER, the signal peptide is
cleaved by a protease and the Wnt protein is modified by the addition of sugars and
lipids by the acyl-transferase porcupine (Tanaka, 2000). This is required for proper
secretion to occur.

The attachment of a palmitate moiety to a conserved cysteine

residue on the Wnts, which converts them into hydrophobic proteins, is essential for
their biological activity (Willert et al., 2003; Zhai et al., 2004). Transport and secretion of
the Wnt protein in secretory vesicles is controlled by the multi-pass transmembrane
protein Wntless (Wls)/Evenness interrupted (Evi) (Ching and Nusse, 2006). TECs are
the main source of Wnt proteins in the thymus, while the Wnt receptor, Frizzled (Fz), is
mostly found on thymocytes, which indicates a crosstalk between TECs and thymocytes
(Pongracz et al., 2003). In our study, we observed unchanged protein levels of Wnt10b
in TECs (Figure 8B, top), along with decreased Wnt/β-catenin signaling in thymocytes
as determined by increased cytoplasmic phospho-β-catenin and decreased nuclear
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ABC (Figure 8B, bottom).

These findings suggest that prenatal Cd treatment is

affecting the palmitoylation processing or secretion steps of Wnt in the epithelium. The
decrease in properly processed/secreted Wnt ligand would lead to degradation of βcatenin in the cytoplasm, which is observed in prenatal Cd-treated offspring.

In

addition, others have demonstrated that ABC enhances the generation of CD8+ cells
from DP cells (Mulroy et al., 2003), thus decreased ABC may be responsible for the
increased CD4+/CD8+ ratio we observed in prenatal Cd-treated offspring.
Cd has been shown to be mitogenic and to influence the expression of genes,
especially the cellular proto-oncogenes, also known as the immediate early response
genes, that encode nuclear transcription factors and influence subsequent expression of
other genes (Vogt and Bos, 1989). Cd-induced accumulation of transcripts of c-fos, cjun, and c-myc has been reported in several cell types of animals and humans (Jin and
Ringertz, 1990; Tang and Enger, 1993; Matsuoka and Call, 1995; Wang and
Templeton, 1998; Achanzar et al., 2000; Joseph et al., 2001).

These genes are

generally associated with cell proliferation, thus their induction indicates a mechanism
by which Cd may promote the development of cancer.

In our study, c-fos was

upregulated in DN, DP, and CD4+ cells, but was unaffected in CD8+ cells; c-myc was
upregulated in DN and DP cells, but was unaffected in CD4+ and CD8+ cells; and c-jun
was unaffected in all cell populations (Figure 8B, bottom). In summation, a significant
increase in at least one of these immediate early response genes was present in every
thymocyte population analyzed except for the CD8+ population. Interestingly, thymocyte
phenotype analysis showed that this was the only population that had a trended
decrease following prenatal Cd exposure. Although c-fos, c-jun, and c-myc are known
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Wnt/β-catenin target genes, it is unlikely that their upregulation is due to an increase in
ABC levels since prenatal Cd exposure caused a decrease in ABC and an increase in
phospho-β-catenin protein levels in total thymocytes when analyzed via western blot.
β-catenin, together with DNA-binding T cell factor/lymphoid enhancer factor (TCF/LEF)
family proteins, functions as a transcription factor to control Wnt target genes, thus,
prenatal Cd exposure may be upregulating TCF/LEF or downregulating repressors such
as Groucho/TLE which would result in upregulation of the proto-oncogenes. It has also
been demonstrated that overexpression of cellular proto-oncogenes by Cd is mediated
by the elevation of intracellular levels of superoxide anion, hydrogen peroxide, and
calcium (Joseph et al., 2001).
In summary, we exposed pregnant mice to an environmentally relevant dose of
Cd throughout pregnancy and analyzed the effects on thymocyte phenotype of the
offspring.

We also examined the effect of prenatal Cd exposure on two signaling

pathways necessary for proper thymocyte maturation. We demonstrated that prenatal
Cd exposure alters Shh and Wnt/β-catenin signaling resulting in aberrant thymocyte
development.

It is likely that prenatal Cd exposure affects the processing and/or

secretion of Shh and Wnt proteins in the thymic epithelium resulting in an attenuated
signal in both pathways as demonstrated by a decrease in Gli:luciferase activity and a
decrease in nuclear ABC levels. The overall upregulation of immediate early response
genes suggests that prenatal Cd also affects an intracellular component of the
thymocyte independent of the effects on the thymic epithelium.

Although it is known

that Shh and Wnt/β-catenin signaling influences fetal thymocyte development, the
specific time points at which they play a role and the regulation of their components, as
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well as their interaction with each other need further investigation. In addition to the
thymus, Hh and Wnt/β-catenin signaling is necessary for proper development of the
kidney (Stark et al., 1994; Kang et al., 1997), bone (Gao et al., 2001; Gong et al., 2001;
Loughlin et al., 2004), lung (Pepicelli et al., 1998; Tebar et al., 2001; Mucenski et al.,
2003; Okubo and Hogan, 2004), and prostate (Podlasek et al., 1999; Truica et al., 2000;
Lamm et al., 2002; Mulholland et al., 2002; Chesire and Isaacs, 2003; Freestone et al.,
2003; Berman et al., 2004), all of which are target organs of Cd toxicity (Bernard, 2008).
Due to Hh and Wnt/β-catenin signaling being highly conserved among organ systems, it
is plausible that prenatal Cd exposure disrupts these pathways in other organs,
resulting in developmental malformations, increased cell proliferation, and possibly
cancer.

142

ACKNOWLEDGEMENTS
The authors wish to thank Courtney Williamson and the Dr. John Hollander lab for their
technical assistance with the luciferase assay.

143

REFERENCES
Achanzar, W. E., Achanzar, K. B., Lewis, J. G., Webber, M. M., and Waalkes, M. P.
(2000). Cadmium induces c-myc, p53, and c-jun expression in normal human
prostate epithelial cells as a prelude to apoptosis. Toxicol Appl Pharmacol 164,
291-300.
Amit, S., Hatzubai, A., Birman, Y., Andersen, J. S., Ben-Shushan, E., Mann, M., BenNeriah, Y., and Alkalay, I. (2002). Axin-mediated CKI phosphorylation of betacatenin at Ser 45: a molecular switch for the Wnt pathway. Genes & development
16, 1066-1076.
Austin, T. W., Solar, G. P., Ziegler, F. C., Liem, L., and Matthews, W. (1997). A role for
the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells.
Blood 89, 3624-3635.
Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and
Birchmeier, W. (1996). Functional interaction of beta-catenin with the
transcription factor LEF-1. Nature 382, 638-642.
Berman, D. M., Desai, N., Wang, X., Karhadkar, S. S., Reynon, M., Abate-Shen, C.,
Beachy, P. A., and Shen, M. M. (2004). Roles for Hedgehog signaling in
androgen production and prostate ductal morphogenesis. Developmental biology
267, 387-398.
Bernard, A. (2008). Cadmium & its adverse effects on human health. The Indian journal
of medical research 128, 557-564.

144

Bhanot, P., Brink, M., Samos, C. H., Hsieh, J.-C., Wang, Y., Macke, J. P., Andrew, D.,
Nathans, J., and Nusse, R. (1996). A new member of the frizzled family from
Drosophila functions as a Wingless receptor. Nature 382, 225-230.
Borgman, R. F., Au, B., and Chandra, R. K. (1986). Immunopathology of chronic
cadmium administration in mice. International journal of immunopharmacology 8,
813-817.
Burke, R., Nellen, D., Bellotto, M., Hafen, E., Senti, K. A., Dickson, B. J., and Basler, K.
(1999). Dispatched, a novel sterol-sensing domain protein dedicated to the
release of cholesterol-modified hedgehog from signaling cells. Cell 99, 803-815.
Chen, Y., and Struhl, G. (1996). Dual Roles for Patched in Sequestering and
Transducing Hedgehog. Cell 87, 553-563.
Chen, Y., and Struhl, G. (1998). In vivo evidence that Patched and Smoothened
constitute distinct binding and transducing components of a Hedgehog receptor
complex. Development 125, 4943-4948.
Chesire, D. R., and Isaacs, W. B. (2003). Beta-catenin signaling in prostate cancer: an
early perspective. Endocrine-related cancer 10, 537-560.
Ching, W., and Nusse, R. (2006). A dedicated Wnt secretion factor. Cell 125, 432-433.
Cook, M. E. (1995). Anthropogenic Sources of Cadmium in Canada. National Workshop
on Cadmium Transport Into Plants, Canadian Network of Toxicology Centres,
Ottawa, Ontario, Canada.
Dong, S., Shen, H. M., and Ong, C. N. (2001). Cadmium-induced apoptosis and
phenotypic changes in mouse thymocytes. Molecular and cellular biochemistry
222, 11-20.

145

Freestone, S. H., Marker, P., Grace, O. C., Tomlinson, D. C., Cunha, G. R., Harnden,
P., and Thomson, A. A. (2003). Sonic hedgehog regulates prostatic growth and
epithelial differentiation. Developmental biology 264, 352-362.
Gao, B., Guo, J., She, C., Shu, A., Yang, M., Tan, Z., Yang, X., Guo, S., Feng, G., and
He, L. (2001). Mutations in IHH, encoding Indian hedgehog, cause brachydactyly
type A-1. Nature genetics 28, 386-388.
Gao, Z. H., Seeling, J. M., Hill, V., Yochum, A., and Virshup, D. M. (2002). Casein
kinase I phosphorylates and destabilizes the beta-catenin degradation complex.
Proceedings of the National Academy of Sciences of the United States of
America 99, 1182-1187.
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M.,
Wang, H., Cundy, T., Glorieux, F. H., Lev, D., Zacharin, M., Oexle, K., Marcelino,
J., Suwairi, W., Heeger, S., Sabatakos, G., Apte, S., Adkins, W. N., Allgrove, J.,
Arslan-Kirchner, M., Batch, J. A., Beighton, P., Black, G. C., Boles, R. G., Boon,
L. M., Borrone, C., Brunner, H. G., Carle, G. F., Dallapiccola, B., De Paepe, A.,
Floege, B., Halfhide, M. L., Hall, B., Hennekam, R. C., Hirose, T., Jans, A.,
Juppner, H., Kim, C. A., Keppler-Noreuil, K., Kohlschuetter, A., LaCombe, D.,
Lambert, M., Lemyre, E., Letteboer, T., Peltonen, L., Ramesar, R. S.,
Romanengo, M., Somer, H., Steichen-Gersdorf, E., Steinmann, B., Sullivan, B.,
Superti-Furga, A., Swoboda, W., van den Boogaard, M. J., Van Hul, W., Vikkula,
M., Votruba, M., Zabel, B., Garcia, T., Baron, R., Olsen, B. R., and Warman, M.
L. (2001). LDL receptor-related protein 5 (LRP5) affects bone accrual and eye
development. Cell 107, 513-523.

146

Hattori, N., Kawamoto, H., Fujimoto, S., Kuno, K., and Katsura, Y. (1996). Involvement
of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T
cell development in the thymus. The Journal of experimental medicine 184,
1137-1147.
Hovland, D. N., Jr., Machado, A. F., Scott, W. J., Jr., and Collins, M. D. (1999).
Differential sensitivity of the SWV and C57BL/6 mouse strains to the teratogenic
action of single administrations of cadmium given throughout the period of
anterior neuropore closure. Teratology. 60, 13-21.
Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., and Kikuchi, A. (1998).
Axin, a negative regulator of the Wnt signaling pathway, forms a complex with
GSK-3beta

and

beta-catenin

and

promotes

GSK-3beta-dependent

phosphorylation of beta-catenin. The EMBO journal 17, 1371-1384.
Ingham, P. W., and McMahon, A. P. (2001). Hedgehog signaling in animal
development: paradigms and principles. Genes and Development 15, 30593087.
Ioannidis, V., Beermann, F., Clevers, H., and Held, W. (2001). The beta-catenin--TCF-1
pathway ensures CD4(+)CD8(+) thymocyte survival. Nature immunology 2, 691697.
Jacquillet, G., Barbier, O., Rubera, I., Tauc, M., Borderie, A., Namorado, M. C., Martin,
D., Sierra, G., Reyes, J. L., Poujeol, P., and Cougnon, M. (2007). Cadmium
causes delayed effects on renal function in the offspring of cadmiumcontaminated pregnant female rats. American journal of physiology 293, F14501460.

147

Jin, P., and Ringertz, N. R. (1990). Cadmium induces transcription of proto-oncogenes
c-jun and c-myc in rat L6 myoblasts. J. Biol. Chem. 265, 14061-14064.
Jin, T., Lu, J., and Nordberg, M. (1998). Toxicokinetics and biochemistry of cadmium
with special emphasis on the role of metallothionein. Neurotoxicology. 19, 529535.
Joseph, P., Muchnok, T. K., Klishis, M. L., Roberts, J. R., Antonini, J. M., Whong, W. Z.,
and Ong, T. (2001). Cadmium-induced cell transformation and tumorigenesis are
associated with transcriptional activation of c-fos, c-jun, and c-myc protooncogenes: role of cellular calcium and reactive oxygen species. Toxicol Sci 61,
295-303.
Kang, S., Graham, J. M., Jr., Olney, A. H., and Biesecker, L. G. (1997). GLI3 frameshift
mutations cause autosomal dominant Pallister-Hall syndrome. Nature genetics
15, 266-268.
Lafuente, A., Gonzalez-Carracedo, A., Romero, A., and Esquifino, A. I. (2003). Effect of
cadmium on lymphocyte subsets distribution in thymus and spleen. J Physiol
Biochem. 59, 43-48.
Lamm, M. L., Catbagan, W. S., Laciak, R. J., Barnett, D. H., Hebner, C. M., Gaffield, W.,
Walterhouse, D., Iannaccone, P., and Bushman, W. (2002). Sonic hedgehog
activates mesenchymal Gli1 expression during prostate ductal bud formation.
Developmental biology 249, 349-366.
Lauwerys, R., Buchet, J. P., Roels, H., Bernard, A., and Gennart, J. P. (1986).
[Biological aspects of occupational exposure to cadmium and several other
metals]. Revue d'epidemiologie et de sante publique 34, 280-285.

148

Liu, J., Liu, Y., Habeebu, S. S., and Klaassen, C. D. (1999). Metallothionein-null mice
are highly susceptible to the hematotoxic and immunotoxic effects of chronic
CdCl2 exposure. Toxicology and applied pharmacology 159, 98-108.
Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data
using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods
(San Diego, Calif 25, 402-408.
Loughlin, J., Dowling, B., Chapman, K., Marcelline, L., Mustafa, Z., Southam, L.,
Ferreira, A., Ciesielski, C., Carson, D. A., and Corr, M. (2004). Functional
variants within the secreted frizzled-related protein 3 gene are associated with
hip osteoarthritis in females. Proceedings of the National Academy of Sciences
of the United States of America 101, 9757-9762.
Mackova, N. O., Lenikova, S., Fedorocko, P., Brezani, P., and Fedorockova, A. (1996).
Effects of cadmium on haemopoiesis in irradiated and non-irradiated mice: 2.
Relationship to the number of circulating blood cells and haemopoiesis.
Physiological research / Academia Scientiarum Bohemoslovaca 45, 101-106.
Marigo, V., Davey, R. A., Zuo, Y., Cunningham, J. M., and Tabin, C. J. (1996).
Biochemical evidence that patched is the Hedgehog receptor. Nature 384, 176179.
Matsuoka, M., and Call, K. M. (1995). Cadmium-induced expression of immediate early
genes in LLC-PK1 cells. Kidney international 48, 383-389.
Minetti, A., and Reale, C. A. (2006). Sensorimotor developmental delays and lower
anxiety in rats prenatally exposed to cadmium. J Appl Toxicol 26, 35-41.

149

Morselt, A. F. W., Leene, W., DeGroot, C., Kipp, J. B. A., Evers, M., Roelofsen, A. M.,
and Bosch, K. S. (1988). Differences in immunological susceptibility to cadmium
toxicity between two rat strains as demonstrated with cell biological methods.
Effect of cadmium on DNA synthesis of thymus lymphocytes. Toxicology 48, 127139.
Mucenski, M. L., Wert, S. E., Nation, J. M., Loudy, D. E., Huelsken, J., Birchmeier, W.,
Morrisey, E. E., and Whitsett, J. A. (2003). beta-Catenin is required for
specification of proximal/distal cell fate during lung morphogenesis. The Journal
of biological chemistry 278, 40231-40238.
Mulholland, D. J., Cheng, H., Reid, K., Rennie, P. S., and Nelson, C. C. (2002). The
androgen receptor can promote beta-catenin nuclear translocation independently
of adenomatous polyposis coli. The Journal of biological chemistry 277, 1793317943.
Mulroy, T., Xu, Y., and Sen, J. M. (2003). beta-Catenin expression enhances generation
of mature thymocytes. International immunology 15, 1485-1494.
Nordberg, G. F. (2006). Lung cancer and exposure to environmental cadmium. Lancet
Oncol. 7, 99-101.
Novak, A., and Dedhar, S. (1999). Signaling through beta-catenin and Lef/Tcf. Cell Mol
Life Sci 56, 523-537.
Okamura, R. M., Sigvardsson, M., Galceran, J., Verbeek, S., Clevers, H., and
Grosschedl, R. (1998). Redundant regulation of T cell differentiation and
TCRalpha gene expression by the transcription factors LEF-1 and TCF-1.
Immunity 8, 11-20.

150

Okubo, T., and Hogan, B. L. (2004). Hyperactive Wnt signaling changes the
developmental potential of embryonic lung endoderm. Journal of biology 3, 11.
Oosterwegel, M., van de Wetering, M., Dooijes, D., Klomp, L., Winoto, A.,
Georgopoulos, K., Meijlink, F., and Clevers, H. (1991). Cloning of murine TCF-1,
a T cell-specific transcription factor interacting with functional motifs in the CD3epsilon and T cell receptor alpha enhancers. The Journal of experimental
medicine 173, 1133-1142.
Outram, S. V., Varas, A., Pepicelli, C. V., and Crompton, T. (2000). Hedgehog signaling
regulates differentiation from double-negative to double-positive thymocyte.
Immunity. 13, 187-197.
Pathak, N., and Khandelwal, S. (2007). Impact of cadmium in T lymphocyte subsets and
cytokine expression: differential regulation by oxidative stress and apoptosis.
Biometals.
Pepicelli, C. V., Lewis, P. M., and McMahon, A. P. (1998). Sonic hedgehog regulates
branching morphogenesis in the mammalian lung. Curr Biol 8, 1083-1086.
Pepinsky, R. B., Zeng, C., Wen, D., Rayhorn, P., Baker, D. P., Williams, K. P., Bixler, S.
A., Ambrose, C. M., Garber, E. A., Miatkowski, K., Taylor, F. R., Wang, E. A., and
Galdes, A. (1998). Identification of a palmitic acid-modified form of human Sonic
hedgehog. The Journal of biological chemistry 273, 14037-14045.
Podlasek, C. A., Barnett, D. H., Clemens, J. Q., Bak, P. M., and Bushman, W. (1999).
Prostate development requires Sonic hedgehog expressed by the urogenital
sinus epithelium. Developmental biology 209, 28-39.

151

Pongracz, J., Hare, K., Harman, B., Anderson, G., and Jenkinson, E. J. (2003). Thymic
epithelial cells provide WNT signals to developing thymocytes. European journal
of immunology 33, 1949-1956.
Porter, J. A., von Kessler, D. P., Ekker, S. C., Young, K. E., Lee, J. J., Moses, K., and
Beachy, P. A. (1995). The product of hedgehog autoproteolytic cleavage active in
local and long-range signalling. Nature 374, 363-366.
Prozialeck, W. C., Lamar, P. C., and Lynch, S. M. (2003). Cadmium alters the
localization of N-cadherin, E-cadherin, and [beta]-catenin in the proximal tubule
epithelium. Toxicology and Applied Pharmacology 189, 180-195.
Rowbotham, N. J., Hager-Theodorides, A. L., Cebecauer, M., Shah, D. K.,
Drakopoulou, E., Dyson, J., Outram, S. V., and Crompton, T. (2007). Activation
of the Hedgehog signaling pathway in T-lineage cells inhibits TCR repertoire
selection in the thymus and peripheral T-cell activation, pp. 3757-3766.
Schilham, M. W., Wilson, A., Moerer, P., Benaissa-Trouw, B. J., Cumano, A., and
Clevers, H. C. (1998). Critical involvement of Tcf-1 in expansion of thymocytes. J
Immunol 161, 3984-3991.
Scott, W. J., Jr., Schreiner, C. M., Goetz, J. A., Robbins, D., and Bell, S. M. (2005).
Cadmium-induced postaxial forelimb ectrodactyly: association with altered sonic
hedgehog signaling. Reproductive toxicology (Elmsford, N.Y 19, 479-485.
Shah, D. K., Hager-Theodorides, A. L., Outram, S. V., Ross, S. E., Varas, A., and
Crompton, T. (2004). Reduced thymocyte development in sonic hedgehog
knockout embryos. J Immunol 172, 2296-2306.

152

Soukupova, D., Dostal, M., and Piza, J. (1991). Developmental toxicity of cadmium in
mice. II. Immunotoxic effects. Functional and developmental morphology 1, 3136.
Staal, F. J., Meeldijk, J., Moerer, P., Jay, P., van de Weerdt, B. C., Vainio, S., Nolan, G.
P., and Clevers, H. (2001). Wnt signaling is required for thymocyte development
and activates Tcf-1 mediated transcription. European journal of immunology 31,
285-293.
Stark, K., Vainio, S., Vassileva, G., and McMahon, A. P. (1994). Epithelial
transformation of metanephric mesenchyme in the developing kidney regulated
by Wnt-4. Nature 372, 679-683.
Stone, D. M. (1996). The tumour-suppressor gene patched encodes a candidate
receptor for Sonic hedgehog. Nature 384, 129-134.
Taipale, J., Cooper, M. K., Maiti, T., and Beachy, P. A. (2002). Patched acts catalytically
to suppress the activity of Smoothened. Nature 418, 892-896.
Tanaka, K., Koji, O, Makoto,A, Norbert, P, Tatsuhiko, K (2000). The evolutionarily
conserved porcupine gene family is involved in the processing of the Wnt family.
European Journal of Biochemistry 267, 4300-4311.
Tang, N., and Enger, M. D. (1993). Cd(2+)-induced c-myc mRNA accumulation in NRK49F cells is blocked by the protein kinase inhibitor H7 but not by HA1004,
indicating that protein kinase C is a mediator of the response. Toxicology 81,
155-164.

153

Tebar, M., Destree, O., de Vree, W. J., and Ten Have-Opbroek, A. A. (2001).
Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing
mouse lung. Mechanisms of development 109, 437-440.
Thevenod, F., Wolff, N. A., Bork, U., Lee, W. K., and Abouhamed, M. (2007). Cadmium
induces nuclear translocation of beta-catenin and increases expression of c-myc
and Abcb1a in kidney proximal tubule cells. Biometals 20, 807-820.
Thompson, J., Wong, L., Lau, P. S., and Bannigan, J. (2008). Adherens junction
breakdown in the periderm following cadmium administration in the chick
embryo: distribution of cadherins and associated molecules. Reproductive
toxicology (Elmsford, N.Y 25, 39-46.
Truica, C. I., Byers, S., and Gelmann, E. P. (2000). Beta-catenin affects androgen
receptor transcriptional activity and ligand specificity. Cancer research 60, 47094713.
Van Den Berg, D. J., Sharma, A. K., Bruno, E., and Hoffman, R. (1998). Role of
members of the Wnt gene family in human hematopoiesis. Blood 92, 3189-3202.
van den Heuvel, M., and Ingham, P. W. (1996). smoothened encodes a receptor-like
serpentine protein required for hedgehog signalling. Nature 382, 547-551.
Verbeek, S., Izon, D., Hofhuis, F., Robanus-Maandag, E., te Riele, H., van de Wetering,
M., Oosterwegel, M., Wilson, A., MacDonald, H. R., and Clevers, H. (1995). An
HMG-box-containing T-cell factor required for thymocyte differentiation. Nature
374, 70-74.
Vogt, P. K., and Bos, T. J. (1989). The oncogene jun and nuclear signalling. Trends in
biochemical sciences 14, 172-175.

154

Wang, Z., and Templeton, D. M. (1998). Induction of c-fos proto-oncogene in mesangial
cells by cadmium. The Journal of biological chemistry 273, 73-79.
Webb, M. (1972). Persistence of stored Cd2+ in the livers and kidneys of female rats
during pregnancy. J Reprod Fertil 30, 99-103.
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T.,
Yates, J. R., 3rd, and Nusse, R. (2003). Wnt proteins are lipid-modified and can
act as stem cell growth factors. Nature 423, 448-452.
Yu, R. M., Lin, C. C., Chan, P. K., Chow, E. S., Murphy, M. B., Chan, B. P., Muller, F.,
Strahle, U., and Cheng, S. H. (2006). Four-dimensional imaging and
quantification of gene expression in early developing zebrafish (Danio rerio)
embryos. Toxicol Sci. 90, 529-538.
Zeng, X., Goetz, J. A., Suber, L. M., Scott, W. J., Jr., Schreiner, C. M., and Robbins, D.
J. (2001). A freely diffusible form of Sonic hedgehog mediates long-range
signalling. Nature 411, 716-720.
Zhai, L., Chaturvedi, D., and Cumberledge, S. (2004). Drosophila wnt-1 undergoes a
hydrophobic modification and is targeted to lipid rafts, a process that requires
porcupine. The Journal of biological chemistry 279, 33220-33227.

155

CHAPTER 3: Prenatal cadmium exposure alters
postnatal immune cell development and function

156

Prenatal cadmium exposure alters postnatal immune cell development and function

Miranda L. Hanson, Kathleen M. Brundage, Rosana Schafer, Rodney A. Brundage, and
John B. Barnett
Department of Microbiology, Immunology and Cell Biology, West Virginia University
School of Medicine, Morgantown, WV 26506

Running title: Prenatal cadmium affects immune cells

Correspondence to:
John B. Barnett, Ph.D.
Department of Microbiology, Immunology and Cell Biology
PO Box 9177
West Virginia University
Morgantown, WV. 26506-9177
(T). 304-293-4029; (F) 304-293-7823
jbarnett@hsc.wvu.edu

157

ABSTRACT
Cadmium (Cd) is an environmental pollutant due to its widespread and continual
use.

Cd is generally found in low concentrations in the environment, while its

concentration in cigarette smoke is high. Although evidence demonstrates that adult
exposure to Cd causes changes in the immune system, there are limited reports in the
literature of immunomodulatory effects of prenatal exposure to Cd. This study was
designed to investigate the effects of prenatal exposure to Cd on the immune system of
the offspring. Pregnant C57Bl/6 mice were exposed to an environmentally relevant
dose of Cd (10 ppm) and the effects on the immune system of the offspring were
assessed at two time points following birth (PND 14 and 49). Thymocyte and splenocyte
phenotypes were analyzed by flow cytometry. Cytokine production of splenic T cells
was determined by ELISA. Prenatal Cd exposure increased the number of double
negative (DN; CD4-CD8-) thymocytes, specifically the DN1 subpopulation (CD44+
CD25-), at PND 14 and 49. In the spleen, prenatal Cd exposure decreased the number
of macrophages in male offspring at both time points. Cytokine analysis of splenic T
cells demonstrated that prenatal Cd exposure decreased IL-2 and IL-4 production in
female offspring at PND14. At PND49, IL-2 production remained decreased in Cdexposed females while IFN-γ production was decreased in both male and female Cdtreated offspring. These findings suggest that even a very low level of exposure to Cd
during gestation can result in long term detrimental effects on the immune system of the
offspring, and these effects are to some extent sex-specific.

Key words: cadmium, prenatal exposure, thymocytes, splenocytes, cytokines
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INTRODUCTION
Cadmium (Cd) is a heavy metal that poses a hazard to human health due to its
toxicity. There is sufficient evidence in humans to classify Cd and Cd compounds as
carcinogens based on epidemiological studies demonstrating a link between Cd and
lung, and possibly prostate, cancer (IARC, 2004). Exposure to the heavy metal and its
compounds primarily occurs in workplaces such as mining, smelting, processing, and
battery manufacturing, whereas non-occupational exposures come from various foods,
contaminated water, and tobacco smoke. Smokers generally have Cd blood levels 4-5
times those of non-smokers (Elinder et al., 1976).
Cd levels in the environment vary widely due to its ability to be transported
through air, water, and soil. Humans normally absorb Cd into the body either by
ingestion or inhalation (Lauwerys et al., 1986). The daily intake is estimated to be
approximately 10–50 µg, but can reach levels of 200–1000 µg in highly contaminated
areas (Nordberg, 2006). The average Cd intake from food generally varies between 825 µg per day (Olsson et al., 2002), while a cigarette contains 1-2 µg. Cd levels in soils,
particularly areas in which phosphate fertilizers have been applied, can range from 10 to
200 µg/g (Cook, 1995).
As a result of humans not having an effective Cd elimination pathway, the
biologic half-life of Cd in the body is estimated to be 15-20 years (Jin et al., 1998).
Excessive Cd accumulation in the body often results in diseases such as kidney failure,
respiratory disease, neurological disorders, and occasionally death (Waalkes et al.,
1992). Although pharmacokinetic studies have demonstrated that Cd does not readily
reach the fetus, it accumulates in high concentrations in the placenta (Piasek et al.,
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2001).

Teratological effects associated with Cd exposure reported for humans are

limited;

however,

maternal

exposure

to

environmental

Cd,

higher

placental

concentration (Loiacono et al., 1992), and/or fetal Cd exposure (Frery et al., 1993) has
been associated with lower birth weights in humans. Moreover, the teratological effects
of Cd in rodents have been extensively documented (Hovland et al., 1999; Scott et al.,
2005; Minetti and Reale, 2006; Jacquillet et al., 2007).
There have been numerous studies on the immunomodulatory effects of Cd in
humans and experimental animals; however, the findings remain controversial
(Descotes, 1992). This conflict amongst findings may be attributed to varying doses,
route of administration, length of Cd treatment, and sensitivity of immune systems
between different animal species. The thymus, the primary site of T-cell production, is a
target organ of Cd-induced toxicity (Morselt et al., 1988). Thymocytes mature through a
series of stages defined by expression of cell surface markers CD4 and CD8. The most
immature thymocytes are CD4-CD8- double-negative (DN). This population gives rise to
CD4+CD8+ double-positive (DP) cells, which then give rise to mature CD4+CD8- singlepositive (SP) and CD4-CD8+ SP cells. The DN population can be further subdivided in
mice based on the expression of surface markers CD25 and CD44: CD44+CD25-(DN1)
cells differentiate into CD44+CD25+(DN2) cells, which then develop into CD44CD25+(DN3) cells, which differentiate into the CD44-CD25-(DN4) population. Following
Cd-treatment, damage to the thymus as well as changes in the proliferation rate of
thymocytes in adult rats results (Morselt et al., 1988).

In adult mice, Dong (2001)

observed a decrease in DP cells. Pathak and Khandelwal (2007a) also demonstrated
that Cd exposure decreased the DP population and increased the number of DN cells.
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In vivo studies exposing adult male rats to varying concentrations of Cd (0-100 ppm)
demonstrated that lower doses of Cd inhibited humoral and cellular immune responses,
while higher concentrations had a stimulatory effect (Lafuente et al., 2004). Analysis of
oxidative stress and apoptosis showed that splenic cells appeared more susceptible
than thymus cells to the adverse effects of Cd both in vitro (Pathak and Khandelwal,
2006a; Pathak and Khandelwal, 2006b) and in vivo (Pathak and Khandelwal, 2007b).
Despite the numerous studies demonstrating the effects of Cd on the adult
immune system, there have been limited reports on the effect of Cd exposure during
gestation on the immune system of the offspring.

We have previously shown that

prenatal exposure to Cd affects thymocyte development of newborn (<12 h old)
offspring (Hanson et al, unpublished). This study was designed to investigate the
continued effects of prenatal exposure to Cd on the immune system of the offspring.
Pregnant mice were exposed to an environmentally relevant dose of Cd (10 ppm) and
the effects on the immune system of the offspring were assessed at two time points
following birth [post-natal day (PND) 14 and 49] to evaluate the effects in relation to
developmental stage. In addition, whether the observed prenatal effects on the immune
system were sex-specific was determined.
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MATERIALS AND METHODS
Breeding and Dosing Methodology
C57Bl/6 mice at 8-10 weeks of age were obtained from Hilltop Lab Animals, Inc.
(Scottsdale, PA). The C57Bl/6 strain of mouse was used for these experiments due to
its reported teratogenic susceptibility to Cd treatment (Hovland et al., 1999). Mice were
allowed to acclimate on site for at least one week. Two females were placed in a cage
with one male for 72 hours to maximize pregnancy rate. Females were inspected for a
vaginal plug and if present, this day was declared as gestational day 0. Ten dams were
used as controls, having free access to deionized distilled water (ddH20), while ten
additional dams had free access to 10 ppm of Cd as CdCl2 (Sigma-Aldrich; St. Louis,
MO) dissolved in ddH20. The dose of 10 ppm was chosen because it is the greatest
concentration that will elicit immunomodulatory effects in adult rodents without causing
systemic effects (Lafuente et al., 2003). Cd administration was stopped at birth. At
PND14 and 49, 3 offspring (at least 1 male and 1 female) selected from each of the
litters were euthanized and thymi and spleens were removed.

Mice born from a

different set of dams were euthanized at PND49 to ensure adequate sample size. The
PND14 time point was chosen to determine if any longer term effects of prenatal
exposure to Cd were evident early in life and PND49 was chosen to assess the effects
of prenatal Cd exposure at the mouse adult stage. This time point would approximate a
younger post-pubescent human which should have a fully developed robust immune
response. All offspring were weaned at PND21 and the dams were euthanized.
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Tissue Isolation and Cell Preparation
Thymi and spleens were harvested from euthanized mice and single cell
suspensions prepared. The organs from each mouse were kept separate. Red blood
cells were lysed using an ammonium chloride lysis buffer.

Viable cells were

enumerated using trypan blue and a hemacytometer.

Cd load
A group of dams whose litters were not used in the present study, but were
dosed in the same manner, were euthanized following partuition to determine Cd load.
To measure Cd content, kidney samples were dissolved in 2 ml of 70% nitric acid. The
acidified samples were neutralized in 5 ml of ddH20 and filtered through Whatman no.1
paper. Samples were then diluted to volume with ddH20 in a 25 ml volumetric flask. Cd
concentrations were measured using an inductively coupled plasma optical emission
spectrometry (ICP-OES) (model P400 Perkin Elmer, Shelton, CT). The minimum level
of detection of the ICP-OES for Cd is 2.5 ppb. The purpose of this assay was to
determine how much Cd was retained in the kidneys of the dams to verify that the dams
were consuming approximately equal amounts of water, and thus, Cd dosing was
consistent between dams.

Cell staining and flow cytometry
Single cell suspensions of thymocytes and splenocytes were prepared as
described above.

Thymocytes were stained using combinations of the following

fluorochrome directly conjugated antibodies: anti-CD45-biotin (eBioscience; San Diego,
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CA), anti-streptavidin-Pacific Blue (Invitrogen; Carlsbad, CA), anti-CD44-PE-Cy5
(eBioscience), anti-CD25-PE-Cy7 (eBioscience), anti-CD4-FITC (BD Biosciences
Pharmingen; San Jose, CA), and anti-CD8-PE (BD Biosciences Pharmingen). SP and DP
cell subpopulations were identified using anti-CD4 and anti-CD8.

To identify the

different DN subpopulations, anti-CD44 and anti-CD25 were determined on the CD4CD8- population. Splenocytes were stained using combinations of the following directly
conjugated Abs: anti-CD4-FITC (BD Biosciences Pharmingen), anti-CD8-PE (BD
Biosciences Pharmingen), anti-F4/80-APC-Alexa Fluor 750 (eBioscience), anti-Gr1Alexa Fluor 700 (eBioscience), and anti-B220-PE-Cy5 (BD Biosciences Pharmingen).
Cells (1 x 106) were stained using the following procedure: cells were washed with
PBSAz (phosphate buffered saline containing 2% FBS and 0.2% sodium azide) and
then incubated with whole rat and mouse IgG (Jackson ImmunoResearch, West Grove,
PA) for 30 min on ice to block Fc receptors, followed by a PBSAz wash. The cells were
incubated for 30 min on ice with flourochrome labeled antibodies.

The cells were

washed several times with PBSAz and fixed overnight at 4°C with 0.4%
paraformaldehyde.

The paraformaldehyde was removed and cells resuspended in

PBSAz. Stained cells were analyzed using a FACSAria and FACSDiva software (BD
Biosciences Pharmingen). A total of 10,000 events were collected for each sample.

Cytokine production
The release of Interleukin-2 (IL-2), Interleukin 4 (IL-4), Interleukin 10 (IL-10), and
Interferon-gamma (IFN-γ) in splenocytes at PND14 and PND49 was measured using
the Mouse TH1/TH2 Ready-SET-Go! ELISA set (eBioscience). Briefly, 1 x 106 cells/ml
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in RPMI media (Mediatech Cellgro; Manassas, VA) supplemented with 10% FBS were
seeded in 48-well plates and stimulated with anti-CD3 (10 µg/ml; eBioscience) and antiCD28 (10 µg/ml; eBioscience). The culture supernatant was collected 24 h after the
stimulation for the assessment of IL-2, and 72 h after the stimulation for the assessment
of IL-4, IL-10, and IFN-γ.

The concentrations of the cytokines were assessed per

manufacturer’s protocol.

Statistical Analysis
Results are expressed as mean ± S.E.M. For Figure 1, a mean of the data from
3 mice/litter was taken and used as the N=1 data for the corresponding dam. For
Figures 2-4, a mean of the data from 5-8 offspring/sex/treatment group/age group was
taken.

Statistical analyses comparing the values for a particular cell population or

cytokine concentration between Cd-exposed (single dose) and control offspring were
performed using the t-test. An alpha value of ≤0.05
p
was considered significant. All
experiments were repeated at least three times.
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RESULTS
Tissue Cd levels
The average Cd concentration for the dams was 4.37±0.76 (SEM) µg/g kidney
tissues, which demonstrates a low environmentally relevant exposure level that is
consistent between dams.

Analysis of Cd levels in the offspring were attempted;

however no Cd was detected in their kidneys, and liver Cd levels were slightly above
the minimum level of detection for the ICP-OES (2.5 ppb) when livers from 3 offspring
from Cd-treated dams were pooled. Cd was not detected in the offspring from control
dams.

This finding demonstrates that the offspring were exposed to Cd; however,

transplacental transfer was very low.

Effect of prenatal Cd exposure on thymocyte phenotype in PND14 and 49 offspring
Thymocyte phenotype of representative offspring from each litter was measured
by cell surface marker expression using flow cytometry. Total thymocyte number was
not significantly different between Cd-treated and control offspring at PND14 (25.9±3.4
x 107 vs. 23.0±3.0 x 107, respectively) or at PND49 (25.4±2.2 x 107 vs. 21.2±1.8 x 107,
respectively). At PND14, the number of DN cells was significantly increased in Cdtreated offspring compared to the control offspring [1.95±0.28 x 107 vs. 1.34±0.20 x 107
(p<0.05), respectively] (Figure 1A).

The significant increase in the DN population

persisted until PND49 [Cd-treated offspring, 2.29±0.21 x 107 DN cells vs. control
offspring, 1.80±0.12 x 107 DN cells (p<0.05)]. No other population of thymocytes was
significantly altered at either day of analysis.

Analysis of subpopulations of the DN

population at PND14 showed that Cd-treated offspring had significantly more DN1 cells
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(4.86±0.97 x106) compared to control offspring (2.80±0.41 x 106) (p<0.05) (Figure 1B).
The increase in DN1 cell number among Cd-treated offspring was still present at
PND49 [Cd-treated, 9.93±0.90 x 106 vs. control, 7.72±0.53 x 106 (p<0.05)]. The DN2
cell numbers also showed an increasing trend in Cd-treated offspring at PND14 and 49,
though the difference was not significant (p<0.06). There were no sex-specific effects
on thymocyte phenotype observed in PND14 or PND49 offspring.

Effect of prenatal Cd exposure on splenocyte phenotype in PND14 and 49 offspring
Splenocyte phenotype of representative offspring from each litter was determined
by flow cytometry using cell markers specific for CD4 and CD8 T cells, B cells,
macrophages, and granulocytes.

Total splenocyte number was not significantly

different between Cd-treated and control offspring (1.1±0.8 x 108 vs. 1.0±0.93 x 108,
respectively). The only cell type that showed a significant difference between the Cdtreated offspring and control animals was macrophage (Figure 2).

Further, this

difference only occurred in male offspring. At PND14, Cd-treated males had 0.78±0.27
x 107 macrophages while control offspring had 1.47±0.14x 107 (p<0.05) macrophages
(Figure 2A). The significant decrease in Cd-treated males was still present at PND49
[(Cd-treated, 1.35±0.22 x 107 vs. control,

2.25±0.27 x107 (p<0.05)] (Figure 2B). All

other cell populations had no significant differences between the two treatment groups.
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Effect of prenatal Cd exposure on spleen cell ex vivo cytokine production at PND14 and
49
In order to determine the effects of prenatal Cd exposure on the immune
response of offspring at PND14 and 49, production of IL-2, IL-4, IL-10, and IFN-γ by
splenic T cells was measured following stimulation with anti-CD3/28. At PND14, Cdtreated females produced significantly less IL-2 than control females [Cd-treated,
2.31±0.77 µg/ml vs. control, 7.40±1.41 µg/ml (p<0.01)] (Figure 3). IL-4 production was
also significantly decreased in Cd-treated females compared to control females [Cdtreated, 202.42±7.15 pg/ml vs. control, 299.76±17.86 pg/ml (p<0.05)] (Figure 3). Cdtreated male offspring did not demonstrate any statistically significant difference in
cytokine production at PND14, although IFN-γ was markedly decreased in Cd-treated
male offspring (p<0.06). At PND49, IL-2 production remained significantly decreased in
Cd-treated females compared to control females [Cd-treated, 3.36±1.02 µg/ml vs.
control, 8.21±1.22 µg/ml (p<0.05)] (Figure 4). IFN-γ was significantly decreased in both
Cd-treated males (Cd treated, 0.47±0.10 µg/ml vs. control, 12.52±2.48 µg/ml) and
females (Cd-treated, 3.69±0.98 µg/ml vs. control, 9.29±2.54 µg/ml) compared to control
animals (p<0.05) (Figure 4). There were no differences in IL-10 or IL-4 production in
either Cd-treated males or females at PND49. In addition, the cytokines Interleukin12p70 (IL-12p70), Tumor Necrosis Factor-α (TNF-α), Monocyte Chemoattractant
Protein-1 (MCP-1), and Interleukin-6 (IL-6) were measured but none of these cytokines
showed any difference between the Cd-treated offspring and the controls (data not
shown). Taken together, cytokine production by prenatally Cd-treated female offspring
is affected at an earlier developmental stage than their male counterparts. In female
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offspring at PND49, the data suggest that the Th1 cells (IL-2 and IFN-γ producing) are
affected, while the Th2 cells (IL-10 and IL-4 producing) are not. In the male offspring at
the same time point, there was no effect on the IL-2, IL-4, or IL-10 production, yet IFN-γ
was significantly decreased.
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Figure 1. Thymocyte phenotype of PND14 and 49 offspring. Thymocytes were
isolated from 14 and 49 day old mice that were exposed to 10 ppm Cd in utero. Single
cell suspensions were prepared for flow cytometry analysis by standard methods. Each
bar represents the mean ± SEM. Data are representative of 3 experiments where N=4
in each group (A) Thymocyte phenotype was determined based on CD4 and CD8 cell
surface expression. (B) DN subpopulation phenotype was determined based on CD44
and CD25 cell surface expression. *p<0.05
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Figure 2. Splenocyte phenotype of PND14 and 49 offspring. Spleen cells were
isolated from 14 (A) and 49 (B) day old mice that were exposed to 10 ppm Cd in utero.
Single cell suspensions were prepared for flow cytometry analysis by standard
methods. Flow cytometric analysis was performed by staining splenocytes with antiCD4, anti-CD8, anti-B220 (B cells), anti-F4/80 (macrophages), and anti-Gr-1
(granulocytes). Each bar represents the mean ± SEM. Data are representative of 3
experiments where N=5-8 offspring/sex/treatment group/age group. *p<0.01
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Figure 3. Cytokine expression of splenic T cells on PND14. Spleen cells were
isolated from 14 day old mice that were exposed to 10 ppm Cd in utero. Cells were
stimulated with anti-CD3/CD28 for 24h (IL-2) or 72h (IFN-γ, IL-10 and IL-4).
Supernatants were analyzed for cytokine expression by ELISA kits. Limit of detection:
IL-2 (2 pg/ml), IFN-γ, (15 pg/ml), IL-10 (30 pg/ml), IL-4 (4 pg/ml). Each bar represents
the mean ± SEM.

Data are representative of 3 experiments where N=5-8

offspring/sex/treatment group. *p<0.05, **p<0.01
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Figure 4. Cytokine expression of splenic T cells on PND49. Spleen cells were
isolated from 49 day old mice that were exposed to 10 ppm Cd in utero. Cells were
stimulated with anti-CD3/CD28 for 24h (IL-2) or 72h (IFN-γ, IL-10 and IL-4).
Supernatants were analyzed for cytokine expression by ELISA kits. Limit of detection:
IL-2 (2 pg/ml), IFN-γ, (15 pg/ml), IL-10 (30 pg/ml), IL-4 (4 pg/ml). Each bar represents
the mean ± SEM.

Data are representative of 3 experiments where N=5-8

offspring/sex/treatment group. *p<0.05
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DISCUSSION

Immunotoxicity after Cd exposure in adult animals is well documented; however,
reports concerning the effect of Cd exposure during gestation on the immune system
are limited.

We have previously demonstrated that prenatal Cd exposure alters

thymocyte development in offspring at PND0 (Hanson et al, unpublished), while another
study showed that proliferative responses of spleen cells to mitogens and activity of
peritoneal macrophages were increased, and delayed type hypersensitivity to sheep red
blood cells after immunization was decreased, in prenatal Cd-exposed offspring
(Soukupova et al., 1991).

Due to organogenesis of the immune system occurring

mostly at the prenatal, and to a lesser extent, at the early postnatal stage, the perinatal
period is not only more sensitive to deleterious effects of immunotoxicants, but
alterations in the immune system can result in persistent effects (Holladay and
Smialowicz, 2000).

Exposure to toxic agents such as halogenated aromatic

hydrocarbons (HAHs), polycyclic aromatic hydrocarbons (PAHs), hormonal substances,
and heavy metals during the developmental period can result in a range of functional
defects in adulthood, including suppression of the immune system (Blaylock et al.,
1992; Keil et al., 2008), hypersensitivity (Miller et al., 1998), and autoimmune disease
(Snyder et al., 2000; Mustafa et al., 2008). In vitro studies have demonstrated that Cd
causes oxidative stress and apoptosis in adult mouse T- and B-cells (Pathak and
Khandelwal, 2006b; Pathak and Khandelwal, 2006a), as well as macrophages (Kim and
Sharma, 2006). The thymus is an important primary lymphoid organ where successive
stages of cell development and selection produce functionally competent T cells from
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immature precursor cells. Several in vivo studies demonstrated that adult exposure to
Cd is able to cause significant weight decrease or atrophy of the thymus in mice using a
wide range of doses (Borgman et al., 1986; Mackova et al., 1996; Liu et al., 1999). In
addition, in vitro studies have demonstrated that exposure to Cd results in apoptosis
and phenotypic changes in thymocytes from adult mice (Dong et al., 2001; Pathak and
Khandelwal, 2007a). The present analysis of offspring thymocyte phenotype following
prenatal Cd exposure demonstrates an increase in the DN population, which is in
agreement with previous reports of Dong (2001) and Pathak (2007a). Examination of
the four DN subpopulations demonstrates that the earliest stage in thymocyte
development, DN1, was significantly increased after prenatal Cd exposure at both
PND14 and 49. We have previously shown a link between prenatal Cd exposure and
dysregulation of the sonic hedgehog (Shh) and Wnt/β-catenin signaling pathways in the
thymus at PND0 (Hanson et al, unpublished). Both of these pathways are needed for
differentiation of DN1 cells to DN2 cells, therefore a continued perturbation of these
pathways at PND14 and 49 may be responsible for the altered thymocyte phenotype.
In vitro and in vivo studies in adult mice have shown that splenocytes are more
sensitive to Cd treatment than are thymocytes (Pathak and Khandelwal, 2006b; Pathak
and Khandelwal, 2006a; Pathak and Khandelwal, 2007b). Although we did not observe
a significant decrease in the total number of splenocytes in prenatally Cd-treated
offspring, an analysis of splenocyte phenotype demonstrated that the macrophage
population was decreased in Cd-treated offspring. More strikingly, this effect was only
present in male offspring. In vivo studies by others indicate that chronic Cd exposure
alters the redox balance in adult male mice, inducing changes in lipid metabolism in
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macrophages, ultimately leading to apoptosis (Ramirez and Gimenez, 2002).

In

addition to being antigen presenting cells and phagocytes, macrophages can recognize
tumor cells and induce cell death by releasing cytotoxic factors such as reactive oxygen
and/or nitrogen intermediates, as well as cytokines; thus, the decrease in macrophage
number in prenatal Cd-treated male offspring may increase susceptibility of males to
tumor incidence. Further studies will have to be conducted to understand the
mechanism of this cell type-, sex-specific effect.
Since cytokines influence or control most immune responses, cytokine production by
splenic T cells of offspring following prenatal Cd exposure was determined. In vitro
studies have suggested that Th1 type cytokines (IL-2, IFN-γ) are depressed to a higher
degree than Th2 type cytokines (IL-10, IL-4) following Cd treatment (Krocova et al.,
2000; Hemdan et al., 2006; Pathak and Khandelwal, 2007a). Studies demonstrating
that a decrease in Shh signaling in peripheral CD4+ T cells down-regulates the
synthesis of IL-2 and IFN-γ (Stewart et al., 2002) and that prenatal Cd exposure
decreases Shh signaling in the thymus of offspring at PND0 (Hanson et al,
unpublished), led to the hypothesis that Th1 cells in the spleen would be more sensitive
to prenatal Cd exposure than Th2 cells. Analysis at PND14 demonstrated that cytokine
production (IL-2 and IL-4) was only decreased in females. Analysis at PND49 revealed
a dramatic Th1 type (IL-2 and IFN-γ) cytokine decrease by T cells from female offspring,
as well as a decrease in IFN-γ secretion by T cells from male offspring. The IL-4 levels
at PND14 reached comparable levels to control females by PND49, thus this cytokine
may be affected in early development but returns to normal levels as the immune
system reaches maturity.

Mouse studies evaluating sex differences following Cd
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exposure are sparse.

In humans, although no studies have been designed to

investigate sex differences directly, related studies have shown that Cd-associated
health effects are more frequent among women than men (Vahter et al., 2002).

This

may be due to a higher Cd body burden in women, reflected as higher Cd levels in
blood, urine, and kidney cortex (Vahter et al., 2007). The main reason for the higher
body burden in women is increased intestinal absorption of dietary Cd at low iron stores
(Akesson et al., 2002; Kippler et al., 2007). Cd and iron compete with one another for
transport into the mucosa cell via the divalent metal transporter 1 (DMT-1). When a
woman is pregnant, enterocytes have an increased DMT-1 density at the apical surface
to increase absorption of micronutrients, thus Cd absorption is increased during
pregnancy (Akesson et al., 2002; Vahter et al., 2007). It has been reported that 90% of
patients with Itai-Itai disease, the most severe form of chronic Cd intoxication in
humans, were postmenopausal women (Jarup et al., 1998). This is due to Cd’s ability
to disrupt calcium homeostasis caused by estrogen depletion during menopause or
following ovariectomy (Jarup et al., 1998).

Another reason for sex-differences in

susceptibility to Cd-induced toxicity may be attributed to Cd having estrogenic effects
(Garcia-Morales et al., 1994; Stoica et al., 2000; Sogawa et al., 2001; Choe et al., 2003;
Johnson et al., 2003). Following in utero exposure to Cd, female offspring experienced
an earlier onset of puberty and an increase in the epithelial area and the number of
terminal end buds in the mammary gland (Johnson et al., 2003). In addition, in vivo
studies using adult female rats suggest that females may be at a greater risk than males
for Cd-induced immunomodulation due to interactions between estrogen and Cd (Pillet
et al., 2006). Pathak and Khandelwal (Pathak and Khandelwal, 2007a) demonstrated
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that IFN-γ is inhibited at a lower Cd concentration than IL-2 in adult male mice, so if
female offspring have a higher body burden or are more sensitive to prenatal Cd
treatment, then a higher dose of Cd may be necessary to elicit a decrease in IL-2 in
male offspring, thus explaining the lack of effect on IL-2 production, but decreased IFN-γ
production in male offspring in the present study.
The immunomodulatory effects of prenatal Cd exposure observed in this study may
provide insight as to why children of women who smoke during pregnancy have an
increased risk for developing cancer later in life. Several studies have indicated that
smoking while pregnant increases the risk of certain types of childhood cancers, such
as leukemias, lymphomas, and central nervous system tumors, in the prenatally
exposed offspring (Filippini et al., 1994; Filippini et al., 2000; Schuz et al., 2001; Brooks
et al., 2004). In the U.S., more than a million newborns are exposed to cigarette smoke
during gestation (DHHS, 2000). A single cigarette typically contains 1-2 µg of Cd. When
burned, Cd is present at a level of 1,000-3,000 ppb in the smoke (ATSDR, 1999).
Approximately 40 to 60% of the Cd inhaled from cigarette smoke is able to pass through
the lungs and into the body (Sahmoun et al., 2005). This means that for each pack of
cigarettes smoked, a person can absorb an additional 1-3 µg of Cd in addition to the
amount taken in from other sources in one’s daily life. Assuming that adult mice drink
approximately 3 ml of water/day, the concentration of Cd being ingested by mice in the
present experiment is nearly equivalent to the concentration of Cd that would be inhaled
from smoking 1 pack of cigarettes/day. A study in which pregnant mice were exposed
to a low concentration of mainstream cigarette smoke throughout gestation increased
the incidence and growth rate of EL-4 induced tumors in male offspring, as well as
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reduced cytotoxic T lymphocyte activity in male offspring at 5 and 10 weeks after birth
(Ng et al., 2006).

Ng et al. (2006) findings support epidemiologic data indicating that

children of mothers who smoke during pregnancy have a greater risk of developing
cancer later in life. The decreased macrophage number, as well as decreased IFN-γ
production in male offspring in the present study may explain the increased
susceptibility to tumor incidence and growth in male offspring exposed to cigarette
smoke in utero.
In summary, we have demonstrated that prenatal exposure to environmentally
relevant Cd levels causes persistent immunomodulatory effects in murine offspring.
Thymocyte phenotype analysis determined that these effects are cell type-specific,
whereas analysis of splenocyte phenotype demonstrates a cell type- and sex-specific
effect. The cytokine profiles suggest an effect on peripheral Th1 cells in females and to
a lesser degree in males. Others have noted different effects in the offspring of animals
prenatally exposed to Cd, such as postaxial forelimb ectrodactyly (Scott et al., 2005),
and delayed effects on renal function (Jacquillet et al., 2007) and sensorimotor
developmental (Minetti and Reale, 2006), but this is the first report of such an effect on
immune cell phenotype and function. The decrease in Th1 type cytokine production in
females and the decreases in IFN-γ production and macrophage cell number in males
may lead to increased susceptibility of the offspring to infections and tumor growth.
These findings suggest that even very low exposure to Cd during gestation may result
in long term detrimental effects on the immune system of the offspring, possibly
resulting in cancer at adulthood, thus reinforcing that exposure to Cd during pregnancy
should be limited.
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GENERAL DISCUSSION I
The overall objective of this dissertation was to determine the effect of prenatal
Cd exposure on the immune system. Specifically, our experiments were designed to
investigate the effect of prenatal Cd exposure on thymocyte development, and to
determine if these effects were linked to dysregulation of the Shh and Wnt/β-catenin
pathways in the thymus. In addition, longer term effects of prenatal Cd on the immune
system were investigated. Studies demonstrating a dysregulation of Shh (Scott et al.,
2005) and Wnt/β-catenin (Thompson et al., 2008) signaling by prenatal Cd exposure,
coupled with the requirement of Shh (Outram et al., 2000) and Wnt/β-catenin
(Oosterwegel et al., 1991; Verbeek et al., 1995; Hattori et al., 1996; Ioannidis et al.,
2001) in thymocyte development, led to the overall hypothesis that prenatal Cd
exposure dysregulates these signaling pathways in the thymus of the offspring, leading
to changes in thymocyte phenotype, ultimately resulting in long term immunomodulatory
effects.
It is well established that Cd exposure in adults results in immunotoxic effects
(Descotes, 1992); however, studies on the effect of prenatal Cd exposure on the
immune system of offspring are limited (Soukupova et al., 1991). In the U.S., more than
a million newborns are exposed to cigarette smoke during gestation (DHHS, 2000).
Cigarette smoke contains 1,000-3,000 ppb Cd. Several studies have indicated that
smoking while pregnant increases the risk of certain types of childhood cancers, such
as leukemias, lymphomas, and central nervous system tumors, in the prenatally
exposed offspring (Filippini et al., 1994; Filippini et al., 2000; Schuz et al., 2001; Brooks
et al., 2004). To an even greater extent, studies have linked maternal smoking with

192

respiratory disease, asthma and/or atopy in the offspring (Hu et al., 1997; Alati et al.,
2006; Jaakkola et al., 2006; Pattenden et al., 2006; Raherison et al., 2007), thus it is
critical to elucidate Cd’s role in these immunomodulatory effects. In this discussion, I
will focus on the immunomodulatory effects of prenatal Cd exposure assessed at three
developmental stages (PND0, 14, and 49) in murine offspring.

In addition, I will

describe a mechanism for the observed effects on PND0, and hypothesize possible
mechanisms for the cell type-, sex- specific effects observed on PND14 and 49.
The focus of Chapter 2 of this dissertation addressed the effect of prenatal Cd
exposure on thymocyte development in offspring at PND0.

We hypothesized that

prenatal Cd exposure alters thymocyte development due to a dysregulation in Shh and
Wnt/β-catenin signaling. In order to understand how we arrived at this hypothesis, a
brief review of the data leading up to this is required.
The thymus is a target organ of Cd-induced toxicity. Cd-treatment of adult rats
results in damage to the thymus as well as changes to the proliferation rate of
thymocytes (Morselt et al., 1988).

Several in vivo studies demonstrated that adult

exposure to Cd is able to cause significant weight decrease or atrophy of the thymus in
mice using a wide range of doses (Borgman et al., 1986; Mackova et al., 1996; Liu et
al., 1999). To our knowledge, there have been no studies that have examined the effect
of in vivo Cd exposure on thymocyte phenotype. Studies that have examined the effect
of direct in vitro Cd exposure on thymocyte phenotype, however, report a decrease in
DP cells (Dong et al., 2001; Pathak and Khandelwal, 2007), an increase in DN cells
(Pathak and Khandelwal, 2007), and a decrease in the CD4+/CD8+ ratio (Dong et al.,
2001; Pathak and Khandelwal, 2007).
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The Hedgehog (Hh) and Wnt family proteins act as morphogens during
thymocyte development. Shh signaling, is critical in the development of thymocytes and
T-cell activation (Shah et al., 2004). Shh proteins act as regulators at several stages of
T-cell development in the thymus. Analysis of Shh-/- thymi showed that Shh is necessary
for efficient proliferation of DN thymocytes (Shah et al., 2004). One study analyzing
Shh’s role in the development of SP cells, showed that Shh signaling in developing
thymocytes influences TCR repertoire selection and differentiation from DP to SP cells
(Rowbotham et al., 2007).

Specifically, in Shh-/- fetal thymic organ cultures, the

CD4+/CD8+ ratio was increased.

In addition to Hh proteins, the Wnt family of

glycoproteins is involved in regulating thymocyte maturation (Staal et al., 2001). Wnt
proteins are secreted morphogens that are involved in a variety of cell activities in
development. Wnt signals are transduced through at least three different signaling
pathways; however, the canonical β-catenin/T-cell factor-lymphoid enhancer factor
(TCF-LEF) primarily functions during thymocyte development.

Inhibition of the Wnt

pathway results in reduced DN proliferation and differentiation, decreased DP survival
(Verbeek et al., 1995; Okamura et al., 1998; Schilham et al., 1998), and decreased
CD8+ generation (Mulroy et al., 2003).
Several studies have shown that prenatal Cd exposure dysregulates Shh
signaling (Scott et al., 2005; Yu et al., 2006) and adult Cd exposure dyregulates Wnt/βcatenin signaling (Prozialeck et al., 2003; Thevenod et al., 2007; Thompson et al.,
2008). Scott et al. (2005) demonstrated that administration of CdSO4 to C57Bl/6 mice
at day 9.5 of gestation induces postaxial forelimb ectrodactyly in the offspring. This
development malformation was due to Cd disrupting Shh signaling in the mouse limb

194

bud. Although Shh signaling was decreased as measured by Shh-Light 2 cells, Shh
transcription and translation was not affected, which led Scott et al. (2005) to propose
that prenatal Cd exposure affects the processing of Shh in the cells in which it is made.
Yu et al. (2006) quantified in vivo changes in Shh expression during early development
in a green fluorescence protein transgenic zebrafish line following Cd exposure. The
study showed that embryos affected by Cd-exposure demonstrated a down-regulation
in Shh expression as determined by a decrease in the number of GFP-expressing cells
measured by flow cytometry, and a decrease in expression of a downstream target of
the Shh signaling pathway.
Prozialeck et al. (2003) demonstrated that Cd exposure in adult male SpragueDawley rats affects cadherin-dependent junctions in the proximal tubule epithelium,
resulting in changes in localization of β-catenin. Thevenod et al. (2007) followed up this
study with data proving that Cd induces nuclear translocation of β-catenin in proximal
tubular cells, using a rat renal proximal tubule cell model. In addition, Thompson et al.
(2008) demonstrated that Cd exposure induced nuclear translocation of β-catenin in
peridermal and ectodermal cells when administered to post-gastrulation chick embryos.
Based on the aforementioned data that demonstrates an effect of adult Cd
exposure on thymocyte development, a requirement of Shh and Wnt/β-catenin signaling
for proper thymocyte development, and an effect of Cd exposure on Shh and Wnt/βcatenin signaling, we proposed to determine the effects of prenatal Cd exposure on
thymocyte development, and to link those effects to a dysregulation in Shh and Wnt/βcatenin signaling.

The data indicated that prenatal Cd exposure dysregulates two

signaling pathways in the thymus, resulting in altered thymocyte development in murine
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offspring at birth.

To determine effects on thymocyte development, thymocyte

phenotype was analyzed by flow cytometry. We showed that prenatal Cd exposure
increased the DN4 subpopulation and the CD4+ cell population. Further, a significant
increase in CD4+ cells and a trended decrease in CD8+ cells resulted in an approximate
10-fold increase in the CD4+/CD8+ ratio. In contrast to our findings, Dong et al. and
Pathak and Khandelwal (2007) showed that in vitro Cd exposure decreased the
CD4+/CD8+ ratio, however, the relevance of these studies to the interpretation of those
reported herein is questionable because of the differences in experimental design such
as in vitro vs. in vivo exposure, Cd dose, length of exposure, mouse strain, and
developmental stage of the exposed cells. In addition, in vitro exposure would not
account for possible effects on the thymic epithelium in addition to the thymocytes,
which could have a significant impact on the phenotype. In our study, thymocytes were
exposed to an indirect, environmentally relevant concentration of Cd. Although Cd was
detected in pooled livers of the offspring, the level was close to the minimum level of
detection, thus we believe that any possible direct Cd effect is minimal to nil. The
increased CD4+/CD8+ ratio observed in our study could have several consequences in
cell-mediated immunity and T-cell host response to infection in the offspring, including
an increased chance of developing autoimmune disease and allergies, as well as an
increased susceptibility to viruses and tumor cells.
To determine the mechanism for altered thymocyte development by prenatal Cd
exposure, we analyzed several components of the Shh and Wnt/β-catenin pathways.
Using the Gli:luciferase reporter cell line, Shh-Light 2, we observed an approximate
24% decrease in Shh signaling in the Shh-producing TECs, although this was not due
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to a decrease in Shh or Gli1 protein levels. A decrease in mRNA level of Shh target
gene Wnt10b in TECs further demonstrated a decrease in Shh signaling. Analysis of
Shh target genes, Ptc1 and Gli1 in Shh-receiving thymocytes, showed that prenatal Cd
exposure increased expression of Shh target genes, Gli1 and Ptc1, in DN and CD8+
thymocytes, despite decreased Shh signaling in TECs. Based on our data and findings
of others that suggest cells near the source of Shh secretion can modulate the range of
the signal by upregulating their expression of Ptc, which can sequester Shh and thereby
prevent it from spreading further (Chen and Struhl, 1996), we hypothesized that in an
environment where Shh signaling is decreased, DN and CD8+ cells may upregulate
Ptc1 in order to sequester the limited signal, and this would contribute to the
upregulation

of Gli1 transcription.

Analysis of thymocyte phenotype showed a

significant increase in the DN4 cell population as well as a trended increase in the DN3
cell population, thus, increased Shh signaling in the DN population may contribute to
increased proliferation of these DN subpopulations. The role that Shh signaling plays in
single positive cells has not been well defined, however, one study showed that Shh
signaling in developing thymocytes influences TCR repertoire selection and
differentiation from DP to SP cells (Rowbotham et al., 2007). Specifically, in Shh-/- fetal
thymic organ cultures, the CD4+/CD8+ ratio was increased, therefore, the decreased
Shh signal from TECs in the present study is likely contributing to the increased
CD4+/CD8+ ratio observed in prenatal Cd-treated offspring. In addition, the increased
transcription of Ptc1 and Gli1 in CD8+ and no change in these genes in CD4+ cells may
also contribute to the significantly increased CD4+/CD8+ ratio observed in thymocyte
phenotype analysis.
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Our data also showed that Wnt/β-catenin signaling was decreased in thymocytes
as determined by an increase in phospho-β-catenin in the cytoplasm and a decrease in
ABC in the nucleus; however, this decrease was not due to a decrease in Wnt10b
protein level in the TECs. Analysis of Wnt/β-catenin target genes, c-fos, c-jun, and cmyc, showed that mRNA levels were affected differentially among thymocyte
populations. There was an overall upregulation of these genes in all of the thymocyte
populations except the CD8+ population. Interestingly, thymocyte phenotype analysis
showed that this was the only population that had a trended decrease following prenatal
Cd exposure. Although c-fos, c-jun, and c-myc are known Wnt/β-catenin target genes,
it is unlikely that their upregulation is due to an increase in ABC levels since prenatal Cd
exposure caused a decrease in ABC and an increase in phospho-β-catenin protein
levels in total thymocytes when analyzed. There are many proteins that are involved in
β-catenin regulation, such as the destruction complex in the cytoplasm and inhibitory
proteins in the nucleus, therefore one or a combination of those proteins may be
affected by prenatal Cd exposure and contributing to our observed results.
Our data demonstrating the effect of prenatal Cd exposure on Shh and Wnt/βcatenin signaling implies that prenatal Cd exposure affects the processing and/or
secretion of Shh and Wnt proteins in the thymic epithelium resulting in an attenuated
signal in both pathways. In order for Shh and Wnt proteins to inititate proper signaling,
they must go through a series of processing steps prior to secretion that involve multiple
proteins. Any one of these steps could be a target of Cd, thus, furthur investigation
should be conducted in order to elucidate this mechanism. Our results also imply that
each thymocyte population responds uniquely to the decreased signals, as
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demonstrated by varying target gene expression.

One hypothesis for the altered

signaling in thymocytes is that prenatal Cd is affecting Zn levels. Studies have shown
that detrimental fetal effects have been attributed to Cd affecting Zn transportation from
dam to fetus by the inhibition of transport proteins, thus decreasing Zn concentration in
the fetal liver and placenta (Sowa and Steibert, 1985; Baranska-Gachowska et al.,
1987). However, a study that used the same dose of Cd (10 ppm), the same strain of
mouse (C57Bl/6), and the same day of analysis (PND0) as the study in Chapter 2,
demonstrated that prenatal Cd exposure increased the hepatic and renal Zn
concentration in the offspring, suggesting that the Zn deficiency may not be the only
explanation for the effect of prenatal Cd (Ishitobi and Watanabe, 2005). To date, there
have been no analyses of thymic Zn concentration following Cd exposure at any
developmental stage. There is a requirement for Zn in the Shh (Hall et al., 1995;
Koebernick and Pieler, 2002) and Wnt/β-catenin (Chen et al., 2009) pathways, therefore
if prenatal Cd is disrupting Zn homeostasis in the thymus, it is likely that these pathways
would be affected.
Another hypothesis for a mechanism that may contribute to Cd’s effect on Shh
and Wnt/β-catenin signaling, involves activation of cellular protein kinases resulting in
enhanced phosphorylation of transcription factors.

Kinases activated following

exposure of cells to Cd include protein kinase C (Beyersmann et al., 1994; Yu et al.,
1997; Watkin et al., 2003), tyrosine kinase and casein kinase II (Saydam et al., 2002),
stress activated protein kinase (Ding and Templeton, 2000), and the mitogen activated
protein kinase family (LaRochelle et al., 2001). In the Wnt/β-catenin pathway, CKI and
GSK3β are responsible for phosphorylating β-catenin, thus targeting it for ubiquitination
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and degradation. Activation of these kinases would explain our findings of increased
phospho-β-catenin in the cytoplasm and decreased active β-catenin in the nucleus of
prenatal Cd-treated offspring.

In the Shh pathway, protein kinase A (PKA) is

responsible for phosphorylating Gli 2/3, thus targeting them for proteolytic processing to
their smaller, repressor form. Activation of PKA would explain our finding of decreased
transcription of Shh target gene, Wnt10b, in the thymus of prenatal-Cd treated offspring.
Due to the combined complexity of each of the pathways and the reported effects of Cd
on specific components of the pathways, a more global analysis of gene expression in
each of the thymocyte populations should be undertaken so that the effect of prenatal
Cd exposure on the Shh and Wnt/β-catenin pathways can be thoroughly elucidated.
The focus of Chapter 3 of this dissertation addressed the effect of prenatal Cd
exposure on postnatal immune cell development and function. Due to organogenesis of
the immune system occurring mostly at the prenatal, and to a lesser extent, at the early
postnatal stage, the perinatal period is not only more sensitive to deleterious effects of
immunotoxicants, but alterations in the immune system can result in persistent effects
(Holladay and Smialowicz, 2000), therefore, we hypothesized that the effects on
thymocyte development observed on PND0 would lead to continued effects on
thymocyte and splenocyte development, as well as immune cell function at later
developmental stages (PND14 and PND49). The data indicated that even a very low
level of exposure to Cd during gestation can result in long term detrimental effects on
the immune system of the offspring, and these effects are to some extent sex-specific.
Prenatal Cd exposure increased the number of double negative (DN; CD4-CD8-)
thymocytes, specifically the DN1 subpopulation (CD44+CD25-), at PND14 and 49. This
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finding implies that prenatal Cd exposure has a continued effect on the thymus of
exposed offspring. Due to the low transplacental transfer of Cd (Piasek et al., 2001), it
is unlikely that we are observing a continued direct effect of Cd, thus we consider the
effect to be immunoteratogenic. Analysis of splenocyte phenotype showed that prenatal
Cd exposure decreased the number of macrophages, albeit only in males at PND14
and 49.

This finding suggests that prenatal Cd exposure exerts a cell-type-, sex-

specific effect in the spleen of exposed offspring. Moreover, this is a persistent effect.
In vivo studies by others indicate that chronic Cd exposure alters the redox balance in
adult male mice, inducing changes in lipid metabolism in macrophages, ultimately
leading to apoptosis (Ramirez and Gimenez, 2002).

In addition to being antigen

presenting cells and phagocytes, macrophages can recognize tumor cells and induce
cell death by releasing cytotoxic factors such as reactive oxygen and/or nitrogen
intermediates, as well as cytokines; thus, the decrease in macrophage number in
prenatal Cd-treated male offspring may increase susceptibility of males to tumor
incidence. An analysis of macrophage function in male offspring should be conducted
as well as additional studies to understand the mechanism of this cell type-, sex-specific
effect.
Data on cytokine production on PND14 demonstrated that cytokine production
(IL-2 and IL-4) was only decreased in females. Analysis at PND49 showed a dramatic
Th1 type (IL-2 and IFN-γ) cytokine decrease by T cells from female offspring, as well as
a decrease in IFN-γ secretion by T cells from male offspring.

The IL-4 levels at PND14

reached comparable levels to control females by PND49, thus this cytokine may be
affected in early development but returns to normal levels as the immune system
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reaches maturity.

In vitro studies have suggested that Th1 type cytokines (IL-2, IFN-γ)

are depressed to a higher degree than Th2 type cytokines (IL-10, IL-4) following Cd
treatment (Krocova et al., 2000; Hemdan et al., 2006; Pathak and Khandelwal, 2007),
thus, our findings are to some extent, in support of the in vitro findings. Mouse studies
evaluating sex differences following Cd exposure are limited; however, in vivo studies
using adult female rats suggest that females may be at a greater risk than males for Cdinduced immunomodulation due to interactions between estrogen and Cd (Pillet et al.,
2006).

In addition, a finding that demonstrated Cd having a hierarchical effect on

cytokine production in males may explain why males had decreased IFN-γ production
but IL-2 was not affected.

Pathak and Khandelwal (2007) demonstrated that IFN-γ is

inhibited at a lower Cd concentration than IL-2 in adult male mice, so if female offspring
in our study have a higher body burden or are more sensitive to prenatal Cd treatment,
then a higher dose of Cd may be necessary to elicit a decrease in IL-2 in male offspring.
Based on the data detailed in Chapters 2 and 3 of this dissertation, and data
demonstrating addition of neutralizing anti-Shh antibody to anti-CD3/CD28 stimulated
CD4+ T cell cultures reduced IL-2 and IFN-γ production, but not IL-10 production
(Stewart et al., 2002), we hypothesize that the changes in splenic T cell cytokine
production are linked to changes in morphogen signaling.
Since cytokines influence or control most immune responses, the decrease in
Th1 cytokines caused by prenatal Cd exposure may increase the offspring’s
susceptibility to bacterial and viral infections. Adult Cd exposure has also been shown
to decrease host resistance in mice caused by viruses [murine coxsakie B3 virus (Ilback
et al., 1995; Glynn et al., 1998) and the enterovirus, encephalomyocarditis (Gainer,
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1977)], bacteria [E.coli (Cook et al., 1975), Listeria monocytogenes (Simonyte et al.,
2003) and Mycobacterium bovis

(Bozelka and Burkholder, 1979)], and parasites

[Hexamita muris (Exon et al., 1975)]. The decrease in Th1 type cytokine production in
females and the decreases in IFN-γ production and macrophage cell number in males,
in our study, may lead to increased susceptibility of the offspring to infections and tumor
growth, therefore; examination of host resistance in offspring exposed prenatally to Cd
will be an important area of analysis.
In summary, data presented in this dissertation indicate that prenatal Cd
exposure dysregulates two morphogen pathways required for proper thymocyte
development, resulting in altered thymocyte phenotype in offspring on PND0. Further,
modifications in thymocyte phenotype remained present in offspring at the adult stage,
in addition to changes in spleen cell phenotype and function. These findings suggest
that the defect caused by prenatal Cd exposure may be permanently encoded into the
offspring and extends to secondary lymphoid organs.

Therefore, even very low

exposure to Cd during gestation may result in long term detrimental effects on the
immune system of the offspring, possibly resulting in susceptibility to infections and
disease at adulthood, thus reinforcing that exposure to Cd during pregnancy should be
limited. The findings detailed in this dissertation are novel in that they are the first to: 1)
demonstrate that prenatal exposure to Cd affects thymocyte development throughout
post-natal development; 2) show that prenatal Cd dysregulates Wnt/β-catenin signaling
in a mouse model, and 3) observe a sex-specific effect on immune cell phenotype and
function following prenatal Cd exposure.

The data presented herein provide a

mechanism for prenatal Cd’s effect on thymocyte development in offspring observed on
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PND0. This mechanism may be applicable to other detrimental effects of prenatal Cd
exposure. In addition to the thymus, Hh and Wnt/β-catenin signaling is necessary for
proper development of the kidney (Stark et al., 1994; Kang et al., 1997), bone (Gao et
al., 2001; Gong et al., 2001; Loughlin et al., 2004), lung (Pepicelli et al., 1998; Tebar et
al., 2001; Mucenski et al., 2003; Okubo and Hogan, 2004), and prostate (Podlasek et
al., 1999; Truica et al., 2000; Lamm et al., 2002; Mulholland et al., 2002; Chesire and
Isaacs, 2003; Freestone et al., 2003; Berman et al., 2004), all of which are target organs
of Cd toxicity (Bernard, 2008). Due to Hh and Wnt/β-catenin signaling being highly
conserved among organ systems, it is plausible that prenatal Cd exposure disrupts
these pathways in other organs, resulting in developmental malformations, increased
cell proliferation, and possibly cancer.
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LITERATURE REVIEW II
Propanil, or 3, 4-dichloropropionanilide (DCPA), is a post-emergent herbicide
used predominately for weed control in rice and wheat production (Dahchour et al.,
1986). In 2001, an estimate by the Environmental Protection Agency (EPA) ranked
DCPA as the 17th most used pesticide in the U.S., as a result of 50-70% of all rice
grown in the U.S. being treated with the chemical. DCPA is used mostly in southern
states along the Mississippi River and in some areas of California. The half-life of
DCPA in the environment is 1-3 days in soil and 2-3 days in water (Wauchope et al.,
1992).

Due to the short half-life and limited use of the herbicide, the majority of

exposed individuals are applicators and residents living near treated fields.
Rice and wheat crops have high levels of acylamidase activity, thus they are
resistant to DCPA’s herbicidal effects due to their ability to enzymatically detoxify the
chemical, while weeds lacking this enzyme are killed (Still and Kuzirian, 1967;
Matsunaka, 1968). In humans and animals, the most common routes of exposure are
inhalation, orbital, dermal, and to a lesser degree, oral. Following absorption, DCPA is
metabolized by acylamidase into the major metabolite 3,4-dichloroaniline (DCA)
(Williams, 1966).

Other metabolites of DCPA include 2’hydroxypropanil and

6’hydroxypropanil (McMillan et al., 1990). DCA is then metabolized to 6-hydroxy-3, 4dichloroaniline and N-hydroxy-3, 4-dichloroaniline. As a result of DCPA being readily
metabolized, detection of DCPA in the blood of rats was detectable for approximately 48
hours following exposure (Izmerov, 1984).
Studies have demonstrated that DCPA is not mutagenic (McMillan et al., 1988),
carcinogenic (EPA, 2003), or toxic to reproduction (Ambrose et al., 1972). Toxicity to
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factory workers exposed to DCPA during its production and packaging has been
reported (Morse et al., 1979). Symptoms of toxicity include blurred vision, small pupils,
chloracne, muscle weakness, fatigue, and increased salivation (Morse et al., 1979).
Animals studies have shown that manifestations of acute propanil toxicity include
central nervous system depression (Singleton and Murphy, 1973), methemaglobinemia
(Singleton and Murphy, 1973), and liver damage (Santillo et al., 1995).
DCPA has been extensively described as an immunotoxicant on both primary
and secondary immune organs. Two studies have demonstrated DCPA’s myelotoxicity
(Blyler et al., 1994; Malerba et al., 2002). Following exposure to 200 mg/kg DCPA,
myeloid stem cells were reduced as analyzed using ex vivo colony-forming assays from
bone marrow of acutely exposed C57Bl/6 mice (Blyler et al., 1994). Effects on early
erythroid stem cells observed following in vitro exposure of human umbilical cord to
DCPA supported the earlier report of myelotoxicity (Malerba et al., 2002). Erythroid
colony-forming units (CFU-E) and erythroid burst-forming units (BFU-E) had 50% of
their growth inhibited by 234 and 441 µM DCPA, respectively (Malerba et al., 2002).
Several studies have indicated that the thymus is a target of DCPA’s toxicity (Barnett
and Gandy, 1989; Cuff et al., 1996).

In acutely exposed mice, thymic atrophy is

observed approximately 2-4 days following exposure (Cuff et al., 1996). This atrophy
has been attributed to increased levels of glucocorticoids (Cuff et al., 1996; de la Rosa
et al., 2005). Following an intraperitoneal (i.p.) dose of 200 mg/kg, a reduction in thymic
weight is present until 7 days following exposure (Barnett and Gandy, 1989), at which
time the thymus has begun recovery from the atrophy (Cuff et al., 1996). The thymus
reaches full recovery after 14 days following exposure (Cuff et al., 1996). In addition, in
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vivo exposure to 200 mg/kg i.p. DCPA results in increased spleen weight (Barnett and
Gandy, 1989).
Both innate and adaptive immunities are affected by DCPA exposure.

The

innate immune system is comprised of cell types including monocytes, macrophages,
polymorphonuclear monocytes (PMN), and natural killer cells (NK), which serve as the
first line of defense against invading pathogens. Studies have demonstrated that DCPA
affects NK cells (Barnett et al., 1992; Pruett et al., 2000) and macrophages (Xie et al.,
1997; Ustyugova et al., 2007) resulting in suppressed function of both cell types. DCPA
also affects macrophage cytokine production. Thioglycollate-elicited macrophages from
mice exposed in vivo by oral gavage to 400 mg/kg, or exposed in vitro to 33.3 µM DCPA
had significantly decreased IL-6 and TNF-α production in response to LPS timulation
(Xie et al., 1997). Further, in vitro phagocytosis of Listeria monocytogenes bacteria by
macrophages is decreased by DCPA exposure (Frost et al., 2001).
The adaptive immune system is comprised of B lymphocytes (B-cells) and T
lymphocytes (T-cells).

The primary function of B-cells is to produce and secrete

antibodies. CD4+ T cells are responsible for activating and regulating cell-mediated
immune responses and the humoral immune response, while CD8+ T cells destroy
infected or transformed cells, thus they are called cytotoxic T lymphocytes (CTLs).
Analysis of B cells in the periphery following DCPA exposure showed that although
DCPA does not affect the number of B cells (Salazar et al., 2005), it does suppress
some B cell functions (Barnett and Gandy, 1989; Barnett et al., 1992). In vivo exposure
to 400 mg/kg DCPA suppresses splenic B cell proliferation following ex vivo stimulation
with the B cell mitogen LPS (Barnett and Gandy, 1989). Analysis of antibody response
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to T-dependent (TD) and T-independent type 2 (TI-2) model antigens showed that
DCPA affects these responses to a greater degree than B cell proliferation (Barnett and
Gandy, 1989; Barnett et al., 1992). DCPA has been demonstrated to decrease the TD
antibody response to sheep red blood cells (SRBC) and the TI response to DNP-Ficoll
(Barnett et al., 1992).
Studies have demonstrated that DCPA exposure results in an overall decrease in
T cell number at several developmental stages (Zhao et al., 1995). Following exposure
to 100 mg/kg DCPA, the number of all CD3+ (CD4+, CD8+, DP) and CD3- (DN) T cell
populations in the thymus were decreased (Zhao et al., 1995), with the DP population
being the most sensitive (Cuff et al., 1996). By day 7 after exposure, the percentage of
cycling thymocyte populations returns to normal, suggesting that recovery from DCPA’s
effect begins soon after exposure (Cuff et al., 1996). T cell function is differentially
affected by DCPA.

CTL function (Barnett et al., 1992) and cell mediated immune

response to Listeria monocytogenes (Watson et al., 2000) were not affected by DCPA
exposure.

However, splenic T cell cytokine production of IFN-γ, granulocyte-

macrophage colony-stimulating factor (GM-CSF), IL-2, and IL-6 were decreased in a
dose-dependent manner following in vivo and in vitro exposure to DCPA and
subsequent in vitro stimulation with concanavalin A (Zhao et al., 1998). DCPA was also
shown to suppress IL-2 production in the murine T cell lymphoma line, EL-4, and the
human T cell lymphoma line, Jurkat (Zhao et al., 1999; Brundage et al., 2004). DCPA
exposure results in both a decrease in IL-2 transcription and an increase in degradation
of IL-2 mRNA (Zhao et al., 1999). The Jurkat cell line has exhibited a greater sensitivity
to DCPA than murine T cells.

IL-2 mRNA levels were reduced by 77% 48 hours
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following in vitro exposure to 5 µM DCPA (Brundage et al., 2004). In addition, 50 µM
DCPA reduced the binding of IL-2 transcription factor, AP-1, to the DNA following one
hour of exposure (Brundage et al., 2004). AP-1 is a heterodimer of two proteins, c-jun
and c-fos. DCPA exposure decreases phosphorylation as well as protein levels of c-jun
following one hour of exposure, which implies a potential mechanism for decreased IL-2
production (Brundage et al., 2004). Analysis of electron-spin resonance showed that
DCPA affects a small component of the cell membrane, but the way in which this
disruption affects IL-2 production has yet to be elucidated (Brundage et al., 2003).
Many intracellular signaling events inhibited by DCPA exposure have one or more
calcium (Ca2+) dependent steps. It was determined that DCPA exposure suppresses
the normal elevated and sustained intracellular Ca2+([Ca2+]i) that follows internal store
depletion in the human leukemic T cell line, Jurkat, and primary BALB/c mice T cells
(Lewis et al., 2008). This inhibition of Ca2+ influx is consistent with inhibition of the Ca2+
release-activated Ca2+ (CRAC) channel. Recent findings suggest that DCPA inhibits
CRAC channels by reducing the aggregation of the Ca2+ sensor, stromal interaction
molecule 1 (STIM1) (Lewis et al, unpublished data). These data suggest that DCPA is
a novel inhibitor of STIM-1 aggregation (Lewis et al, unpublished data).
Although the immunotoxic effects of DCPA have been extensively studied, the
way in which DCPA modulates intracellular functions leading to these effects is less
understood. In order to understand the mechanism of DCPA’s intracellular toxicity, it is
necessary to determine whether the molecule actually transports into the cell. The
following study was conducted with the intent to resolve this issue.
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ABSTRACT
3,4-Dichloropropionanilide (DCPA), or propanil, a post-emergent herbicide used
on rice and wheat crops in the United States, is immunotoxic in vivo and in vitro.
Although it has been documented that DCPA exerts differential effects on specific
immune cell types and is toxic to the liver, the subcellular localization from which DCPA
modulates immune cells and hepatocytes has not been identified. In this study, Jurkat
T cells were exposed to 100 µM DCPA for 1.5 hours after stimulation with antiCD3/CD28.

Following

incubation,

the

cytosol,

membrane/organelle,

and

nuclear/cytoskeletal fractions of the cells were isolated. In addition, hepatocytes from
C57Bl/6 mice were exposed to 100 M DCP A for 1.5 hours . Following incuba tion, the
cytosol, light mitochondrial, and peroxisomal fractions of the cells were isolated. DCPA,
when present, was removed from each cell fraction by liquid-liquid extraction. The
extraction product was then analyzed for the presence of DCPA using liquid
chromatography tandem mass spectrometry (LC-MS/MS). The cellular uptake of DCPA
was monitored by detection of the molecular ion and product ion of DCPA.

The

analyses demonstrate that DCPA, a lipophilic compound, localizes primarily in the
cytosol of T cells and hepatocytes. Low levels of DCPA were detected in the light
mitochondrial fraction in the hepatocytes, while DCPA

was absent in the

membrane/organelle and nuclear/cytoskeletal fractions in T cells, and the peroxisome
fraction in hepatocytes. These results indicate that DCPA is able to cross the plasma
membrane and is accessible to intracellular immunomodulatory effectors.
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INTRODUCTION

Propanil (3,4-dichloropropionalide, DCPA) is an herbicide used extensively on
rice and wheat crops in the United States. DCPA is in the acetanilide chemical family,
and is a dichlorinated aromatic compound of low molecular weight.

The major

metabolite of DCPA is 3,4-dichloroaniline (DCA), which is mediated through an
acylamidase-catalyzed hydrolysis of the parent compound (Singleton and Murphy,
1973; McMillan et al., 1990). Individuals involved in agriculture, in particular, are at risk
for high-level exposure to DCPA. DCPA can be absorbed through the respiratory tract,
the gastrointestinal tract, and the intact skin (Richards et al., 2001). In experimental
animals, the half life of DCPA is rapid without respect to route of entry. Following a
single intraperitoneal dose of DCPA in rats, the complete elimination from the body is
within 48 to 72 hours (Izmerov, 1984). The pharmacokinetic profile of DCPA in humans
is not available in the literature.
There are well-known immunotoxic effects on various compartments of the
immune system following in vitro DCPA exposure, including T-helper lymphocytes (Cuff
et al., 1996), B lymphocytes (de la Rosa et al., 2003), and macrophages (Frost et al.,
2001).

DCPA exposure decreases contact hypersensitivity responses, reduces

proliferative responses to T-and B-cell mitogens, and impedes mixed lymphocyte
reactions (Barnett and Gandy, 1989).

Exposure to DCPA has also been found to

induce splenomegaly and thymic atrophy in a dose-dependent manner in mice at 7 days
postexposure (Barnett and Gandy, 1989). In addition to immunotoxicity, reports have
demonstrated that DCPA is hepatotoxic to humans (De Silva and Bodinayake, 1997)
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and rodents (Santillo et al., 1995).

Following absorption by mammals, DCPA is quickly

hydrolyzed, primarily to 3,4-DCA by the liver enzyme acylamidase (Williams, 1966).
DCA

is

then

metabolized

to

6-hydroxy-3,4-dicloroaniline

and

N-hydroxy-3,4-

dicloroaniline. Oxidation of DCPA occurs, most often, on the propionyl group of and at
the 6-position on the phenyl ring (McMillan et al., 1990).
Although it has been documented that DCPA exerts differential effects on
specific immune cell types and is hepatotoxic, to date, the subcellular localization from
which DCPA modulates immune cells and hepatocytes has not been examined. The
high lipophilicity of DCPA has led to the suggestion of a higher affinity of DCPA for
membranes (Corsini et al., 2007). The aim of this study is to determine the localization
of DCPA in T cells and hepatocytes following in vitro exposure.

A combination of

differential detergent fractionation (DDF) and centrifugation was used to thoroughly
separate the cellular compartments. The product from a liquid-liquid extraction was
analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Our

results demonstrate that DCPA, a lipophilic compound (Finizio, 1997), localizes
primarily in the cytosol of both T cells and hepatocytes.

This study improves our

understanding of the cellular location in which DCPA exerts its toxic effects.
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MATERIALS AND METHODS

T cell treatment with DCPA
Experiments were performed using the human T cell leukemia cell line, Jurkat
clone E6-1, obtained from the ATCC (American Tissue Culture Collection, Manassas,
VA). Jurkat cells were maintained in complete Roswell Park Memorial Institute (RPMI)
media (Mediatech Inc., Herndon, VA) supplemented with 10% heat inactivated fetal
bovine serum (v/v) (FBS) (Hyclone Inc. Logan, UT), 100 units/ml penicillin
(BioWhittaker), 100 µg/ml streptomycin (Bio Whittaker), 20 mM glutamine (BioWhittaker)
and 50 µM 2-mercaptoethanol (Sigma, St. Louis, MO). The cultures were kept at 37°C
in 5% CO 2 . Cells in suspension were grown to obtain approximately 5 x 107 cells. A 10
ml volume of cells was stimulated with anti-CD3 (10 µg/ml) and anti-CD28 (2 µg/ml) (BD
PharMingen, San Diego, CA) and at the same time exposed to 100 µM DCPA or
ethanol (vehicle control) for 1 hour (h) at 37°C, 5% CO 2 . The cells were harvested and
centrifuged at 1200 rpm for 8 minutes (min) at 4°C.

Protein Extraction by Differential Detergent Fractionation (DDF) and Centrifugation of T
cells
DDF relies on detergents to sequentially extract proteins from eukaryotic cells.
The cytosolic fraction was extracted by resuspending cells in 1 ml of 0.01% digitonin
solution and incubated on ice for 30 min. The suspension was centrifuged at 14,000 x g
for 2 min at 4°C. Digitonin interacts with cholesterol to form pores in the cell membrane
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and extract soluble proteins from the cytosol. The membrane/organelle fraction was
extracted by resuspending the pellet from the digitonin extraction step in 0.6 ml 2%
Triton-X 100 solution and incubated on ice for 1 h. The suspension was centrifuged at
14,000 x g for 10 min at 4°C.

Triton X-100 solubilizes membrane and organelle

proteins. The nuclear/cytoskeletal fraction was extracted by dissolving the pellet from
the TX-100 extraction step in 1 ml 4% CHAPS solution for 1-2 h at room temperature
(RT)

The suspension was centrifuged for 10 min at 14,000 x g at RT to remove

insoluble material. CHAPS results in the permeabilization of the nuclear envelope. The
pellet was washed with Dulbecco’s phosphate buffered saline (DPBS) after each
fraction removal to limit cross-contamination.

Western blot
Protein quantitation was determined using the 2D Quant Kit (Amersham
Biosciences). A 30 µg aliquot of each fraction sample was boiled for 5 min to denature
the proteins and electrophoresed through a 12% Tris polyacrylamide gel with a 4%
stacking gel at 15 mAmps for 18 h. Proteins were

transferred onto Hybond-P

membranes (Amersham Pharmacia, Piscataway, NJ) at 200 V, 0.5 mA for 2 h. Blots
were washed in TBS for 5 min at RT, blocked for 1 h in TBS + 0.1% Tween 20 (TBS/T)
plus 5% dry milk at RT and then washed three times in TBS/T. Blots were incubated
overnight at 4°C with primary antibodies specific for GAPDH, Oct-1, and Vdac/Porin
(Santa Cruz Biotechnology, CA) in TBS/T plus 5% BSA. The next day, blots were
washed three times in TBS/T, incubated for 1 h at room temperature with anti-Biotin
(Cell Signaling Technology, Inc., Danvers, MA) and a rabbit anti-goat IgG-HRP (Sigma-
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Aldrich). Finally, the blots were washed three times in TBS/T and developed using
Phototope-HRP detection kit for western blots (Cell Signaling Technology, Inc) and
bands were visualized on X-Ray film (BioMax MR, Eastman Kodak Company).

Mouse hepatocyte isolation
Female C57Bl/6 mice at 8-10 weeks of age were obtained from Hilltop Lab
Animals, Inc (Scottsdale, PA).

Normal mouse hepatocytes were isolated using the

method described by Muller et al. (Muller et al., 1972). All animal methods were carried
out utilizing an ACUC approved protocol. Briefly, mice were anesthetized utilizing IP
injection of Pentabarbitol (100 mg/kg). The liver was exposed and perfused with Krebs
Ringer with glucose (3.6 mg/ml) and 0.1 mM EGTA to remove the blood, while
maintaining temperature with a heating lamp. Beldzyme 3 (Roche) was then perfused
in slowly (50 ml of 0.02 mg/ml in Krebs Ringer plus glucose and CaCl 2 (1.37 mM). The
liver was gently massaged following perfusion to assist in distribution of the enzyme
solution. The liver was then carefully removed and minced in chilled perfusion buffer.
Cells were dispersed with a large bore pipette and passed through a 70 µm filter to
remove debris. Cells were washed 3 times by centrifugation (50 x g, 2 min, 4°C) with
cold culture media (DMEM supplemented with 10% FBS and 100 units/ml penicillin, 100
µg/ml streptomycin, 20 mM glutamine and 50 µM 2-mercaptoethanol). Cells were
cultured overnight on collagen coated dishes (37°C, 5% CO 2 ) prior to exposure to
DCPA.
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Peroxisome purification
Overnight cultures of isolated primary hepatocytes were incubated with 100M
DCPA or ethanol for 1.5 h at 37°C, 5% CO 2 prior to preparation of peroxisomes. Cells
were scraped from the dishes and pelleted (300 x g, 10 min, 4°C). The resulting cell
pellets were resuspended in 3 ml of ice cold homogenization buffer (HM; 9% sucrose,
1mM EDTA, 10mM Tris, 5mM MOPS, 0.1% ethanol, pH 7.2 ). The resuspended cells
were homogenized on ice using 50 strokes of a P/J homogenizer fitted with a Teflon
pestle and attached to a variable speed hand drill. The homogenate was centrifuged
(500 x g, 5 min, 4°C) and the supernatant was saved. The remaining cell pellet was rehomogenized and centrifuged. The resulting supernatant fractions were combined
(crude homogenate fractions). The crude homogenates were centrifuged in corex tubes
(6000 x g, 10 min, 4°C). The pellets were resuspended in 3 ml of ice cold HM (Pellet
#1).

The resulting supernatants (Supernatant #1) were centrifuged in corex tubes

(20,000 x g, 15 min, 4°C). The resulting supernatant was reserved (Supernatant #2Cytosol Fraction) and the pellet was resuspended in 3 ml of ice cold HM buffer (Light
Mitochondrial Fraction). The resuspended pellet was then centrifuged over a cushion of
30% Optiprep (Sigma) using a Ti50.2 rotor (40,000 x g, 3.25 h, 4°C) The pellet was then
resuspended in 600 µl of ice cold HM buffer (crude peroxisome fraction)

Mass spectrometric analysis of cell fractions
Volumes of all fractions were adjusted using PBS to achieve a protein
concentration of 0.5 µg/µl. DCPA was extracted from cell fractions using a liquid-liquid
extraction procedure as follows: 25 µl of each cell fraction was diluted to 500 µl with
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deionized water. Then, 50 µl of the internal standard acetaminophen was added at a
final concentration of 1.1 µg/ml. To the vortexed sample, 2 ml of ethyl acetate was
added and shaken vigorously. This served to partition the DCPA and acetaminophen
into the organic phase. The samples were centrifuged at 3000 rpm for 5 min at RT to
ensure separation of layers before keeping the ethyl acetate extract.

The organic

portions were dried under a stream of nitrogen and reconstituted with 100 µl of
deionized water. A 5-point standard curve of a DCPA concentration range of 5-500
ng/ml was used to estimate the quantity of DCPA in cell fractions.
LC-MS/MS was used to determine DCPA localization in cells. High performance
liquid chromatography (HPLC) separation was achieved using a reversed-phase C 8 (50
mm x 4.6 mm) column with a flow rate of 200 µl/min and a gradient as follows: 80%
mobile phase A (0.05% formic acid, aq) from 0-1.5 min; increased from 20-60% mobile
phase B (0.05% Formic acid in acetonitrile) from 1.5-3.5 min; 60% B held from 3.5-7
min; column re-equilibrated from 60-20% B from 7-9 min. Tandem mass spectrometry
operated in the positive ion mode with sheath gas (nitrogen) flow rate: 80 arbitrary (arb.)
units (with 20 arb. units auxiliary gas flow rate), spray voltage 5.2 kV, capillary voltage 9
V, and heated capillary temperature 300̊C. Acetaminophen eluted at approximately 2
min.

From 0-4 min, MS/MS was performed on m/z 152 (acetaminophen) and the

selected ion monitored (SRM) range was set for m/z 110 (fragment of acetaminophen).
From 4-10 min, MS/MS was performed on m/z 218 ± 4 amu (to encompass all ionized
forms of DCPA of m/z 216, 218, and 220). A SRM was set up with a range of m/z 162 ±
4 amu (to encompass all DCPA MS/MS fragments of m/z 160, 162, and 164,
respectively).

236

Results and Discussion

Analysis of fractionated T cells following stimulation and treatment with 100 µM
DCPA for 1.5 h demonstrated that DCPA localizes in the cytosol (Figure 1A) at a
concentration of 26.26±2.02 ng/ml (Table 1).

DCPA was not detected in the

membrane/organelle fraction (Figure 1B) or in the nuclear/cytoskeletal fraction (Figure
1C). Therefore, DCPA, a lipophilic molecule, passes through the plasma membrane
and resides in the cytosol of T cells following 1.5 h of exposure.
Analysis of fractionated hepatocytes following treatment with DCPA for 1.5 h
demonstrated that the molecule localizes mostly in the cytosol (Figure 2A) at a
concentration of 120.24±5.78 ng/ml (Table 1). DCPA was also detected in the light
mitochondrial fraction (Figure 2B), but the level was minimal relative to the level
detected in the cytosol (Table 1). There was no DCPA detected in the peroxisomal
fraction of hepatocytes (Figure 2C). Therefore, DCPA localizes predominately in the
cytosol of hepatocytes following 1.5 h of exposure.
The

greater DCPA

concentration

observed

in

the

hepatocyte

cytosol

(120.24±5.78 ng/ml) compared to that in the T cell cytosol (26.26±2.02 ng/ml) is likely
attributed to differences in cell size and cell composition. Hepatocytes are among the
largest of cells, with an average diameter of 18-22 µm. In addition, they display an
eosinophilic cytosplasm which contains numerous mitochondria. The high density of
mitochondria present in hepatocytes may contribute to identification of DCPA in those
organelles in hepatocytes and not T cells. T cells have an average diameter of 7-12 µm
with the nucleus being the major constituent of the cell, thus there is little eosinophilic
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cytoplasm. The finding that DCPA is only detected in the cytosol of T cells coupled with
the size of this constituent, suggests that DCPA’s mechanism of action has specificity.
We hypothesized that DCPA exerts its effects on immune cells and hepatocytes by
interfering with cell activation and cell signaling processes at the cell membrane, due to
DCPA being a highly hydrophilic, lipophilic compound. Our finding that DCPA is not in the
membrane does not eliminate the possibility that DCPA is affecting membrane proteins or
channels as it migrates into the cytosol. An earlier finding in our lab demonstrated that
DCPA exposure does not disrupt the motional properties of lipid hydrocarbon chains in the
bilayer, but does alter distribution of lipids in distinct motional environments in the
membrane (Brundage et al., 2003). The present study provides an explanation for the
limited effect observed in hydrocarbon chain mobility. The finding that DCPA is able to
move through the membrane of T cells and hepatocytes and localize in the cytosol will aid
in the understanding of DCPA’s mechanism of toxicity to cellular functions.
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Figure 1
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Figure 1.

Chromatograms of DCPA localization in T cells. Jurkat T cells were

stimulated with anti-CD3/CD28 and exposed to 100µM DCPA for 1.5 hours. Cells were
fractionated using DDF and centrifugation. LC-MS/MS was used to determine DCPA
location in cell fractions. Acetaminophen was used as an internal standard. Protein
concentration

of

each

fraction

was

0.5

µg/µl.

(A)

Cytosol

fraction,

(B)

Membrane/Organelle fraction, (C) Nuclear/Cytoskeleton fraction. Representative of 3
separate experiments.
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Figure 2
A
Intensity (x106)

4.2
DCPA

2.1

0

4

6

5

7

8

9

8

9

8

9

Time (min)

B
Intensity (x106)

4.2

2.1

0

DCPA

4

6

5

7

Time (min)

C
Intensity (x106)

4.2

2.1

0

4

6

5
241

7

Time (min)

Figure 2. Chromatograms of DCPA localization in hepatocytes. Primary mouse
hepatocytes were exposed to 100 µM DCPA for 1.5 hours. Cells were fractionated
using homogenization and centrifugation. LC-MS/MS was used to determine DCPA
location in cell fractions. Acetaminophen was used as an internal standard. Protein
concentration of each fraction was 0.5 µg/µl. (A) Cytosol fraction, (B) Light Mitochondrial
fraction, (C) Peroxisome fraction. Representative of 3 separate experiments.
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Table 1. DCPA concentration in T cell and hepatocyte fractions.
T cells

DCPA concentration

Hepatocytes

(ng/ml)

DCPA concentration
(ng/ml)

Cytosol

26.26±2.02

Cytosol

120.24±5.78

Membrane/organelle

0

Light mitochondrial

25.30±3.14

Nuclear/cytoskeletal

0

Peroxisomal

0

Each value is mean ± SEM, n=3
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GENERAL DISCUSSION II
The aim of the study described in the Appendix of this dissertation was to
determine the subcellular localization of the herbicide DCPA. Due to the immunotoxic
effects of DCPA on T cells (Barnett et al., 1992; Zhao et al., 1995; Cuff et al., 1996; Zhao et
al., 1998; Zhao et al., 1999; Brundage et al., 2004; Lewis et al., 2008), the localization of
DCPA in Jurkat T cells was determined. Hepatocytes were also analyzed in the study due
to the liver being the major site for metabolism of DCPA and because of reports
demonstrating that DCPA is hepatotoxic to humans (De Silva and Bodinayake, 1997) and
rodents (Santillo et al., 1995).

We hypothesized that due to DCPA’s lipophilic and

hydrophobic nature, it would localize in the cell membrane.

Analysis of the cytosol,

membrane/organelle, and nuclear fractions of T cells demonstrated that DCPA does not
reside in the membrane, but rather accumulates in the cytosol. Similarly, analysis of the
cytosol, light mitochondrial, and peroxisomal fractions of hepatocytes demonstrated that
DCPA accumulates mostly in the cytosol, while minimal levels were detected in the light
mitochondrial fraction. The results suggest that cell size and composition affects DCPA
accumulation and, to some degree, its localization. Knowing the subcellular localization of
DCPA in T cells and hepatocytes will aid in the understanding of DCPA’s mechanism of
toxicity to cellular functions.
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